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Abstract approved: 
Rainbow trout (Oncorhynchus mykiss) has been used as a model species for 
toxicology and cancer study due to  its  sensitivity to  chemicals.  Previous purified 
trout LMC5  P450 showed 6P-hydroxylation activity of steroids and cross-reacted 
with antibodies raised against human CYP3A4 on the SDS-PAGE. These findings 
suggest that rainbow trout P450 systems include CYP3A forms.  Therefore, study 
was conducted to isolate and to characterize the CYP3A forms in rainbow trout. 
A new CYP3A form containing 518  amino acids was cloned and assigned 
to  CYP3A27 by the  Cytochrome P450 Nomenclature Committee to  represent the 
first  CYP3A  subfamily  member  characterized  in  aquatic  species.  The  major 
expression site for  CYP3A27 mRNA was  intestinal ceca and  liver.  Southern blot 
analysis demonstrated that multiple CYP3A27-related genes exist in rainbow trout. 
To  examine  the  cellular  localization  and  the  expression  pattern  of 
CYP3A27,  immunohistochemical  (IH)  studies  were  performed.  The  relative 
distribution of CYP3A27 mRNA and protein along the trout gastrointestinal tract 
analyzed by Northern and  Western blots were supportive of the IH  observations. 
These  results  confirmed  that  the  rainbow  trout  possesses  a  similar  tissue 
distribution pattern of  CYP3A expression to that observed in mammals. 
In  Western blot analysis,  the  CYP3A27  protein expressed in baculovirus 
system comigrated with the purified LMC5  P450 and  was recognized by LMC5 
Redacted for PrivacyIgG.  The  expressed  CYP3A27  protein  showed  catalytic  activities  against 
progesterone, nifedipine, and testosterone. These results demonstrated not only that 
trout CYP3A27 has the  capability to  metabolize  steroid hormones,  but also  that 
trout  have  a  system  to  support  CYP3A-catalyzed  first-pass  metabolism  of 
xenobiotics in the intestine as reported for mammalian CYP3A forms. 
A second new  CYP3A  subfamily member was  isolated in intestinal  ceca 
and  assigned  as  CYP3A45  by  the  Cytochrome  P450  Nomenclature  Committee. 
Major expression sites of CYP3A45 mRNA were found  in the intestinal ceca and 
proximal descending intestine rather than in liver. The Western blot result showed 
that the expressed CYP3A45 protein in insect cells comigrated with purified LMC5 
P450 and was recognized with LMC5 IgG on the SDS-PAGE. 
Results obtained from  this  study contribute to  a further  understanding of 
trout CYP  systems  and  provide  a  basis  for  studying  xenobiotic  metabolism and 
comparative toxicology in that species. © Copyright by Su-Jun Lee 
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Cytochrome P450 3A Forms in Rainbow Trout (Oncorhynchus mykiss) 
Chapter 1 
Introduction and Literature Review 
Introduction 
Cytochromes P450 (P450s or CYPs) are a heme containing superfamily of 
enzyme responsible for the oxidative and reductive metabolism of a wide range of 
structurally diverse substrates. Their major functional roles include the metabolism 
of pollutants, steroids, and drugs. There has been a great increase in the number of 
identified  cytochrome  P450  sequences  with  more  than  1181  P450s  available 
obtained from plants, animals, lower eukaryotes, and bacteria (Nelson, 1999; P450 
Committee  home  page,  http://drnelson.utmem.eduicytochromeP450.html).  The 
major expression site of P450s in animals is the liver, however specific isozymes 
are  expressed  in extrahepatic  tissues,  such  as  lung,  kidney,  and  gastrointestinal 
tract. Expression of P450 enzymes in particular tissues can result in tissue and cell 
specific  toxicities  from  the  P450-mediated  activations  of toxic  or  mutagenic 
substrates. 
Most P450 enzymes are located in the endoplasmic reticulum in which they 
are  active  with  redox  partner  NADPH-cytochrome  P450  reductase  in  the 
metabolism of foreign compounds and endogenous substrates.  Cytochrome P450 
reactions increase the hydrophilicity of  lipophilic substrate molecules, which can be 
further  conjugated  by  phase  II  reactions  to  eliminate  the  lipophilic  foreign 
compounds  from  the body,  often resulting in the first  line of defense against the 
toxic or mutagenic effects of  drugs or environmental pollutants. 2 
Although  one  of the  major  functions  of P450-mediated  reactions  is  the 
detoxification  process,  certain  substrates  are  bioactivated  by  P450  metabolism, 
leading to the generation of  an electrophilic reaction product with increased toxicity 
or mutagenicity.  As  a result,  inter-individual  variations  in  P450  expression  can 
effect  profound  toxicological  consequences.  Many  P450  genes  are  expressed 
polymorphically (Smith et aI., 1994; Ingelman-Sundberg et aI.,  1999) or induced by 
certain  chemicals  (Waxman,  1999),  providing  a  further  complexity  in  the 
metabolism of foreign chemicals and in the effects of environmental pollutants on 
the body. 
Rainbow trout (Oncorhynchus mykiss) has been used as a model species for 
toxicology and cancer study due to its sensitivity to chemicals (Bailey et aI.,  1996). 
Fish, therefore, may be a uniquely useful model in aquatic toxicology as well as for 
water pollution monitoring.  The P450  system of the rainbow trout has  been the 
most intensively studied in aquatic species (Buhler and Wang-Buhler,  1998). The 
rainbow trout P450s are diverse as found with mammalian P450 systems. 
The first purification of a major benzo(a)pyrene-hydroxylase form of P450 
(L~b) in  rainbow  trout  was  obtained by  Williams  and  Buhler  (1982)  and  the 
nucleotide  sequence  obtained  from  the  probing  of a  trout  cDNA  library  by 
antibodies  of L~b was  designated  as  CYP1A1  (Heilmann  et  aI.,  1988).  This 
CYP1A1 cloning was the initial application of  molecular biology techniques in the 
rainbow trout P450 area and was subsequently extended to other fish species. Five 
forms  of constitutive  P450s,  LMC1  to  LMC5,  were  purified  from  the  liver  of 
rainbow  trout  (Miranda  et  aI.,  1989).  Two  of these  P450s  have  been  cloned, 
sequenced,  and  assigned  to  two  new  subfamilies  by  the  P450  Nomenclature 
Committee as CYP2M1 (LMC1) (Yang et aI., 1998) and CYP2K1'(LMC2) (Buhler 
et  aI.,  1994).  Catalytic  activities  of CYP2K1  and  CYP2M1  following  their 
expressions in baculovirus system were reported by Yang et al. (1998, 2000). Three 
P450s (CYP11A1, CYP17, and CYP19) involved in steroid biosynthesis have been~, 3 
cloned in rainbow trout ovary (Takahashi, et aI.,  1993; Sakai, et aI.,  1992; Tanaka, 
et aI.,  1992). The sequence of a new P450, CYP4T1, was obtained from rainbow 
trout  liver  (Pe1ckh,  et  aI.,  1997).  As  a  summary,  six  different  P450  families 
including CYP1,  CYP2, CYP4,  CYP11, CYP17 and CYP19 with eleven cDNAs 
have been reported into GenBank from rainbow trout. 
The major P450 families in liver involved in xenobiotic biotransformations 
include three main P450 families, CYP1, CYP2 and CYP3. Among these P450s the 
CYP3A family in humans is the most abundantly expressed in liver and intestine 
and  has  a  significant  role  in  the  metabolism  of approximately  half the  foreign 
compounds including drugs  (Guengerich,  1999;  Bertz  and Granneman,  1997).  It 
was  suggested  that  the  rainbow  trout  LMC5  P450  and  human  CYP3A4  had 
structural similarities on the basis of the ability of LMC5 P450 to catalyze the  6~­
hydroxylation of progesterone and testosterone (Miranda et  ~I., 1989). Polyclonal 
antibodies generated against LMC5 P450 and human CYP3A4 IgG also were found 
to cross-react with each other (Miranda et aI.,  1991). Since steroid  6~-hydroxylase 
activity  is  the  major  characteristic  of mammalian  CYP3A  forms,  this  finding 
suggest that rainbow trout cytochrome P450 systems include CYP3A forms for the 
metabolism of steroids and xenobiotics. Therefore, the objectives of this study are 
to  further  characterize CYP3A  forms  in  rainbow  trout.  To  achieve  these  goals, 
studies include the following specific aims: 
(1) Clone and sequence P450 LMC5 related genes (CYP3A forms). 
(2) Determine tissue specific distribution and immunohistochemical 
localization of  CYP3A forms. 
(3) Determine the catalytic activities ofthe cloned CYP3A forms. 
(4) Isolate and analyze the promoter region of  a cloned CYP3A form. 4 
Literature Review 
Microsomes 
The  liver  microsomal  fraction  contains  several  enzymes  involved  in 
xenobiotic  metabolism  including  cytochrome  P450,  amme  oxidase,  epoxide 
hydrolase  and  UDP-glucuronosyltransferase  (Snell  and  Mullock,  1987). 
Microsomes are defined as the artifactual vesicles, 20-200 nm diameter, formed by 
resealing of fragments of the endoplasmic reticulum (ER) during disruption of the 
cell (Baudhuin et aI., 1967). 
Microsomal fractions  are  easily isolated by differential centrifugation and 
the  ribosomes  are  always  found  on the  outside surface,  so  that  the  interior of a 
microsome is biochemically equivalent to the luminal space of the ER (Gaetani et 
aI.,  1983). Microsomes derived from rough ER are called rough microsomes that 
represent  small  versions  of the  rough  ER.  Vesicles  of micro somes  that  lack 
attached ribosomes are called smooth microsomes. Since there are unusually large 
quantities of smooth ER  with high cytochrome P450 content in the hepatocyte, 
most micro somes prepared from  liver homogenates are derived from  smooth ER 
and  these  micro  somes  allow  investigators  to  undertake  detoxification  and  drug 
metabolism studies (de la Iglesia et aI, 1976; Amar-Costesec et aI., 1984). 
Discovery of cytochrome P450s 
It was in the early 1950s that research was strongly conducted to  study the 
cellular metabolism of drugs  and other foreign  compounds. Axelrod (1955)  first 
indicated  that  an  enzyme  localized  in  microsome  was  responsible  for  drug 
metabolism  by studying  the metabolism of amphetamine.  The  first  hint that the 5 
microsomal  enzymes  were  cytochromes  was  from  the  observation  by Ryan  and 
Engel (1957) that the oxidation of  estrogen was inhibited by carbon monoxide. For 
the first time, Omura and Sato (1964) described the presence of cytochrome P450 
in  micro  somes  and  Omura  et  ai.  (1965)  demonstrated  that  this  pigment  was 
responsible  for  the  oxidative  metabolism  of drugs  and  steroids.  The  name  of 
cytochrome  P450  is  from  the  fact  that the  reduced  form of P450s  binds carbon 
monoxide  and  then  absorbs  light  most  intensively  at  a  wavelength  of 450 
nanometers. 
Evolution of  P450 
P450s are widely located in many species of microorganisms,  plants and 
animals.  Since  cytochrome  P450  can  perform  both  oxidative  and  reductive 
metabolism, the current view is that it started around 3.5 billion years ago with only 
the reductive capabilities (Nelson and Strobel, 1987; Goeptar et aI.,  1995). About 2 
billion years ago oxygen started to accumulate in the atmosphere of the earth and 
this  led to  a gradual  change in  the  functions  of the  enzyme to  give it oxidative 
capabilities  (Goeptar  et  aI.,  1995).  It is  suggested  that  the  cytochrome  P450 
superfamily evolved from a single ancestral gene before the time of  prokaryote and 
eukaryote divergence, probably 1.4 billion years ago (Nebert and Gonzalez, 1987; 
Nebert and Nelson, 1991). 
The  major  appearance  of new  genes  for  cytochrome P450  is  estimated 
about  1 billion years ago when animals and plants emerged (Nelson and Strobel, 
1987).  At  that  time  animals  began  to  eat  plants  and  the  plants  responded  by 
producing phytoalexins.  Subsequently, animals  developed new  cytochrome P450 
genes  to  detoxify  the  phytotoxins.  It is  further  suggested  that  the  most  rapid 
appearance of  new genes has been in the last 400 to 600 million years (Nelson and 
Strobel, 1987; Gonzalez, 1990). Information on the sequences ofcytochrome P450s 6 
appeared  slowly  until  the  advent  of molecular  biology  techniques  in  the  mid­
1980's. By 1987 there were 31  known genes,  154 in 1990, 481  in 1996, and over 
750 in 1999 (Nelson et aI.,  1993;  1996; Nelson, 1999). Currently, there have been 
more than  1181  P450s in the plant and animal kingdoms and the number keeps 
increasing sharply (http://drnelson.utmem.edulcytochromeP450.html). 
P450 Nomenclature 
The first Nomenclature Committee on P450s was organized to categorize 
the rapid growing number of the P450 sequences and to simplify the complex of 
P450  names  (Nebert  et  aI.,  1987).  It has  been  extended to  subsequent updates 
(Nebert  et  aI.,  1989;  1991;  Nelson  et  aI.,  1993;  1996).  Researchers  with newly 
discovered P450 cDNA or deduced amino  sequences are requested to  send their 
information to  the P450 Nomenclature Committee.  The assignment of names to 
newly  discovered  P450  genes  is  by  agreement  among  members  of the  P450 
Nomenclature Committee. 
The P450 proteins with more than 40% identity in amino acid sequence are 
grouped into a family and with more than 55%  sequence identity are assigned to 
the  same  subfamily.  The  italicized  root  symbol  "CYP"  (Cyp  for  mouse  and 
Drosophila)  represents  '~ochrome ~450', the  next  following  Arabic  number 
indicating  the  family,  a  letter  designating  subfamily,  and  an  Arabic  number 
representing the individual gene within the subfamily. 
The naming of genes is carried out chronologically, meaning that delays in 
submitting  a  new sequence  to  this  Committee result  in assignment  of a higher 
number. The P450-like genes or proteins whose sequences have not been examined 
by  the  Nomenclature  Committee  can  cause  odd  confusion  to  the  literature  in 
journal publication. For example, the nomenclatures of  the two trout CYPIA genes, 7 
CYPIAI and CYPIA2, identified by Bemdtson and Chen (1994), were renamed to 
CYPIA3 and CYPIAl, respectively, by the P450 Nomenclature Committee. 
To reflect the evolutionary relationships of P450 sequences, Nelson (1999) 
introduced "trees" which  are  made  from  the  assembly of P450  sequences  from 
plant,  animal  and  fungal  origins  (http:dme1son.utmem.eduIP450trees.html).The 
addition of  many sequences to the P450 sequence trees showed the deeper branches 
from place to place. These branches were grouped into a small number of  kingdom­
specific clusters  which include  multiple  families.  A new nomenclature  level has 
been created to name these clusters "clans" and currently there are 14 clans which 
probably represent  genes that  diverged  from  a single common ancestor (Nelson, 
1999). 
Structure of cytochrome P450 
All cytochromes P450 share three characteristics: (1) they contain a heme 
moiety,  iron-protoporphyrin IX;  (2)  they  are  intrinsic  membrane bound proteins 
except bacterial P450s such as  P450cam;  (3)  they use reducing equivalents from 
NADPH  and  a  molecular  oxygen.  These  essential  properties  require  similar 
structural features in all P450s to be a catalytically active form.  The iron cation in 
heme  is  liganded  to  the  four  pyrrole  nitrogens.  Two  additional  non-porphyrin 
ligands, the  fifth  ligand and the sixth ligand, are positioned in axial positions. In 
cytochrome P450 enzymes, the heme sits deeply inside the protein with its fifth site 
ligated to a cysteine thiolate group from an essential cysteine near the carboxyl end 
of  the protein and the sixth ligand site is occupied by a hydroxyl group from water 
in the substrate free state (Ortiz de Montellano, 1995). 
The primary structures (amino acid sequences) of many cytochromes P450 
vary from about 10 to over 90% in sequence identity (Coon et aI.,  1992). The most 
important amino acid in the protein sequence is the thiolate-donating cysteine, the 8 
fifth ligand to the heme iron, whose region is highly conserved in all P450 enzymes 
and  used  to  align  different  P450  sequences  (Gonzalez,  1990).  The  bacterial 
cytosolic  P450cam  has  been  studied  via  X-ray  crystallography  by Poulos  and 
colleagues (Poulos et aI., 1985; 1986). 
However,  there  is  no  information based on X-ray  crystallography on the 
structure  of membranous  P450s  from  vertebrates,  which  may  be  significantly 
different  from  the bacterial cytochrome P450.  Therefore,  it is  unknown why so 
many cytochromes P450 exist with broad substrate overlapping activities and low 
turnover number rather than having greater specificity and higher catalytic rates. 
Reaction Mechanism of Cytochrome P450 
Substrate binding 
It is suggested that substrates bind to the cytochrome P450 in a hydrophobic 
pocket located near the catalytic site (Blanck et aI.,  1977; Jarug et aI.,  1977; KUhn­
Velten, 1991). Upon substrate binding, the oxidized cytochrome P450 which is in a 
low-spin  state  with  hexacoordinated  form  changes  to  the  high-spin  form  with 
pentacoordinated form  without sixth ligand  (Backes and Canady,  1981;  Kumaki 
and Nebert, 1978; Schenkman et aI.,  1981). This shift is of critical importance for 
the  enzymatic reaction to  proceed the  first  reduction  step to  occur (Backes  and 
Eyer,  1989).  Then,  the  heme  iron is reduced  from  the  ferric  (Fe
3+)  state to  the 
ferrous  (Fe
2+)  form  by  the  addition  of a  single  electron  from  the  NADPH­
cytochrome P450 reductase (Backes and Eyer, 1989). The majority of compounds 
metabolized by cytochrome P450 produce a difference spectrum in the Soret region 
characterized by a minimum at 417 nm and a maximum at 387 nm, which is type I 
difference spectrum (Schenkman et aI., 1967). 9 
Ligand binding 
Cytochrome P450 ligands are compounds able to bind as a sixth ligand to 
the  heme  iron  and  this  ability  results  from  the  presence of a  functional  group 
characterized by available electron pairs (Testa and Jenner, 1981). Type II spectra, 
absorption maxima between 425 and 445 nm and minima between 390 and 420, are 
caused by direct interaction of the compounds with the heme (Schenlanan et aI., 
1967;  Ullrich  et  aI.,  1975).  Many  compounds  causing  type  II  spectra  include 
inhibitors  with  displacement  of one  of the  axial  ligands  from  the  heme  iron 
(Schenlanan  et  aI.,  1967;  Ullrich  et  aI.,  1975).  The  interaction of ligands  with 
cytochrome P450 is primarily electrostatic in nature instead of hydrophobic nature 
(Jiinig  et  aI.,  1977).  Typical  ligands  include  as  follows:  (l) nitrogen-containing 
compounds  such  as  primary  amines  and  aromatic  heterocyclic  derivatives.  (2) 
oxyen-containing  compounds  such  as  alcohol,  phenols,  ketones  and  ethers.  (3) 
certain  anions  such  as  cyanide.  Nitrogen-containing  compounds  are  stronger 
ligands than oxygenated compounds (Repond et aI., 1986). 
The  complexity  arises  from  the  ability  of many  ligands  to  act  either 
substrate or inhibitor, producing a type I or type II spectrum (Repond et aI.,  1986; 
Andersson and Dawson,  1984;  Kumaki  and  Nebert,  1978).  It  is  suggested  that 
cytochrome P450 ligands could inhibit metabolism by displacement ofthe substrate 
or by keeping the P450 in a  low-spin fonn that cannot be reduced by NADPH 
cytochrome P450 reductase (Ruckpaul and Rein,  1989; Backes and Eyer,  1989). 
Therefore, the control of activity can be affected from the ability of  the substrate or 
the  ligand because they  can induce  structural  changes,  which may result in the 
modulation  of the  electron  transfer  reaction  caused  by  changes  of the  spin 
equilibrium. 10 
Molecular oxygen binding 
Molecular  oxygen  has  a  strong  affinity  for  ferrous  state  of cytochrome 
P450,  the  reduced  form  of cytochrome  P450  (Jung  et  aI.,  1979;  Traylor et  aI., 
1981). The ferrous-02 complex represents a branching point in the catalytic cycle 
of cytochrome  P450.  For  the  monooxygenation  reaction  to  occur,  the  second 
electron must be delivered rapidly, otherwise the complex dissociates with release 
of superoxide  anion  and  if the  cycle is  interrupted  after the  introduction of the 
second electron, oxygen is released as hydrogen peroxide (White and Coon, 1980). 
The  Fe2+02  complex  is  converted  to  a  Fe2+OOH  complex  by the  addition of a 
proton  (H+)  and  a  second  electron,  which is  derived  from  NADPH-cytochrome 
P450 reductase or cytochrome b5 (Backes and Eyer, 1989). The introduction of  the 
2+  3+
second proton cleaves  the  Fe  OOH  complex  to  produce water and  an  (FeO) 
complex, which transfers  its oxygen atom to  the  substrate (Strobel,  et aI.,  1980; 
1989). 
Electron transfer system 
NADPH-cytochrome P450 reductase, also known as NADPH-cytochrome c 
reductase,  is  the  major  oxidoreductase  transferring  electrons  to  microsomal 
cytochrome P450. NADPH-cytochrome P450 reductase is distinct from many other 
flavoproteins  in  that  it  contains  one  molecule  each  of FAD  (flavin-adenine 
dinucleotide) and FMN (riboflavin 5
1-phosphate) per polypeptide chain (Porter and 
Kasper,  1985). The preferred source of reducing equivalents is NADPH, because 
its  Km value is  in  the micro molar range, but NADH's Km is in the millimolar 
range  (Kurzban  et  aI.,  1990;  Noshiro  and  Omura,  1978).  Two  physiological 
electron acceptors are cytochrome P450 and cytochrome c, a small metalloprotein, 11 
which acts as an electron carrier in the respiratory chain of all aerobic organisms 
(Wendoloski et aI., 1987). 
The electron flow  within NADPH-cytochrome P450 reductase has been a 
difficult problem to elucidate due to the complexity of  the possible electronic states 
of FAD and FMN (Oprin and Coon,  1982). FAD acts as the acceptor of the two 
electrons from NADPH and the high-potential FMN serves as  electron carrier to 
cytochrome P450 (Eyer and Backes, 1992). Cytochrome b5 can be the carrier ofthe 
second electron in the P450 reaction cycle (Canova-Davis et aI., 1985). 
Mitochondrial  and  bacterial  cytochrome  P450  are  reduced  by their  own 
electron  carrier  systems,  different  from  microsomal  cytochrome  P450.  In 
comparison with microsomal cytochrome P450,  mitochondrial cytochrome P450 
generally exhibits a high degree of  both substrate and product selectivity (Honeck, 
1978).  The  electron  carrier  system  reducing  P450  comprises  two  enzymes, 
adrenodoxin  reductase  (ferredoxin)  and  adrenodoxin  (adrenal  ferredoxin). 
Adrenodoxin  reductase  contains  a  FAD  as  cofactor  and  exhibits  a  very  high 
selectivity for NADPH and adrenodoxin is a non-heme iron protein which is iron­
sulfur protein and  its  active  center consists  of two  iron atoms  (Lambeth et  aI., 
1984). Each iron is coordinated by two cysteinyl sulfurs and bridged by two sulfur 
atoms.  Many  details  of electron  transfer  in  mitochondrial  P450  have  been 
elucidated (Ichikawa and Hiwatashi, 1982). 
Reaction summary 
The basic reaction mechanism of cytochrome P450 is monooxygenation in 
which one atom of oxygen is incorporated into a substrate (RH), and the other is 
reduced to water with reducing equivalents derived from NADPH as follows: 
Substrate (RH) + 02 + NADPH + H+ -+ Product (ROH) + H20 + NADP+ 12 
Cytochrome P450 and NADPH-cytochrome P450 reductase are embedded 
in  the  phopholipid  bilayer  of the  endoplasmic  reticulum  which  facilitates  their 
interactions.  The  catalytic  cycle  of  cytochrome  P450  associated  with 
monooxygenation  reactions  is  explained  in  figure  1-1.  During  catalysis, 
cytochrome P450 binds directly to the substrate and molecular oxygen, but it does 
not interact directly with NADPH or NADH.  The mechanism of electron transfer 
from  NADPH  to  cytochrome  P450  depends  on  the  subcellular  localization  of 
cytochrome  P450  with  a  high-spin  form  and  this  transfer  is  achieved  by  a 
flavoprotein  called NADPH-cytochrome  P450  reductase  via FMN and  FAD.  In 
mitochondria,  which  contains  many  of P450s  involved  in  steroid  hormone 
biosynthesis and vitamin D metabolism, electrons are transferred from NADPH to 
cytochrome  P450  via  two  proteins,  an  iron-sulfur  protein  called  adrenodoxin 
known  as  ferredoxin  and  a  FMN-containing  flavoprotein  called  adrenodoxin 
reductase also known as ferredoxin reductase. 
Briefly, the first part of the P450 reaction cycle involves the activation of 
oxygen and the final part of the cycle involves substrate oxidation, which entails 
the  abstraction  of a hydrogen  atom  or  an  electron  from  the  substrate  and  then 
oxygen rebound. The substrate of cytochrome P450 system includes a large variety 
of  chemicals as shown in table 1-1. 13 
Fig. 1.  1.  Catalytic cycle of cytochrome P450 associated with monooxygenation 
reactions. [Fe3+] =  ferricytochrome P450; hs =  high spin; Is  =  low spin; [Fe2+] = 
ferrocytochrome  P450;  Fp1  =  NADPH-cytochrome  P450  reductase;  Fp2  = 
NADPH-cytochrome  b5  reductase;  cyt  b5  =  cytochrome  b5;  XH  =  substrate. 
(Reproduced from Mesnil et aI., 1984) [Fe~:]XH 
~i 
[Fe~:]XH 
NADPH 
~ 
Fp1 15 
Table 1.1. Summary of  substrates, inducers, and procarcinogens whose oxidation is 
catalyzed by  cytochrome  P450.  The  information in this table has  been collected 
from several review articles (Gonzalez, 1990; Gonzalez and Gelboin, 1994; Nelson 
et  aI.,  1993;  1996;  P450  home  page  for  human, 
http://drnelson.utmem.edulhum.html  revised  in  2000;  Guengerich,  1994;  1999; 
Omiecinski  et  al.,  1999).  The  substrates  bioactivated  by  P450  reactions  are 
indicated with bold letter.  The abbreviations used  in table are:  P  AHs,  polycyclic 
aromatic  hydrocarbons;  3-MC,  3-methylcholanthrene;  ~NF,  ~-naphthoflavone; 
TCDD,  2,3,7,8-tetrachlorodibenzodioxin;  2-AAF,  2-aminoacetyl  fluorene;  MeIQ, 
2-amino-3  ,8-dimethyl-imidazo  [4,5-t]quinoline;  PhIP,  2-aminol-methyl-6­
phenylimidazo-[  4,5-b  ]pyridine;  NNK,  4-(methylnitrosamino )-I-(3-pyridyl)-I­
butanone;  DHEA,  dehydroepiandrosterone;  DHEA-S,  dehydroepiandrosterone  3­
sulfate; M, mitochondria; and ND, not determined. 16 
Table 1. 1. 
Enzyme/ 
tissue 
Endogenous 
substrates 
Xenobiotic substrates 
Induction 
CYPIAI 
Many tissue 
prostaglandin 
0)-2 oxidation; 
testosterone 
6~-hydroxylation; 
17~-estradiol-C2-
hydroxylation 
benzo[a]pyrene; PAHs; 
7  -ethoxycoumarin; 
7  -ethoxyresorufin; 
R-warfarin 
3-MC ~NF· '  , 
TCDD; PAHs; 
omeprazole; 
cruciferous; 
vegetables; 
cigarette 
smoking 
CYPIA2 
Liver 
17~-estradiol-C2-
hydroxylation; 
prostaglandin 
0)-1  oxidation; 
testosterone 
6~-hydroxylation 
2-AAF; acetaminophen; 
aflatoxin Bl; MeIQ; 
PhIp; caffeine; 
7  -ethoxyresorufin; 
7  -methoxyresorufin; 
phenacetin; theophylline; R-
warfarin; imipramine; 
fluoroquinolone 
3'-hydroxylation 
3-MC; 
PNF;TCDD 
omeprazole; 
cruciferous 
vegetables; 
cigarette 
smoking 
CYPIBI 
Breast 
tumor 
testosterone6~, 
16a-hydroxylation; 
17p-estradiol C4­
hydroxylation 
arylarenes; nitroarenes; 
heterocyclic amines; 
ethoxyresorufin 
3-MC· pNF·  ,  , 
TCDD 17 
Table 1. 1. (continued) 
CYP2C9 
Liver 
Intestine 
NO 
chloramphenicol; diclofenac; 
hexobarbital; diflunisal; 
ibuprofen; losartan; mefenamic 
acid; mephenytoin; naproxen; 
omeprazole; phenytoin; 
retinoids; tolbutamide; 
torsemide; warfarin. 
Rifampin 
CYP2C18 
Liver 
NO 
diazepam N-demethylation; 
S-mephenytoin-4­
hydroxylation; phenytoin p­
hydroxylation. 
rifampin 
CYP2C19 
Liver 
NO 
diazepam; felbamate; 
hexobarbital; imipramine; 
mephenytoin; mephobarbital; 
omeprazole; phenytoin; 
proguanil; propanolol 
rifampin 18 
Table 1. 1. (continued) 
CYP2D6 
Liver 
Intestine 
Kidney 
ND 
NNK; amitriptyline; bufarolol; 
clozapine; codeine; 
debrisoquine; desipramine; 
dextromethorphan; encainide; 
ethylmorphine; flecainide; 
imipramine; metoprolol; 
mexiletine; nortriptyline; 
odansetron; perhexiline; 
perphenazine; propafenone; 
sparteine; thioridazine; timolol; 
tramadol 
ND 19 
Table 1. 1. (continued) 
CYP2EI 
Liver 
Intestine 
Leukocyte 
Alcohol nitrosamines 
acetaminophen; acrylonitrile; 
benzene; chloroform; 
dichloromethane; 
nitrosamines; styrene; 
trichloroethylene; 
vinylbromide; aniline; 
chlorzoxazone; dapsone; 
disulfiram; enflurane; ethanol; 
halothane; isoflurane; 
isoniazid; p-nitrophenol 
alcohol; acetone; 
pyrazole; 
isoniazid 
CYP3A4 
Liver 
Intestine 
Testosterone 
6p(major), 
2p,6a,16p, 15P­
hydroxylation; 
cortisol 6P­
hydroxylation; 
androstenedione  6P­
hydroxylation; 
acetaminophen; aflatoxin Bl; 
benzo[a]pyrene-7,8­
dihydrodiol; 
cyclophosphamide; 
isofosfamide; alfentanil; 
aminodarone; antipyrine; 
carbamazepine; 
chloropromazine; 
phenobarbital; 
dexamethasone; 
glucocorticoid; 
PCN 
rifampin; 
phenytoin; 
carbamazepine. 20 
Table 1. 1. (continued) 
progesterone 6/3­ clarithromycin; clozapine; 
hydroxylation;  cyclosporine A; dapsone; 
estradiol 2­ dexamethasone; diazepam; 
hydroxylation;  diltiazem; erythromycin; 
DHEA-3-sulfate  ethinylestradiol; fluvastatin; 
imiquimod; indinavir; 
lidocaine; lovastatin; 
midazolam; nelfinavir; 
nifedipine; omeprazole; 
orphenadrine; paclitaxel 
(Taxol); prednisone; proguanil; 
quinine; quinidine; 9-cis­
retinoic acid; rapamycin; 
rifabutin; ritonavir; saquinavir; 
simvastatin; tacrolimus; 
tamoxifen; terfenadine; 
temazepam; triazolam; 
trimethadione; trimethoprim; 
verapamil; R-warfarin; 
zidovudine 
CYP3A5 
Liver 
Stomach 
Intestine 
testosterone 
6/3(major), 2/3­
hydroxylation 
same as CYP3A4 
rifampin; 
dexamethasone. 
CYP3A7 
Fetal liver 
DHEA; DHEA-S 
16a-hydroxylation 
midazolam; nifedipine 21 
Table 1. 1. (continued) 
CYP5 
Platelet 
prostaglandins to 
thromboxane A 
ND  ND 
CYP7A 
Liver 
cholesterol (7a­
hydroxy) 
ND  ND 
CYP7B 
Brain 
pregnenolone (7-a­
hydroxy) 
dehydroepiandrostero 
ne (7-a-hydroxy) 
ND  ND 
CYPIIAI 
Liver (M) 
Cholesterol side 
chain cleavage 
(cholesterol to 
pregnenolone) 
ND  ND 
CYPIIBI 
Liver (M) 
Il-deoxycortisol to 
cortisol 
lI­
deoxycorticosterone 
to corticosterone 
ND  ND 
CYPl7 
Adrenal 
gland; testis 
steroid 17a 
hydroxylase in 
testosterone and 
ND  ND 22 
Table 1. 1. (continued) 
estrogen synthesis 
CYP19 
Ovary; 
adipose 
tissue 
steroid aromatase in 
estrogen synthesis 
ND  ND 
CYP2l 
adrenal 
gland 
steroid 21­
hydroxylase in 
cortisol synthesis 
ND  ND 
CYP27Bl 
Liver 
1-(1 hydroxylase of 
vitamin D3 
ND  ND 
CYP51  lanosterol 14-(1 
demethylase in 
cholesterol synthesis 
ND  ND 
CYP2A6 
Liver 
ND 
coumarin; butadiene; 
nicotine  barbiturates 23 
Regulation of CYP3A Gene Expression 
Members of CYP3A subfamily include five  forms  from rat and four from 
mice and human (Nelson, et aI.,  1996). The CYP3A family is the most abundant 
family in human, accounting for 30% of total cytochrome P450s in liver and 70% 
of those in gastrointestinal tract (Wrighton et aI.,  1992; Guengerich, 1994; Kolars, 
et aI.,  1994). Among the CYP3A subfamily, CYP3A4 is most abundantly expressed 
form  in  human  liver  and  intestine  (Guengerich,  1994;  Kolars,  et  aI.,  1994). 
CYP3A5 is found in entire gastrointestinal tract and liver and the major form found 
in the stomach (Kolars et aI.,  1994). CYP3A7 was originally found  in fetal  liver 
(Komori et aI.,  1989),  but also identified in adult liver, placenta and endometrial 
tissues (Schuetz et aI., 1993). 
The  major  glucocorticoid-responsive  CYP3A  gene  in  rat  is  CYP3A23, 
whereas  CYP3A4 and CYP3A5  are inducible forms  in human (Wrighton et aI., 
1985; Watkins et aI.,  1985; Komori et aI.,  1994; Schuetz et aI.,  1996; Cooper et aI., 
1993). Regulation of rat CYP3A23 is most extensively characterized (Huss et aI., 
1996; Huss and Kasper, 1998). Early studies of  rat CYP3A induction were unusual 
because both glucocorticoid (such as dexamethasone) and anti-glucocorticoid (such 
as pregnenolone 16a.-carbonitrile, PCN) induced the same CYP3A form (Wrighton 
et  aI.,  1985;  Gonzalez  et  aI.,  1986).  One  difference  compared  to  the  other 
glucocorticoid-responsive gene, such as  tyrosine aminotransferase was that a 100­
fold  greater  concentration  of dexamethasone  was  required  to  elicit  a  maximal 
CYP3A induction than was required for  tyrosine aminotransferase (Schuetz and 
Guzelian,  1984).  It  was  determined  that  the  region  supporting  dexamethasone 
responsiveness in the CYP3A23 promoter didn't bind with glucocorticoid receptor 
(GR)  (Huss et aI.,  1996;  1998; Quattrochi et aI.,  1995).  Those data excluded the 
possibility of direct GR-mediated transactivation of the gene.  Huss  et al  (1996) 
found three nuclear protein binding sites  in -60 to-170 site of the CYP3A23  5'­24 
regulatory region.  After serial mutagenesis studies  in three binding sites, one of 
three sites (Site A, hepatocyte nuclear factor 4 (HNF-4)) was found to have a role 
in  mediating  basal  and  dexamethasone  induction  responsiveness  and  other  two 
regions were involved in nuclear receptor binding (Huss et aI., 1996; 1998). 
A novel orphan nuclear receptor, named the pregnane X receptor (PXR)was 
cloned from mouse liver (Kliewer et aI., 1998). PXRs exist as two isoforms, PXR.l 
and PXR.2, that were induced by steroids such as pregnenolone, progesterone, and 
synthetic  glucocorticoids  and  anti-glucocorticoids  (Kliewer  et  aI.,  1998).  The 
discovery  of PXR  provided  a  steroid  hormone  signaling  pathway  for  steroid 
metabolism as well as in the regulation of CYP3A forms. PXR was most strongly 
expressed in liver and intestine which are the major. tissues of CYP3A expression 
and  it  functioned  through  a  response  element  conserved  in  the  CYP3A  gene 
promoter (Kliewer et aI.,  1998).  Masuyama et al  (2000) showed that endocrine 
disrupting chemicals (EDCs),  such as  phthalic acid  and nonylphenol,  stimulated 
PXR-mediated transcription, which may result in altered endocrine function. In the 
yeast two-hybrid protein interaction assay,  PXR interacted with nuclear receptor 
coactivator protein in the presence of EDCs (Masuyama et aI.,  2000), suggesting 
that  EDC-occupied  PXR  may  regulate  its  specific  gene  expression  through 
heterodimers. 
Blumberg et al (1998) cloned PXR's counterpart, steroid and xenobiotic 
receptor  (SXR),  in  humans.  Characterization  of human  SXR and  mouse  PXR 
indicated  that  these  receptor  heterodimerized  with  RXR.  These  heterodimers 
efficiently transactivated DR3 element in the rat CYP3A genes (direct nucleotide 
repeats separated by 3 bp; AGTTCA-N3-AGTTCA) and ER6 elements in human 
CYP3A  genes  (everted  repeats  separated  by  6  bp;  TGAACT-N6-AGGTCAB) 
(Blumberg et aI., 1998; Bertilsson et aI.,  1998; Mangelsdorf and Evans, 1995). The 
targeted disruption of the mouse PXR gene abolished the induction of CYP3A by 
dexamethasone  and  PCN  (Xie  et  aI.,  2000).  However  transgenic  mice,  which 25 
contain mutated PXR and activated fonn of human SXR, showed the constitutive 
upregulation of Cyp3a gene expression. Also these transgenic mice showed Cyp3a 
induction  similar  to  human  CYP3A  responses  and  this  induction  enhanced 
protection against xenobiotic compounds toxic to mice (Xie et aI., 2000). A broad 
range  of drugs,  environmental  chemicals,  and  steroids  have been  showed  to  be 
CYP3A  inducers  in  mammals,  however,  species  differences  in  the  induction 
response  have  been  described  (Wrighton  et  aI.,  1985).  Barwick  et  al  (1996) 
demonstrated  that  the  species-specific  induction  responses  are  not  due  to  the 
differences  in the  individual  CYP3A  gene  promoter structures,  but  rather are  a 
function of factors provided by the host species. This suggestion is verified by Xie 
et al (2000) that the species origin of  the receptor rather than the promoter structure 
of  CYP3A genes dictates the species-specific pattern of CYP3A inducibility. It was 
concluded  that  SXR  in  human  and  PXR  in  mice  encode  the  primary  species­
specific  xeno-sensor that  mediate  the  adaptive  hepatic  response  against harmful 
environmental chemicals (Xie et aI., 2000; Barwick et aI., 1996). 
Mammalian CYP3A Forms 
Human CYP3A family 
Four of CYP3A gene (CYP3A4, CYP3A5, CYP3A7, and CYP3A43) have 
been cloned in humans and all of  them are located on chromosome 7 (Nelson et aI., 
1996;  http://dmelson.utmem.edulhum.html).  These  cDNA have  been  isolated  as 
follows,  where  old  names  are  described  in parenthesis;  CYP3A3  (p450HLp  or 
hPCN2) (Molowa et aI.,  1986) (This fonn is removed from the P450 database by 
the P450 Nomenclature Committee since it was an allele of CYP3A4 rather than a 
separate gene), CYP3A4 (NFI0, NF25 and hPCN1) (Beaune et aI., 1986; Gonzalez 
et aI.,  1988; Bork et aI.,  1989), CYP3A5 (hPCN3 and P450HLp2) (Aoyama et aI., 26 
1989;  Schuetz  et aI.,  1989),  CYP3A  7 (P450HFL33)  (Komori  et aI.,  1989),  and 
CYP3A43  (assembled from  the human genome project).  Two of these CYP3As 
have  been  purified  from  human  adult  and  fetal  liver,  respectively:  CYP3A4 
(P450NF) and CYP3A  7 (P450HFLa) (Guengerich et aI.,  1986; Kitada et aI.,  1987). 
Three  CYP3A  genes  (CYP3A4,  5,  7)  share  over 85%  sequence  identity  at  the 
amino  acid  level  and  are  encoded by relatively  large  genes  with a  single  gene 
spanning approximately 25-30 kb ofgenomic DNA (Hashimoto et aI., 1993). 
CYP3A4 is the most abundantly expressed in human liver and  the  major 
P450  present  in the  human  small  intestine  (Wrighton et  aI.,  1992;  Guengerich, 
1994;  Kolars  et  aI.,  1994).  CYP3A4  contributes  to  the  metabolism  of 
approximately  half the human drugs  (Bertz  and  Granneman,  1997;  Guengerich, 
1999). The level of  CYP3A4 expression in human liver samples has been shown to 
vary up  to  60-fold and to be highly correlated with the total hepatic P450 levels 
(Forrester et aI.,  1992).  There are also  variations in catalytic activity in the small 
intestine  (de  Waziers  et  aI.,  1990).  The  interindividual  variations  of CYP3A 
expression  in  intestine  could  contribute  to  the  availability  in  pharmacokinetic 
parameter oforally administered CYP3A4 substrates. 
The  size  of CYP3A4  gene  is  27  kb  with  13  exons  and  is  located  on 
chromosome 7 (Hashimoto et aI.,  1993; Jounai'di et aI.,  1994). The 5'-untranslated 
region  contains  a  basal  transcription  element  (-35  to  -50),  putative  AP-3,  p53, 
hepatocyte nuclear factor-4 and factor-5, a glucocorticoid response element (GRE), 
and estrogen receptor element sequences (Hashimoto et aI., 1993; Itoh et aI.,  1992). 
The CYP3A4 gene is known to be induced by barbiturates, glucocorticoids, and 
rifampin in humans and in isolated hepatocytes (Beaune et aI.,  1986; Gonzalez et 
aI.,  1988; Wrighton et aI.,  1992). In humans, the CYP3A induction by xenobiotics 
requires functional nuclear receptors such as steroid and xenobiotic receptor (SXR) 
and retinoid X receptor (RXR) (Waxman 1999).  The humanized transgenic mice 
that  contain  functional  human  SXR but no  functional  mouse  PXR showed  the 27 
responsIveness  to  human  specific  inducers  of CYP3A4  such  as  the  antibiotic 
rifampicin,  allowing  animals  to  respond  to  human-specific  inducers  (Xie  et  aI., 
2000). 
CYP3A4, a 52 kDa protein, has the broadest substrate specificity among the 
P450 systems. In drug metabolism CYP3A4 is the most effective form accounting 
for about 50% of the drug metabolism, followed by CYP2D6 (20%), CYP2C9 and 
CYP2C19  (15%),  and  the  remaining  metabolism  is  carried  out  by  CYP2El, 
CYP2A6,  CYPIA2  and  unidentified  cytochrome  P450s  (Bertz  and  Granneman, 
1997).  The  substrates  for  CYP3A4 vary  in size  from  smaller molecule  such  as 
acetaminophen  (Mr  151)  to  cyc1osporin  A  (Mr 1201)  (Combalbert  et  aI.,  1989; 
Patten,  et  aI.,  1993).  There  is  a great similarity of substrate  selectivity between 
CYP3A4 and P-170, an ATP-dependent glycoprotein that pumps xenobiotics out of 
cells  (Arias,  1990).  Most of the purified CYP3A4 from  heterologous  expression 
showed  complicated patterns  of optimal  reconstitution  with  relatively  very  low 
specific activity compared with other P450s (Guengerich, 1999). CYP3A4 does not 
couple well with yeast NADPH-cytochrome P450 reductase (Brian et aI.,  1990). 
Hosea et al (2000) suggested that CYP3A4 contain multiple ligand binding sites, 
which may support its broad selectivity and low  specific  activity for  substrates. 
Mammalian  cells  have been used  to  express  CYP3A4  where the reductase  and 
cytochrome b5  are coexpressed to improve catalytic activity (Crespi et aI.,  1996). 
Bacterial systems (Blake et aI.,  1996; Parikh et aI.,  1997) and baculovirus system 
(Lee et aI., 1995; Buters et aI., 1994) also have been used for reconstitution systems 
in  CYP3A4  studies.  It is  suggested  that  CYP3A4  expressed  in  baculovirus  or 
bacteria  seems  to  function  well  compared  to  the  other  expression  system 
(Guengerich, 1999). 
Inhibitors  of CYP3A  enzymes  decrease  metabolism  of substrates  and 
generally lead to increased drug or toxic effects, unless the substrate is a pro drug 
and is required for bioactivation to a pharmacologically active form. Ketoconazole, 28 
an  antifungal drug, is a potent inhibitor of CYP3A4 (Daneshmend and Warnock, 
1988).  Erythromycin  is  a  mechanism-based  suicide  inhibitor  in  which  the 
metabolism is believed to form a reactive product that interacts with the active site 
of P450 protein (Murray,  1984).  Troleandomycin is oxidized to  an inhibitor that 
forms  a  tight  iron complex  (Larrey,  1983).  Grapefruit juice which  contains  the 
flavonoid  naringenin and  furanocoumarin  dimers was  found  to  inhibit  first  pass 
metabolism of many drug and substrates that are detoxified through the CYP3A4 
and ATP-driven antiporter system in the intestine (Tassaneeyakul et aI., 2000). 
The  human  CYP3A5  gene  encodes  a  502  amino  acid,  57.1  kDa protein 
which shares 84% amino acid and 89% nucleotide sequence homology to CYP3A4. 
CYP3A5  is  weakly  expressed  in  human  liver but the  major  form  found  in  the 
stomach and  kidney (Kolars  et  aI.,  1994).  Therefore,  CYP3A4 is  suggested as  a 
ubiquitously expressed CYP3A form in humans, but CYP3A5 is the major CYP3A 
member found  in renal tissue. It has  been  reported that CYP3A5  is present in  a 
higher percentage of children and adolescents compared with the adult population 
(Wrighton  et  aI.,  1990).  Catalytic  activity  using  recombinant  vaccinia  virus­
expressed CYP3A4 and  CYP3A5  in mammalian cells showed that both enzymes 
are similarly active in the metabolism of nifedipine, testosterone, progesterone and 
androsterone,  but  CYP3A4  exhibits  several-fold  higher  activity  than  CYP3A5 
(Aoyama et aI.,  1989). 
CYP3A  7  is  the  primary  CYP3A  form  expressed  in  human  fetal  hepatic 
microsomes, and its potential role in human embryotoxicity is an important issue. 
CYP3A  7 contains an open reading frame of 1509 bp,  encoding a 503  amino acid 
protein. CYP3A  7 was originally identified as a fetal-specific  prot~in related to the 
human nifedipine oxidase gene (Komori et aI.,  1989; Schuetz et aI.,  1994). But it 
has  now  been  identified in adult  human  liver,  placenta and  endometrial tissues, 
with the levels of mRNA and protein increased during pregnancy and at different 
points  during  the  menstrual  cycle  (Schuetz  et  aI.,  1993).  CYP3A7  catalyzes 29 
dehydroepiandrosterone  3-sulphate  hydroxylation,  a  physiologically  important 
reaction for the formation of estriol in pregnancy (Kidata et aI.,  1987). Chen et al 
(2000)  showed  that  CYP3A  7  obtained  from  human  fetal  liver  microsomes 
catalyzed the 4-hydroxylation of retinoic acids (4-0H retinoic acid exhibits much 
less embryo toxicity and teratogenicity than retinoic acid), suggesting that CYP3A  7 
might play an important role in protecting the human fetus  against retinoic acid­
induced embryo toxicity. 
Rat CYP3A family 
Members  of the  CYP3A  subfamily  in  rat  include  CYP3A1  (PCN1), 
CYP3A2  (PCN2),  CYP3A9,  CYP3A18  and  CYP3A23  (Nelson  et  aI.,  1996; 
Gonzalez et aI.,  1986). A P450 protein that is induced by synthetic pregnenolone 
16a-carbonitrile  (PCN)  was  first  purified  from  rats  (E1shourbagy  and  Guzelian, 
1980) and designated PCN1  (Gonzalez et aI.,  1986). A full length CYP3A1 cDNA 
coding  for  PCN  inducible  P450  (PCN1)  was  isolated  (Gonzalez  et  aI.,  1985). 
CYP3A1  (PCN1) mRNA is 2038 bp and encodes a protein of 504 amino acids. In 
its deduced amino acid sequence, a cysteine residue in the C-terminal region rather 
than the N-terminal region established more firmly that the cysteine located in the 
carboxyl terminal region serves the thiolate ligand to the heme iron at that time. 
Wrighton  et  al.  (1985)  demonstrated  that  there  are  multiple  glucocorticoid 
inducible P450s and mRNAs in the  liver by Northern blotting using a CYP3A1 
partial fragment (897 bp). A complete cDNA (2026 bp) with an open reading frame 
encoding  502  amino  acids  with  11  amino  acid  changes with CYP3A1  (PCN1), 
termed  cDEX,  was  isolated  from  rat  liver  (Kirita  and  Matsubara,  1993).  This 
CYP3A1  (cDEX)  was  transcriptionally  induced  in  the  liver  by  dexamethasone 
treatment.  CYP3AI  was  found  to  be  induced  by  dexamethasone  treatment  in 
epithelia from  stomach and jejunum, but not from colon or esophagus (Kolars et 30 
aI.,  1992).  It  was  concluded  that  CYP3A  fonns  in  rat  were  present  in  mature 
epithelia throughout the gastrointestinal tract (Kolars et aI., 1992). 
CYP3A2  cDNA  was  isolated  from  a  rat  liver  cDNA  library  by  use  of 
polyclonal  anti-P450PCN1  antibody  (Gonzalez  et  aI.,  1986).  This  CYP3A2 
contains 2014 bp encoding for a protein of  504 amino acids. CYP3A2 (P450PCN2) 
showed 90% nucleotide and 89% amino acid similarity with CYP3Al (P450PCN1) 
and this CYP3A2 gene spanned about 25  kb and consisted of 13  exons (Miyata et 
aI.,  1991).  CYP3A2 (P450PCN2) was  found  to  be an abundant CYP3A fonn in 
livers of the male rats in Northern blot analysis and CYP3A2 protein expressed in 
COS-1  cells  catalyzed  testosterone  6P-hydroxylation  (Miyata  et  aI.,  1994). 
Transcriptional  elements  directing  a  liver  specific  expression  of CYP3A2  were 
analyzed by showing hepatocyte nuclear factor-4 (HNF-4) involvement in CYP3A2 
expression  (Miyata et  aI.,  1995).  Complete CYP3A9  cDNA,  designated  3aH15, 
was isolated from rat brain which encoded a 503 amino acid residues (Wang et aI., 
1996). The deduced amino acid sequence of CYP3A9 was 92% identical to mice 
Cyp3a13. CYP3A9 was not induced by dexamethasone in rat brain and expressed 
CYP3A9  in  E.  coli  was  active  in  the  demethylation  of erythromycin  and 
benzphetamine (Wang et aI.,  1996). CYP3A9 expression is  female specific in rat 
liver as judged by its 10-fold higher expression in females than in males (Wang and 
Strobel,  1997).  In  a  tissue  distribution  study,  a  short DNA fragment  with 97% 
homology  with CYP3A9,  but clearly distinguishable  from  CYP3Al, 3A23  and 
3A2' showed a high expression in the rat intestinal tract, suggesting that CYP3A9­
like isofonns may be a major fonn in rat intestinal tract (Gushchin et aI.,  1999). 
A cytochrome P450 cDNA encoding a CYP3A18 protein (497 amino acids) 
was isolated from rat liver cDNA library (Nakata et aI.,  1996). This CYP3A18 was 
found to  be a male dominant fonn and induced by PCN and dexamethasone and 
expressed  CYP3A18  in  COS-1  cells  showed  catalytic  activities  of 16p-and  6(1­
hydroxylations oftestosterone (Nakata et aI., 1996). 31 
CYP3A23 (RL33) was cloned from rat cDNA library of untreated male rat 
(Komori  and  Oda,  1994).  The  isolated  CYP3A23  cDNA  contains  a  2032  bp 
encoding  a  protein  of 502  amino  acids.  Compared  with  CYP3A1,  CYP3A23 
showed 98 and 97% identities in the nucleotide and deduced amino acid sequences, 
respectively.  The expression level of CYP3A23  probed by a CYP3A23  specific 
oligonucleotide showed that CYP3A23 represented over 70% of the total CYP3A 
form from untreated, PB and DEX treated rat liver, indicating that CYP3A23 is the 
major CYP3A form  both in treated and  in  untreated rat liver (Komori  and  Oda, 
1994). Although CYP3A4 and CYP3A5 are inducible forms in human (Komori et 
aI.,  1994; Schuetz et aI.,  1996), the major glucocorticoid-responsive CYP3A gene 
in rat is CYP3A23. CYP3A2 is only weakly induced by glucocorticoids (Cooper et 
aI.,  1993;  Komori  and  Oda,  1994).  Regulation  of rat  CYP3A23  has  been most 
extensively  characterized  among  rat  CYP3A  forms  (Huss  et  aI.,  1996,  1998; 
Quattrochi et aI.,  1995). 
Mouse CYP3A family 
Members  of CYP3A  subfamily  in  mlce  include  Cyp3a11,  Cyp3a13, 
Cyp3a16, Cyp3a25, and Cyp3a41 (Nelson et aI.,  1996). Cyp3a11 was isolated from 
the  mouse  fetal  liver (Yanagimoto  et aI.,  1992)  and its gene is  composed of 13 
exons and 12 introns (Toide et aI.,  1997). In combined studies with Cyp3a11  and 
Cyp3a13 , Cyp3a11  mRNA is  predominantly expressed  in mouse  liver and  both 
mRNAs  reached  the  maximum  level  between  4  and  8  weeks  after  birth 
(yanagimoto et aI.,  1997). The treatment of dexamethasone, phenobarbital, PCB, 
PCN,  and  rifampicin  increased  the  expression  of the  Cyp3a11  mRNA  more 
extensively than that ofCyp3a13 (Yanagimoto et aI., 1997). 
Cyp3a13  was  isolated  from  mouse cDNA library and  shared  71%  amino 
acid  identity  with  Cyp3al1  (Yamagimoto  et  aI.,  1994).  In  cDNA  directed 32 
expreSSIOn  In  CR119  cells,  aflatoxin  B I-dependent  cytotoxicity  was  observed, 
suggesting that CYP3A in mice,  which are relatively insensitive to  aflatoxin B 1, 
can activate aflatoxin Bl to a genotoxic product (Yanagimoto et aI.,  1994). 
Cyp3a16 was cloned from mouse fetal  livers and the deduced amino acid 
showed 87.3% and 66.3% identities with Cyp3all and Cyp3a13, respectively (Itoh 
et aI.,  1994). The expression level of  Cyp3a16 mRNA reached a maximum level at 
2 weeks of  age and was undetectable 5 weeks after birth, indicating that Cyp3a16 is 
a fetal specific cytochrome P450 in mice (Itoh et aI.,  1994). 
Cyp3a25 was cloned and submitted to P450 Nomenclature Committee, but 
this gene is not published yet (GenBank accession number, AF204959). A female­
specific member of the  CYP3A gene,  Cyp3a41, was isolated in the adult mouse 
liver (Sakuma et aI., 2000). Cyp3a41 cDNA encoding a protein of  504 amino acids 
showed 92,  68,  88,  and 69%  amino acid sequence identity with mouse Cyp3all, 
13,  16,  and  25,  respectively.  In  the  female  liver,  Cyp3a41  mRNA levels  were 
comparable to that ofCyp3all, the major CYP3A enzyme in the adult mouse liver. 
The  expression  level  of Cyp3a41  mRNA  was  increased  with  age  in  females, 
whereas it was gradually reduced in males,  indicating the major CYP3A form  in 
female mouse liver (Sakuma et aI., 2000). The enzyme activity of  Cyp3a41 remains 
unknown. 
Teleost CYP3A Forms 
Purification and characterization of  CYP3A-like proteins 
Since  the  first  indication  that  rainbow  trout  contains  cytochrome  P450 
systems  (Buhler and  Rasmusson,  1968),  multiple  forms  of CYP3A-like  protein 
have been purified from several teleost species, including P450 LMC5 (Miranda et 
aI.,  1989) and P450con (Celander et aI.,  1989) from rainbow trout (Oncorhynchus 33 
mykiss), P450A (Klotz et aI.,  1986) from  scup (Stenotomus chrysops), and P450b 
(Goksoyr, 1985) from Atlantic cod (Gadus morhua). 
The P450 LMC5 (Mr 59,000 on SDS-PAGE) was purified from  the livers 
of untreated juvenile rainbow  trout  and  it  showed  a  maximum  peak  at  448nm 
(Miranda  et  aI.,  1989).  Although  there  have  been  less  successful  reconstitution 
studies  in  purified  fish  CYP3A-like  proteins,  P450  LMC5  was  successful  in 
catalyzing the  6~- and  16~-hydroxylation of testosterone and the  6~-hydroxylation 
of progesterone in reconstitution systems (Miranda et aI.,  1989). Since this steroid 
metabolism  is  related to  the  mammalian  CYP3A  subfamily,  the  immunological 
relationship between trout LMC5 and mammalian CYP3A forms was investigated. 
Polyc1onal antibodies against trout P450 LMC5 (LMC5 IgG) reacted strongly with 
rat  CYP3A1  and  with  human  CYP3A4  (Miranda  et  aI.,  1991).  In  reciprocal 
immunoblots,  rat  CYP3Al  IgG  did  not  recognize  trout  P450  LMC5,  however, 
human  CYP3A4  IgG  was  found  to  cross  react  strongly  with  P450  LMC5. 
Progesterone  6~-hydroxylation  by  P450  LMC5  was  markedly  inhibited  by 
CYP3A4 IgG and by gestodene, a mechanism-based inactivator of CYP3A4. These 
results provided an evidence for a close structural similarity between P450 LMC5 
and human CYP3A4 (Miranda et aI., 1991). 
In the  analysis of trout  liver microsomes,  polyc1onal  antibodies  to  trout 
P450con,  P450  LMC5,  and  scup  P450A  recognized  only  one  bands  that  are 
identical in migration to purified P450 LMC5 (Ce1ander et aI., 1996). Furthermore, 
P450con  and  P450  LMC5,  isolated  from  two  different  labs,  showed  specific 
reciprocal cross-reactivity with scup P450A and cod P450b (Ce1ander et aI., 1996). 
These data suggested that these fish  proteins would be members  of the  CYP3A 
gene  family.  Western  blot  analysis  of hepatic  micro somes  probed  with  trout 
P450con  IgG  showed  that  killifish  (Fundulus  heteroclitus)  and  winter  flounder 
(Pleuronectes  americanus) had  CYP3A-like  proteins  (Celander  et  aI.,  1996).  In 
mullet (Mugil cephalus) liver microsomes, Western blot data revealed the presence 34 
of multiple  forms  of P-450s  that  appear  to  be  related  to  trout  CYPIAI  and 
CYP2Kl,  however  there  was  no  cross  reaction  with  anti-trout  P450  LMC5 
antibody (Miranda et aI., 1994). 
Modulation of  CYP3A expression: inducibility, sex, hormone, and temperature 
In contrast to  mammals, very little is known about the inducibility of the 
CYP3A form  in fish  (Stegeman et aI.,  1990).  Celander et al  (1989) reported that 
levels of P450con protein were slightly elevated by cortisol and PCN in juvenile 
rainbow trout hepatic microsomes.  It was  suggested that DEX-treatment in trout 
seemed to have no effect on CYP3A-like protein levels (Celander et aI.,  1989; Lee 
et aI.,  1993). Levels ofhepatic microsomal P450s were depressed by administration 
of 17p-estradiol and elevated by treatment of testosterone in both male and female 
juvenile brook  trout  (Stegeman  et  aI.,  1982).  In  this  study,  estradiol  treatment 
depressed  the  rates  of  6P-hydroxylation  of  testosterone,  but  testosterone 
administration did not cause this change. The effects of  androgens and estrogens on 
the  expression  of CYP3A27  mRNA  and  protein  were  studied  in rainbow  trout 
(Buhler et aI., 2000). Treatment with testosterone had no effect or a small increase 
in 6p-progesterone hydroxylase  activity in males  and  the changes of CYP3A27 
mRNA and protein levels  were negligible in both sexes.  However,  17p-estradiol 
(E2) treatment showed significantly lower levels of CYP3A27 mRNA and protein 
levels  compared  to  control  groups,  suggesting  that  environmental  endocrine 
disrupters can affect at least a part ofphysiological processes through altered levels 
of  CYP3A27 expression. 
Although fish respond to inducers of  the 3-methy1cholanthrene (3-MC) type 
compounds,  a number of investigators  have  demonstrated that  fish  appear to  be 
refractive  to  induction  by  phenobarbital-type  agents  and  others  (Buhler  and 
Rasmusson,  1968; Vodicnik et aI.,  1981; Fent et aI.,  1998). Tributyltin (TBT) is a 35 
toxic contaminant in aquatic environments and the interaction of TBT with hepatic 
microsomal cytochrome P450 has  been studied in fish  (Oberdorster et  aI.,  1998; 
Morcillo et aI.,  1998; Vodicnik et aI.,  1981; Fent et aI.,  1998). Fent and Stegeman 
(1993,  1991)  reported that  the  inhibitory actions  of TBT  on cytochromes P450 
include the conversion of spectrally active P450 to its degraded form P420 and the 
decreased  protein  levels  of CYPIAI  and  P450A  (a putative  CYP3A  form)  in 
marine  fish  scup.  This result suggests  that the  action of TBT may result  in the 
reduced induction response to other pollutants such as P  AHs, and PCBs. However, 
TBT-treated blue  crab  (Callinectes  sapidus)  increased  the  protein  cross-reacting 
with anti-scup CYP3A without CYPIAI elevation (Oberdorster et aI.,  1998). The 
effect  of TBT  on  the  clam  (Ruditapes  decussata)  was  a  significant  increase  in 
testosterone level in the tissue of TBT  -exposed and a dose dependent decrease in 
the  aromatization of testosterone to  estrone and estradiol (Morcillo et  aI.,  1998), 
indicating  a  interaction  of TBT  with  androgen  metabolism  in  the  clam.  The 
treatment of  the organotin fungicide triphenyltin chloride (TPT) in the scup showed 
the  reduction  of CYPIAI  content,  but no  decrease  in  CYP3A-like  protein  and 
CYP2B-like protein (Fent et aI.,  1998). Fent et al (1998) concluded that organotin 
compounds  have  a  general  degenerative  effect  on  fish  CYP  system  and  have 
consequences on endocrine disruption.  However,  further studies of the induction 
relationship between organotin compounds and CYP3A forms  in fish need to  be 
carried out to  clearly understand whether they  are  inhibitory or not on CYP3A 
enzymes. 
Sex differences in total P450 content have been documented in several fish 
species with the lower levels of  total P450 content and P450 mediated activities in 
females than males (Gray et aI.,  1991; Larsen et aI.,  1992; Vrolijk et aI.,  1994). In 
sexually mature rainbow trout, males showed higher levels of a putative CYP3A 
protein  in  liver  microsomes  than  females  (Celander  et  aI.,  1989)  and  sexually 
mature  male  Atlantic  salmon  showed  similar  differences  (Larsen  et  aI.,  1992). 36 
Kidney micro somes from sexually mature males displayed higher cytochrome P450 
specific content and rates ofhydroxylation of  lauric acid, testosterone, progesterone 
and aflatoxin B1 than female's (Williams et aI., 1986). 
Influence  of water  temperature  on  the  total  P450  content  and  activity 
(CYP1A activity) has been studied (Andersson and Koivusaari, 1985; Hietanen et 
aI.,  1982), however the information of CYP3A against water temperature remains 
to be elucidated. Total P450 content varied during the year in the liver of  rainbow 
trout  as  the  followings  (Hietanen  et  aI.,  1982).  In autumn,  the  P450  activities 
increased with the cooling of  waters and in November it appeared that the activities 
remained  unchanged.  After adaptation to  the  cold  water,  mature trout  showed a 
lowering  of  the  monooxygenase  activities  with  the  P450  levels.  During 
prespawning period, there was a sex difference in monooxygenase activities. The 
mature female  fish  showed much lower P450 content than in both the  immature 
fish and in mature male. When the spawning period was over, P450 content started 
to  increase.  This  increase  coincided  with  the  warming  of waters.  Before  the 
intensive growth period, the monooxygenase activity is increased to  help  fish  to 
handle the increasing amounts of  foreign compounds during summer season. 
Cloning of  CYP3A forms in aquatic species 
The  first  CYP3A  form  in aquatic  species,  CYP3A27,  designated  by the 
Cytochrome P450  Nomenclature  Committee,  has  been cloned from  the  rainbow 
trout  liver  cDNA  library  and  then  sequenced  (Lee  et  aI.,  1998).  The  detail 
information  of CYP3A27  is  described  in  this  dissertation  (chapter  2).  After 
successful isolation of CYP3A27, there has been a rapid growth in the cloning of 
CYP3A  forms  in  aquatic  species.  Nine  of CYP3A  members  in  addition  to 
CYP3A27  have been submitted to  P450 Nomenclature  Committee from  aquatic 
species.  These CYP3A forms  include:  CYP3A30  (partial fragment)  from marine 37 
Fundulus  heteroclitus  (Celander  and  Stegeman,  1997),  CYP3A32  from  minke 
whale (Balaenoptera acutorostrata) (no accession number), CYP3A33 from dall's 
porpoise  (Phocoenoides  dalli)  (no  accession  number),  CYF3A34  from  steller 
sealion (Eumetopias jubatus) (no  accession number), CYF3A35 from spotted seal 
(Phocalagha) (no accession number), CYP3A36 from ribbon seal (Phoca fasciata) 
(no  accession number), CYF3A38 from medaka (Oryzias latipes) (Kullman et aI., 
2000),  CYF3A40  from  medaka  (no  accession  number),  and  CYP3A45  from 
rainbow trout (accession No AF267126) (see chapter 5). 
A full length of CYF3A38 cDNA clone was isolated containing a 1758 bp 
with an open reading frame  encoding a 500  amino  acids (Kullman et aI.,  2000). 
Comparison of the deduced amino acid sequence of  the medaka CYP3A38 to other 
known cytochrome P450 proteins  indicated that the  medaka sequence was  most 
similar to CYP3A27 of  rainbow trout with a 72% amino acid identity. Northern and 
Western blotting data demonstrated the presence of two  CYP3A related genes in 
liver of both  male  and  female  medaka  examined.  CYF3A45  was  isolated  from 
rainbow trout intestinal ceca by RACE PCR and RT-PCR (Lee and Buhler, to be 
published).  Sequencing  and  tissue  expression of CYF3A45  is  described  in  this 
dissertation chapter 5. 38 
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Abstract 
Screening ofAgt11 and Agt22A cDNA libraries oflivers from adult females 
and  embryos of rainbow trout (Oncorhynchus  mykiss),  respectively,  using rabbit 
anti-rainbow  trout  cytochrome  P450  LMC5  antibodies  showed  that  there  were 
identical  cDNAs  of 1,802  bp  nuc1eotides  with  open  reading  frames  coding  for 
proteins  containing  518  amino  acids  (59,206  Da,  pI  =  6.39).  The  cDNA  was 
assigned  CYP3A27  by  the  P450  Nomenclature  Committee to  represent  the  first 
CYP3A subfamily member reported for  aquatic species.  The deduced N-terminal 
sequence of CYP3A27 was in agreement with 8 of the  first  12  confirmed amino 
acid residues from Edman degradation of LMC5, a P450 previously isolated from 
juvenile  trout  liver.  In  similarity  comparison  between  species  by  positional 
alignment,  the  deduced  amino  acid  sequence  of rainbow  trout  CYP3A27  was 
56.4% identical with dog  CYP3A12,  56.0% with monkey CYP3A8,  54.9% with 
human  CYP3A4,  54.7%  with  rat  CYP3A9,  and  54.2%  with  sheep  CYP3A24. 
Marked differences in sex, age, and tissue expression of  CYP3A27 in rainbow trout 
were  observed  at  the  mRNA  level  as  shown  by  Northern  blots.  The  major 
extrahepatic  expression  site  for  CYP3A27  was  upper  small  intestine.  Females 
expressed considerably more  CYP3A27  mRNA than  male in the  fish  examined. 
Southern blot analysis of  restriction enzymes-digested rainbow trout genomic DNA 
demonstrated that multiple CYP3A27-related genes exist in rainbow trout. 40 
Introduction 
Cytochromes P450 (CYP) are a superfamily ofheme-containing 
monooxygenases  that  catalyze  the  oxidative  and  reductive  metabolism  of both 
exogenous  and  endogenous  substrates  (Guengerich  and  Shimada,  1991;  Lewis, 
1996; Hodgson and Levi, 1994). Coon, M.  J.  et al.  (1996) predicted that the total 
number of P450s per mammalian species is at least 60. About 500 P450s divided 
into 74 gene families have been reported by 1996 (Nelson et aI.,  1996). The first 
four  P450 families,  CYP1  to  CYP4, are  responsible for catalyzing the oxidation 
reactions that primarily convert foreign lipophilic compounds to more hydrophilic, 
readily  excretable  products;  however certain  substrates  are  metabolized  to  more 
toxic species (Nelson et aI., 1993; Gonzalez, 1990). 
P450s in rainbow trout are likely as diverse as known mammalian forms. 
Rainbow trout (Oncorhynchus  mykiss)  is used frequently  as  a model species for 
endocrine, toxicological and carcinogenesis research (Anderson et aI., 1996; Bailey 
et aI.,  1996).  Many studies have been reported on the isolation, purification and 
characterization of P450 isoforms from  rainbow trout (Buhler and Wang-Buhler, 
1998).  Five  forms  of P450,  LMC1  to  LMC5  with  relative  molecular  mass  of 
50,000,  54,000,  56,000,  58,000,  and  59,000  have  been  purified  and  partially 
characterized from the liver of untreated juvenile male rainbow trout (Miranda et 
aI.,  1989). Two of these P450s have been cloned, sequenced and assigned to two 
new P450 subfamilies by the P450 Nomenclature Committee as CYP2Ml (LMCl) 
(Yang  et  aI.,  1998)  and  CYP2Kl  (LMC2)  (Buhler  et  aI.,  1994).  We  now  are 
reporting  the  first  CYP3A  family  member,  CYP3A27,  in  an  aquatic  species 
(rainbow trout) which encodes a LMC5-like protein. An earlier report (Miranda et 
aI.,  1991) suggested that LMC5 and human CYP3A4 had structural similarities on 
the  basis  of the  ability  of P450  LMC5  to  catalyze  the  6~-hydroxylation of 
progesterone and testosterone and the inhibition ofits activity by mechanism-based 
inhibitors  and  an  antibody  against  humanCYP3A4.  It was  reported  recently 41 
(Celander  et aI.,  1996)  that rainbow  trout  LMC5,  rainbow  trout  P450con,  scup 
P450A, cod P450b and mammalian CYP3A (human CYP3A4, rat CYP3A1) are all 
immunochemically related.  The current study confirmed that CYP3A27  (LMC5) 
from rainbow trout is structurally very close to many CYP3A subfamily members. 
A  372-bp  cDNA  fragment  from  killifish  liver,  CYP3A30,  has  recently  been 
reported (Celander and Stegeman, 1997). In this study, we have also examined the 
transcriptional expression of  CYP3A27 in various tissues and at different ages and 
sexes. Preliminary data on CYP3A27 appeared earlier (Lee et aI., 1997). 42 
Materials and Methods 
Experimental animals 
Various  ages  of rainbow trout  (0.  myldss) of the Mt.  Shasta strain were 
supplied from  the MarinelFreshwater Biomedical Sciences Center aquatic facility 
of  Oregon State University, Corvallis, Oregon. 
Sampling of  tissues 
Livers from rainbow trout embryos (1-2 days prior to hatching) were 
Removed by dissection and tissues  from  older trout were collected as  described 
previously (Buhler et aI., 1994; Wang-Buhler et aI., 1997). 
Materials 
Restriction  enzymes  (EcoRI,  HindUI,  Kpnl,  Notl,  San,  and )(bal),  were 
from  Stratagene  (La  Jolla,  CA)  or  New  England  Biolab  (Beverly,  MA).  The 
SuperScript Lambda system  for  cDNA  synthesis  and  A.  cloning  using  A.gt11  or 
""gt22A  vector were from  GIBeO BRL (Grand Island,  NY).  [125I]-protein A (30 
JlCilJlg)  was  from  ICN  (Costa  Mesa,  CA),  and  isopropyl-l-thio-P-D­
galactopyranoside (IPTG) was from GBT (Gold Bio Technology, St.  Louis, MO). 
Other reagents used were from  the same source as  described earlier (Yang et aI., 
1998; Buhler et aI., 1994) or as stated in the text. 43 
Extraction of poly (AtRNA 
Poly (At RNA from 1-y, 2-y and 3-y male, female, liver and kidney were 
extracted by using QuickPrep mRNA Purification Kit (pharmacia-LKB, Uppsala, 
Sweden) except that the tissue homogenization step was replaced by grinding the 
frozen tissue under liquid nitrogen as described earlier (Wang-Buhler et aI.,  1997). 
Embryonic liver mRNA was prepared the same way except that the total number of 
embryos (1-2 days before hatching) used was 100 which gave about 45 mg ofliver 
(wet weight). The total amount of mRNA recovered from the livers of those 100 
embryos was about 3 J.l.g. 
Extraction of total RNA 
Total  RNA  from  various  tissues  were  extracted  by using  TRI  Reagent 
(Molecular Research Center, Cincinnati, OH) and quantitated as  described earlier 
(Wang-Buhler et aI., 1997). Tissues examined were: livers and kidneys of6-mo and 
3-y fish;  and brain, liver, muscle, upper small intestine, kidney (head and trunk), 
stomach (top, middle, and bottom sections), heart, and testis/ovary of2-y fish. 
Genomic DNA isolation 
Rainbow trout genomic DNA was isolated from the liver of 2-year female 
by the use ofDNAzol (GIBCO BRL, Grand Island, NY). 
Construction of the eDNA library 
A A.gt11  cDNA library was constructed from poly(At RNA of 1- to 3-year 
female  liver and the library of A.gt22A  cDNA was  from the mRNA of 1-2  days 44 
before hatching embryo livers, respectively, as described earlier (Yang et aI., 1998; 
Buhler et aI.,  1994) using SuperScript Lambda system for cDNA synthesis and  ')... 
cloning  according  to  the  manufacturer's  manual.  The  adapter  arms  contained 
EcoRl,  Not1,  and  Sail  sites.  The  ')...  gtll  cDNA  library  was  amplified  in 
Escherichia coli Y1088 and ')...gt22A cDNA library was not amplified. 
Screening of  19t1l and 19t22A cDNA libraries with Anti-LMC5 IgG 
Specific CYP3A27 clone was isolated by screening the cDNA libraries with 
polyclonal  antibodies  raised  in  rabbit  against  purified  rainbow  trout  liver P450 
LMC5 as described (Yang et aI.,  1998; Buhler et aI., 1994; Young and Davis, 1983) 
using  a  secondary  antibody  and  color  reaction  or e
25I]-protein  A  to  detect  the 
positive clone. Approximately 5 x10
6  phage (accumulated) from the Agtll  library 
and  10,000 pfu from Agt22A  cDNA library  (unamplified) were screened.  After a 
sequential  fourth  round of screening,  positive plaques  were selected.  The phage 
was  amplified  in  E.  coli  YI088,  the  WNA was  extracted  and  its  insert  was 
subcloned into  pSPORT  1 vector  through the  Sal  I  site of the  adapter  arm  for 
subsequent sequencing. 
Sequencing the positive clones from anti-LMC5 IgG screening 
Recombinant  plasmid  pSPORT1-cDNA  from  the  positive  clone  was 
amplified in shaking culture in LB  medium and was purified using FlexiPrep Kit 
(pharmacia-LKB Biotech). DNA sequencing was carried out by an automatic DNA 
sequencer CABI PRISM Model 377), serviced by the Center for Gene Research and 
Biotechnology,  Oregon  State  University.  Sequencing  was  done  by  the  chain 
terminator method  of Sanger with  fluorescence  dye-labeled  dideoxynucleotides. 
Each  base  was  determined  at  least  once  in  both  directions  by  synthetic 45 
oligonucleotide  pnmers  designed  from  determined  nucleotide  sequence. 
Chromatograms (ABI prisms) of sequenced data were analyzed and assembled by 
the use of the MacVector 5.0.1  software and also edited visually. Deduced amino 
acid sequences of  other CYP3A family members were obtained from the GenBank 
database for alignment analysis. 
Edman degradation 
Trout liver cytochrome P450 LMC5  was purified previously (Miranda et 
aI.,  1989).  The purified protein (100 pmol) was e1ectroblotted onto Immobilon-P 
(Millipore)  neutral  nylon membrane  and  amino  acid  residues  of the  N-terminal 
amino  acid  sequence  were  then  identified  by  the  Edman  method  using  an 
automated protein sequencer, Applied Biosystem 477 A. 
Delayed  extraction-matrix-assisted  laser  desorption/ionization  mass 
spectrometry (DE-MALDI MS) 
The molecular mass of  the purified  LMC5 was determined by DE-MALDI 
mass spectrometry on a custom-built time-of-flight mass spectrometer as described 
(Yang et al.,  1998; Buhler et al.,  1994) except with a-cyano 4-hydroxy cinnamic 
acid (Aldrich Chemical Company, Milwaukee, WI)  as the matrix and aCHG (a-
chymotrypsinogen) (SIGMA, 8t. Louis, Mo) as the standard. 
Northern blot 
Northern blot analysis was  carried out as  described previously (Buhler et 
aI.,  1994).  Briefly,  total  RNA  samples  were  glyoxyiateIDM80  treated  and 
separated on 0.8% agarose  gel  in circulating  10  mM sodium phosphate, pH 7.0, 
buffer.  After transfer and hybridization, the  final  stringency wash was 20 min at 46 
SO°c.  The washed membrane was exposed to  an X-ray film (XAR S,  Kodak) for 
quantitation. Quantitation was carried out using a Personal Densitometer SI (PDSI­
PC, Molecular Dynamics, Sunnyvale, CA). The quantitative values of the detected 
mRNAs were normalized with the  internal  standard  (a small  subunit of the  18S 
rRNA, which was detected by a [ 'Y-32p] -labeled universal  IS-mer oligonucleotide 
(Lane et aI.,  1985).  The densities in pixels of the  samples were corrected for the 
background by either automatic  local average or by  manual  subtraction for  each 
individual band. The images on the X-ray film were scanned and presented using a 
ScanJet  4C  scanner  (Hewlett-Packard)  and  PowerPoint  software  (Microsoft), 
respectively. The composition of many solutions and buffers used in the Northern 
blots were described in the standard laboratory manual (Sambrook et aI.,  1989). 
Southern blot 
Southern blotting (Southern,  1975) was performed as  described (Buhler et 
al  1994; Yang et aI.,  1998) with slight modification. Briefly, trout genomic DNA 
was  digested  with  EcoRl,  KpnI,  Hind  III,  XbaI  and  various  combinations.  The 
CYP3A27  cDNA  nucleotide  sequence  did  not  contain  those  restriction  sites. 
Digested DNA was separated by electrophoresis on a 0.7% agarose gel in IX TBE 
buffer (90 mM Tris-Borate, 2 mM EDTA, pH 8.0). After separation, the DNA was 
transferred to  a Hybond N+ membrane (Amersham) with the transferring medium 
of 7.S  mM NaOH for 30 hr. The transferred DNA on the membrane was fixed by 
baking at 80°C for 2 hrs. The nucleotide sequence at the central part of CYP3A27 
eDNA,  which  is  away  from  the  N-terminal  membrane  binding  region  and  the 
proximal cysteine-containing heme binding domain, was chosen as a probe for the 
Southern  blot.  This  probe  was  obtained  by  PCR  using  a  forward  primer of S'­
TCTTCTACCCTGCTGAGC-3',  a  reverse  pnmer  of  S'­
TCAACACACAGTCCAAA  TGGTCCA-3' and CYP3A27 eDNA as the template. 47 
PCR was performed by a Robocycler (Stratagene La Jolla, CA) and was carried out 
for  35  cycles after a 4 min hot start at  94°C  with TaqStart antibody (Clonetech, 
Palo Alto, CA). The PCR protocol consisted of denaturing/annealing /extending at 
1 min each at 95°C/56°C172°C for 35 cycles followed by a final extension at 72°C 
for 30 min. The final PCR product was named as 3A27PCR637 and used as a probe 
for  Southern blotting.  The probe was random labeled with  [a)2P]CTP  the same 
way as in Northern blot. Hybridizations were carried out with Rapid Hyb solution 
(Amersham Pharmacia biotech) at 65°C for 2hr with labeled probe then washed as 
described (Yang et aI.,  1998; Buhler et aI.,  1994). Final stringency wash was with 
O.IX  SSC/O.l%  sodium dodecyl  sulfate  at 65°C  for  30 min (a  Ix SSC solution 
contains  150  mM sodium chloride  and  15  mM  sodium  citrate).  The  hybridized 
DNA bands were visualized by autoradiography on X-ray film and presented the 
same way as for the Northern blots. 48 
Results and Discussion 
Establishing the foundation for the cloning of a cDNA encoding for a rainbow 
trout LMC5-like protein 
Northern blot analysis of poly (At RNAs from  1,  2,  and 3-year male and 
female  liver  and  kidney  probed  with  e
2P]-labeled  oligo  LMC5N23  (5'­
ATGTTYYTITTYYTICCITAYTT-3', where Y is CIT, 1 is inosine) generated from 
the N-terminal amino acids, showed faint bands for female livers of all ages tested 
(Fig.  2.1 A).  Therefore, equal amounts of female liver mRNA from  1, 2 and 3-year 
were mixed and used for the construction of a cDNA library in  Agt11  expression 
vector, which was subsequently used in the screening. Western blot analysis using 
anti-LMC5  IgG  as  a  primary  antibody  and  detected  by  [1251]  protein  A  was 
conducted on female  trout liver homogenate,  Agt11  phage,  and  the host cells to 
examine the antibody's specificity (Fig. 2.1B). Results demonstrated that the Agt11 
phage and the host cells that we planned to  use  in the screening process did not 
produce proteins that were immunologically reactive with anti-LMC5 IgG. 
Screening of  cDNA libraries and cloning the adult and embryonic CYP3A27 
The screening  and cloning protocols were described under Materials  and 
Methods.  Screening  for  LMC5  gave  us  much more  difficulty than our previous 
screening of LMCI (Yang et at, 1998) and LMC2 (Buhler et at, 1994). Repeated 
antibody  screening  of Agtll  cDNA  library  with  anti  LMC5  yielded  only  one 
positive clone  and antibody  screening  of Agt22  cDNA  library  gave  two  positive 
clones. Separation of Sail digested recombinant ADNA indicated the expected size 
(close to 2kb) insert (Fig. 2.1C). The DNA band shown in Fig.  2.1C was cut and 
the DNA was recovered by spin column (Supelco, Bellefonte, P  A), and ligated into 49 
Fig. 2.  1.  Establishing the foundation  for  the cloning of a cDNA encoding for  a 
rainbow  trout  LMC5-like  protein.  The  details  of each  experiment  are  in  the 
Methods.  A.  Northern blot analysis of mRNAs. Each group of males and females 
consisted of l-y, 2-y and 3-y old fish (from left to  right) and the organs (liver or 
kidney) are indicated on the top.  Each lane was loaded with 0.3  Ilg of mRNA. The 
probe  was  LMC5N23  as described in  Methods.  B.  Western blot probed with anti 
LMC5  IgG:  lane  1,  purified LMC5  (l pmol) as  positive control;  lane  2,  loading 
buffer  as  a  blank;  lanes  3  and  5,  50  Ilg  protein  from  a  female  trout  liver 
homogenate;  lanes  4 and 6,  10  Ilg  protein from  a female trout liver homogenate; 
lane 7, "'gtll phage; and lane 8, host cell (YI090r). C.  Separation of Sal I digest 
of positive phage DNA on  1%  agarose  gel.  Lane  1 was  DNA  1 kb  size marker. 
Lanes 2 and 4 were  loaded 5 Ilg of digested DNA.  Arrow indicates the expected 
cDNA position. D. Verification ofpSPORT 1 inserts in 1% agarose gel.  Lane  1,  1 
kb DNA ladder; lane 2, pSPORT 1 untreated; lanes 3 and 4, positive clone digested 
with restriction enzyme, Sal I; and lanes 5 and 6, positive clone undigested. Arrow 
indicates insert. A  Liver  Kidney 
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pSPORT 1 vector through Sal I site for  subsequent sequencing. The  1.8-kb insert 
was verified by Sal I digestion (Fig. 2.1D). 
Sequence analysis 
The recombinant plasmid, pSPORT-cDNA, was sequenced using SP6 and 
T7  primers  and  870  bp  was  registered  from  the  sequencing  for  both  primers. 
BLAST searching through GenBank found  high matches with CYP3A subfamily 
members.  Subsequent sequencing was  carried out by  plasmid walking 7 times (4 
senses of 18-mers; s273, s609, s943, and s1456, and 3 anti-senses also of 18-mers: 
a1553,  a1248,  and  a 404;  where the  number represent the  5'  starting  nucleotide 
position in reference to  Fig.  2.  2) to confirm the nucleotides for both strands. The 
nucleotide and the deduced amino acid sequences of  the cDNA are shown in Fig.2. 
2.  The  isolated  1802-bp  nucleotide  encoding  for  a protein of 518  amino  acids 
(PI=6.39  from  MacVector software) and a deduced minimum molecular mass of 
59206 Da, which matches closely with the mass of 59,289 ± 68  (±2cr) Da obtained 
from  DE-MALDI  MS  analysis  of the  purified  LMC5  protein.  The  nucleotide 
sequence was submitted to the P450 Nomenclature Committee and was assigned as 
CYP3A27 to represent the first CYP3A family member of cytochrome P450 in an 
aquatic species. 
A poly(A) tail is not present in this clone, perhaps due to the fact that this 
cDNA was not primed by an oligo(  dT) primer (cDNA was constructed using both 
oligo(dT)  primer  and  random  hexamer  as  primers).  In addition  to,  no  putative 
polyadenylation  signal  was  found  but  the  cDNA  clone  had  (CT)9-11  repeats  (8 
nucleotide downstream of a CCCTACCC sequence which could be a substitute for 
CCCACCC protein binding motif) separated by TCC, and C4-5 repeats separated by 
TC. The meaning of  this CT  -rich region in rainbow trout is unclear but it could be 
related  to  regulation of protein translation  which  sometimes  is  via binding of a 52 
Fig. 2. 2.  Nucleotide and deduced amino acid sequences of CYP3A27 from rainbow 
trout. The start codon A  TG is shaded and the stop codon TGA has an asterisk.  The 
heme-binding domain is boxed in with double lines (amino acids No. 439 to 454). The 
single  line  boxes  spread  throughout  the  entire  sequence  indicate  short  consensus 
amino acids sequences among the selected 17 CYP3A subfamilies listed in Table 2.  2. 
The double underlined sequences were the primers used to obtain PCR fragment (nt: 
609-1245,  3A27PCR637, Fig.  2.  5A)  which was used  for  the  Southern blot.(Fig.  2. 
5B). 53 
Tcagaccatcggagaagtgaacttgaacgaacctgagagaaaacggagcctttgttttctgccgcgtcac  70 
agaagaaccacactagaacttgaacagaaaaaaacaactcaaaacctgagaagcagcagggagccgaaccggaggaaag  149 
ATG  ATG  AGT  TTT  CTA  CCA  TAC  TTC  TCC  GCT  GAG  ACC  TGG  ACC  CTC  CTG  GCC  CTC  CTC  ATC  209 
M  M  S  F  L  P  Y  F  S  A  @  T  ~  T  L  L  ALL  I  20 
ACC  CTC  ATT  GTA  GTG  TAC  GGG  TAC  TGG  CCC  TAT  GGT  GTA  TTC  ACT  AAG  ATG  GGT  ATC  CCT  269 
T  L  I  V  V  Y  G  Y  W  P  Y  G  V  F  T  K  M  F  I  ~  40 
GGT  CCC  AAA  CCC  CTA  CCT  TAC  TTT  GGC  ACA  ATG  TTG  GAG  TAT  AAA  AAG  GGC  TTC  ACT  AAC  329 
I G  P  K  P  L  ply  F  G  T  M  LEY  K  K  G  F  T  N  60 
TTT  GAC  ACA  GAG  TGC  TTT  CAG  AAG  TAC  GGG  AGA  ATC  TGG  GGG  ATC  TAT  GAT  GGG  AGG  CAG  389 
F  D  T  E  C  F  Q  ~  Y  G  R  I  W  G  I  Y  D  G  R  q  80 
CCT  GTT  CTG  TGT  ATC  ATG  GAC  AAA  AGC  ATG  ATC  AAG  ACC  GTC  CTG  ATT  AAG  GAG  TGT  TAC  449 
~  V  ij  C  I  M  D  K  8  M  ~  K  T  V  L  IKE  C  ij  100 
AAC  ATC  TTC  ACC  AAC  CGC  AGG  AAC  TTC  CAT  CTG  AAT  GGT  GAG  CTG  TTT  GAT  GCG  TTG  TCC  509 
N  I  ~  T  N  R  ~  N  F  H  LNG  ELF  D  A  L  8  120 
GTT  GCC  GAG  GAC  GAT  ACA  TGG  AGA  CGG  ATC  CGC  AGT  GTC  CTC  TCA  CCT  TCC  TTT  ACC  TCT  569 
V  A  E  ~  D  T  W  R  R  I  R  8  V  L  8  P  8  F  T  81  140 
GGA  CGA  CTA  AAA  GAG  ATG  TTT  GGT  ATC  ATG  AAG  CAG  CAC  TCT  TCT  ACC  CTG  CTG  AGC  GGA  629 
I G  R  L  K  E  M  Fj  G  I  M  K  Q  H  8  8  T  L  L  8  G  160 
ATG  AAG  AAG  CAG  GCA  GAT  AAA  GAC  CAG  ACC  ATT  GAA  GTG  AAG  GAG  TTC  TTT  GGG  CCC  TAC  689 
M  K  K  Q  A  D  K  D  Q  TIE  V  KEF  F  G  P  ~  180 
AGT  ATG  GAC  GTG  GTC  ACC  AGC  ACA  GCT  TTC  AGT  GTG  GAC  ATT  GAC  TCT  CTG  AAC  AAC  CCT  749 
IBM  D  V  I  V  T  8  T  A  F  8  V  D  II  D  8  L  N  N  ~  200 
TCA  GAC  CCC  TTT  GTC  TCC  AAC  GTC  AAG  AAG  ATG  CTC  AAG  TTC  GAC  CTG  TTC  AAC  CCA  CTG  809 
S  ~  P  F  VI  S  N  V  K  K  M  II'  K  F  III  L  F  N  P  L  220 
TTC  CTC  CTA  GTC  GCT  TTG  TTT  CCC  TTC  ACT  GGT  CCT  ATT  TTG  GAG  AAG  ATG  AAG  TTT  TCT  869 
F  L  L  V  A  L  F  P  F  T  G  P  I  L  E  K  M  K  F  S  240 
TTC  TTC  CCG  ACT  GCG  GTG  ACA  GAC  TTC  TTT  TAC  GCC  TCG  CTG  GCT  AAG  ATC  AAA  TCT  GGA  929 
F  F  PTA  V  T  D  F  F  Y  A  S  L  A  K  I  K  S  G  260 
CGT  GAC  ACT  GGG  AAC  TCA  ACT  AAT  CGG  GTG  GAT  TTC  TTA  CAG  CTG  ATG  ATC  GAC  TCT  CAG  989 
R  D  T  G  N  S  T  N  W V  D  F  L  Q  L  MID  S  q  280 
AAA  GGC  AGT  GAC  ACA  AAG  ACA  GGA  GAG  GAA  CAG  ACT  AAA  GGA  CTG  ACT  GAT  CAT  GAG  ATC  1049 
K  G  S  D  T  K  T  GEE  Q  T  K  G  LTD  H  E  I  300 
TTG  TCT  CAG  GCC  ATG  ATC  TTC  ATC  TTC  GCC  GGC  TAC  GAG  ACC  AGC  AGC  AGT  ACT  ATG  AGT  1109 
L  S  Q  A  M  ~  F  I  FAG  Y  E  ~  S  S  8  T  M  S  320 
TTC  CTG  GCC  TAT  AAC  TTG  GCA  ACC  AAC  CAC  CAT  GTC  ATG  ACC  AAA  CTG  CAG  GAG  GAG  ATA  1169 
F  LAY  N  L  A  T  N  H  H  V  M  T  ~  L  Q  E  E  II  340 
GAT  ACT  GTG  TTC  CCC  AAC  AAG  GCT  CCA  ATC  CAG  TAC  GAA  GCT  CTG  ATG  CAG  ATG  GAC  TAT  1229 
[£J  T  V  F  P  N  K  A  P  I  Q  YEA  L  M  Q  M  D  Y  360 
TTG  GAC  TGT  GTG  TTG  AAC  GAG  TCT  CTG  AGA  CTG  TAC  CCC  ATC  GCC  CCG  CGA  CTA  GAG  AGG  1289 
L  D  C  & L  N  ~  8  II'  R  L  Y  P  I  APR  L  E  ~  380 
GTC  GCC  AAG  AAG  ACG  GTG  GAG  ATC  AAC  GGC  ATC  GTC  ATC  CCC  AAA  GAC  TGC  ATT  GTC  CTG  1349 
~  A  K  K  T  V  E  I  N  G  I  V  I  P  K  DeI  V  L  400 
GTT  CCC  ACG  TGG  ACC  CTC  CAT  CGT  GAC  CCA  GAG  ATC  TGG  TCT  GAC  CCT  GAG  GAG  TTC  AAA  1409 
V  P  T  W  if  L  H  R  ij  PEl  W  S  D  ~  E  E  ij  K  420 
CCA  GAG  CGG  TTC  AGT  AAG  GAG  AAC  AAG  GAG  TCT  ATT  GAT  CCG  TAC  ACA  TAC  ATG  CCA  TTT  1469 
IPER  F  SJ  KEN  K  E  SID  IP  Y  T  ij  M  E:3  440 
GGG  GCG  GGG  CCC  AGG  AAC  TGT  ATC  GGG  ATG  CGC  TTC  GCC  CTG  ATC  ATG  ATC  AAA  CTG  GCC  1529
@ A  G  P  R  N  C  I  G  M  R  F  A  4  I  M  I  ~  L  ~  460 
ATG  GTC  GAG  ATC  CTC  CAG  AGT  TTC  ACT  TTC  TCC  GTC  TGT  GAC  GAG  ACC  GAG  ATC  CCT  CTG  1589 
M  V  E  I  L  Q  S  F  T  F  S  V  C  D  E  T  E  I  P  L  480 
GAG  ATG  GAC  AAC  CAG  GGT  CTG  CTG  ATG  CCA  AAA  CGA  CCA  ATC  AAA  CTG  AGG  CTG  GAG  GCC  1649 
E  M  D  N  Q  G  L  L  M  P  K  R  P  I  K  L  R  LEA  500 
CGT  AGA  AAC  ACC  CCT  AGC  AAC  ACC  ACC  GCT  ACC  ACT  CTG  AAG  AGT  CCA  ACA  ACG  TGAtcaa  1710 
R  R  N  T  P  S  N  T  TAT  T  L  K  S  P  T  T  *  518 
Atgcaggagcaccctaccctggagtacctctctctctctctctcttccctctctctctctctctctctcttccccctct 1786 
cccccctcccccc  1802 54 
protein to its pre-mRNA at the 3'-UTR (Boelens et aI.,  1993).  It has been reported 
that multifunctional DNA-binding protein, Abflp, in yeast binds specifically to the 
d(CT)  repeat  sequence  in the  promoter  region  of HIST gene,  affecting  its  gene 
regulation (Springer et aI.,  1997).  An autoregulation feed-back process also could 
occur in the 3'-UTR (Poulos et aI.,  1987).  The regulation in the  3'-UTR could be 
function-specific (Poulos et aI.,  1987). The 3' CT repeat also could be involved in 
mRNA stabilization. 
The deduced 518 amino acid sequence was compared with other sequence 
data in  a  BLAST  search.  The  peptide  sequence  was  found  to  have  the  highest 
percentage  identity with dog  3A12  (56.4%),  followed  by monkey  3A8  (56.0%), 
human 3A4 (54.9%), rat 3A9 (54.7%), and sheep 3A24(54.2%). Figure 2.2 shows 
that there are many short consensus sequences (in boxes) within the open reading 
frames  of the  17  CYP3A  family  cDNAs.  The  high  percentage  identities  in 
alignment of CYP3A27 with other mammalian CYP3A forms  suggests that there 
was  a  significant  sequence  retention  during  evolutionary  divergence  between 
terrestrial and aquatic vertebrates. 
One of  the two positive clones obtained from screening the "'gt22A cDNA 
library  from  embryonic  trout  livers  also  was  subcloned  into  pSPORT  1  and 
subsequently sequenced the same way as for the positive clone obtained from the 
",gtll  cDNA  library.  An identical  sequence  was  obtained.  In  humans,  an  adult 
specific form  (CYP3A4) and a fetal  specific form  (CYP3A7) have been reported 
(Komori et aI.,  1990). While this does not seem to be the case in trout, this isolated 
cDNA form  from  embryo  liver cDNA  library  may  not  represent all the  CYP3A 
forms  in the entire embryonic mRNA pool.  Hence the possibility still exists that 
there are other CYP3A forms  in the  embryonic stage of development in rainbow 
trout. 55 
N-terminal amino acid comparison and analysis 
The N-terminal amino acid sequences for the purified P450 LMC5 obtained 
from Edman degradation was compared with that of  amino acid sequences deduced 
from CYP3A27 nucleotide sequences. The deduced amino acid sequences showed 
agreement 8 of  the first 12 confirmed Edman amino acid residues (Table 2.  1). This 
low percentage (66%)  match suggests that the  cloned  CYP3A27  may  not  be  the 
cDNA coding  for  LMC5  but  for  a closely  related  LMC5-like  protein.  The  low 
percentage agreement  in sequence  could  also  be  due  to  the  uncertainties  in  the 
Edman analysis resulting from the high sample molecular mass, the small sample 
size used for the analysis, or an impure LMC5 sample. 
The first 40 amino acids obtained from the N-terminal sequence of 
CYP3A27  showed  hydrophobic  characteristics  of membrane  bound  proteins. 
Comparison (by the Mac Vector program) of this N-terminal sequence with other 
CYP3A  families  revealed  similar  hydrophobic  plot  patterns  using  Mac Vector 
program  (data  not  shown).  The  N-terminal  leucine-rich  region  coding  for  the 
peptide  with  the  greatest  hydrophobicity  has  been  proposed  to  be  involved  in 
membrane recognition and binding (Black, 1992). 
Comparison and analysis of the CYP3A27 putative heme-binding domain with 
those of other CYP 3A members 
Comparison of the CYP3A27 putative heme-binding domain, residues 439 
to  455,  with  16  of other  CYP3A  members  showed  a  consensus  amino  acid 
sequence of PFGXGPRNCIGMRF  ALM (Table 2.  2).  This sequence is  very close 
to  the proximal  cysteine-containing  consensus  decapeptide  responsible  for  heme 
binding in "classical P450s" (Poulos et aI.,  1987). Several highly conserved amino 
acids with special functions are present. Those amino acids are F, G, R, C, I and G 
and their  special  function  have  been  described  by  Mansuy  and  Renaud  (1995). 56 
Table 2.1. Comparison ofthe N-tenninal amino acid sequences between LMC5 
and CYP3A27. 
Source  Method  Amino acid sequences 
LMC5  Edman  M  M(F)a  L  F  L  pa(l)  Y  F  E(D/G) a A  W(D/R) a .D(T) a 
Degradation 
CYP3A27  Deduced  MM  SFLP  YFS  A  E  T 
Note.  More  Edman  degradation  infonnation  as  follows:  (1)  Sample  (purified 
LMC5) amount analyzed was 100 pmol. The estimated relative molecular mass of 
the  purified  LMC5  was  59,  000.  (2)  Theoretical  initial  yield  was  2.49  pmol 
(2.49%). (3) Total Edman degradation cycle was 20; only the first  12  amino acids 
are  presented  in  the  table.  There  were  two  more  matches  at  the  corresponding 
position in the next 8 amino acids. (4) Average amino acid repetitive yield of  the 20 
cycle was 92.54%. (5) Combined amino acid repetitive yield of the 20 cycles was 
92.41 % with variance of 0.192.  aThis amino acid was manually edited. All  other 
amino  acids  were  assigned  by  the  built-in  computer  of the  automated  protein 
sequencer. Table 2.2. Comparison of  amino acid sequences in heme-binding domains of  rainbow trout CYP3A27 
and mammalian CYP3A subfamilies 
CYP3A (source)  Accession No.  Amino acids in the heme-binding domains of selected CYP3As 
------------------------~----------------------
CYP3A27 (trout) (U96077) 
CYP3A12 (dog)  (X54915) 
CYP3A8 (monkey) (S5304 7) 
CYP3A4 (human)  (M18 907) 
CYP3A4 (human)  (X12387) 
CYP3A9(rat)  (U46118) 
CYP3A24 (sheep) (U59378) 
Cyp3a13 (mouse) (X63023) 
CYP3A6 (rabbit) (J05034) 
CYP3A5 (human)  (J04813) 
CYP3A3 (human)  (000003) 
CYP3A7 (rabbit) (000408) 
CYP3A6 (rabbit) (M19139) 
CYP3A1(rat)  (M10161) 
CYP3A23 (rat)  (X96721) 
CYP3A11 (mouse) (X60452) 
CYP3A2(rat)  (M13646) 
CYP3A  heme-binding 
domaina(consensus) 
439  
P 
P 
P 
P 
P 
P 
P 
P 
P 
P 
P 
P 
P 
P 
P 
P 
P 
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F 
F 
F 
F 
F 
F 
F 
F 
F 
F 
F 
F 
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G 
G 
G 
G 
G 
G 
G 
G 
G 
G 
G 
G 
G 
G 
G 
G 
P  F  G 
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N 
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G  P  R 
G  P  R 
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G  P  R 
G  P  R 
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G  P  R 
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G  P  R 
G  P  R 
G  P  R  N 
-
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aAmino acids underlined have special functions as described in Mansuy and Renaud (1995). Among them 
the cysteine is a required amino acid for heme binding. bX refers to amino acids, S, N, A, or T. 
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These  CYP  heme  binding  regIOns  have  been  remarkably  conserved  during 
evolution. 
Transcriptional expression of CYP3A27 in various tissues with respect to age 
and sex 
Northern  blot analysis  was  carried  out  as  described  under Materials  and 
Methods to investigate the tissue specific expression of CYP3A27 at transcriptional 
level using the  full  cDNA as  probe.  Obvious sex differences in expression in the 
2-year old fish  were seen in  both liver and  intestine samples.  In male  liver,  two 
major CYP3A27 hybridized bands at about 4 and 2.8  kb  and a minor band at  1.9 
kb, one minor band at 1.9 kb, and two faint bands at 4 and 6 kb were observed (Fig. 
2. 3B). We have seen similar mRNA patterns in Northern blot for other trout P450s 
e.g.  CYP2Kl  (Buhler  et  aI.,  1994),  and  CYPIAI  in  embryo  and  adult  livers 
(unpublished data).  The  nature  of each band  is  unknown.  They could  represent 
different CYP3A27-related genes and they also could be  the result of alternative 
splicing  affected  by  age,  hormone,  tissue-specific  factors,  environment,  etc.  We 
also  could not rule  out the possibility of alternate polyadenylation signals  which 
have been reported for other genes (Black, 1992). In male intestine, the 2.8-kb band 
was barely detectable (Fig. 2. 3A, lanes 4 and 7; much less intensity than the band 
seen in the liver- Fig.  2.  3A,  lane 2) in this fish.  In  contrast, the female  intestine 
expressed more than 2-fold CYP3A27 hybridizable mRNA than liver (Fig.  2.  3B, 
lanes 4 and 7 vs lane 2). Sex differences also were observed in the 3-year old trunk 
kidney (Fig. 2.  4B, lanes 7-12) where male showed high expression of the 2.8-kb 
mRNA (Fig.  2.  4B, lanes 7-9) but very little expression of the same size mRNA 
were seen in the female trunk kidney (Fig. 2. 4B, lanes 10-12). We had previously 
shown two similar major bands at 2.8 and 1.9 kb with rainbow trout CYP2kl (P450 
LMC2) which demonstrated major sex-related differences of LMC2-related protein 
expression in liver and trunk kidney microsomes during the late reproductive stage 59 
Fig. 2. 3. Northern blot analysis of CYP3A27 mRNA in various tissues of 2-y old 
rainbow trout.  Total RNA, 6  J..lg,  was  loaded in  each lane and separated on 0.8% 
agarose gel as described in Methods. The abbreviations are as follows: B (brain). L 
(liver), M (muscle), I (intestine, lanes 4 and 7 which were duplicate samples), HK 
(head kidney), TK (trunk kidney), St (stomach top, near esophagus), Sm (stomach 
middle),  Sb (stomach bottom part, near pyloric ceca),  H (heart),  T (testis), and 0 
(ovary). Size in kb was estimated based on previous RNA markers in relation to the 
18S  and  28S  methylene  blue  stains.  Internal  standard  was  18S  rRNA  (bottom 
sections with arrows) probed with 1406R. A. Male. B. Female. A.  Male - 2-y 
1  2  3  4  5  6  7  8  9  10  11  12  kb 
285  ~4 
~ 2.8 
185  ~ 1.9 
B  L  M  I  HK  TK  I  St  Sm  Sb  H  T 
B.  Female - 2-y 
1  2  3  4  5  6  7  8  9  10  11  12 
kb 
~6 
~4 
..- 2.8 
~ 1.9 
1406R · . 
0\ (18S)  B  L  M  I  HK  TK  I  St  Sm  Sb  H  0  o 61 
Fig. 2.  4.  Northern blot analysis of total RNA from  liver and kidney of different 
age  and  sex.  Five  ~g of total  RNA were  loaded in each lane.  Samples were  in 
triplets. A. Liver and kidney from 6-month-old (6-mo) trout of both sexes. B. Liver 
and kidney from  3-year-old (3-y) trout of both sexes.  Internal standard was  18S 
rRNA (bottom insert with arrow) probed with 1406R. ML, male liver; FL, female 
liver; MK male trunk kidney; and FK, female trunk kidney. 62 
ML  FL  MK  FK  kb 
~ 
A  1  2;  3  4  5  6  7  e  9  10  1 1  .)r ~ .  
.  /~j~ :"  ~ '~'  ~~~~ .:, I .  6-Mo ...  ,< 
4  
2.8 
1.9 
1406R 
(18S) 
B 
3-Yr 
4 

2.8 
1.9 
1406R 
(18S) 63 
of rainbow trout (Buhler et aI.,  1994). Recently, explanation was provided for the 
CYP2Kl cDNA hybridizable 2.8- kb mRNA band existing in sexually mature male 
kidney as CYP2K4 which has an extra 1 kb 3'-untranslated region. 
There were significant differences in the expression of  CYP3A27 in the 
various tissues examined. Table 2. 3 summarizes the relative intensities in pixels of 
the CYP3A27 hybridizable 4 and 2.8 kb bands from the various tissues of 2-y old 
male and  female  fish.  The highest expression site of the  4 kb  mRNA in  2-y  old 
male  occurs  in  the  liver  with  a  reduced  level  of expression  in  the  brain,  head 
kidney,  testis  and heart;  the  female  expressed relatively  little  4  kb  mRNA.  The 
highest expression site  of 2.8  kb  mRNA in 2-y  old female  was  the upper  small 
intestine and the ovary followed by the liver and the stomach. Expression of P450 
mRNA varied with cell types and their surroundings.  Hybridization intensities of 
the stomach sections were not the same, suggesting that the precise sampling sites 
were  important.  Several  reports  also  have  shown  a  hormone  effect  on  the 
appearance of a male specific or a female  specific CYP3A form  (Morgan et aI., 
1985; Simmons et al., 1985). 
Age-related differences in CYP3A27 expression also were noted (Fig.4). 
Liver  from  younger  (6-mo  old)  male  trout  showed  expression  of CYP3A27 
hybridizable mRNA at 4 kb  and 2.8  kb  (Fig.  2.  4A,  lanes  1-3)  but only  2.8  kb 
mRNA bands were seen in the 3-y old male liver (Fig.  2.  4B,  lane  1-3).  Kidney 
from younger (6-mo old) male trout exhibited barely detectable mRNA bands at 2.8 
kb (Fig. 2. 4A, lanes 7-9) in contrast, kidney of sexually mature 3-y male expressed 
high amount of the 2.8 kb mRNA and to a lesser extent the 1.9 kb mRNA (Fig.  2. 
4B, lanes 7-9). A similar high trunk kidney expression of CYP2Kl mRNA in 3-y 
male  and  not  female  trout  was  noted  previously  (Buhler  et  al.,  1994).  The 
physiological significance of those  age-,  sex- and tissue-specific expressions are 
unclear  and  need  further  study.  Recent  discovery  of tissue-specific  promoters 
involving aromatase cytochrome P450 (CYPI9) (Simpson et aI.,  1997) makes it of 64 
Table 2. 3. Comparison of  the expression of  the 4.0-kb and 2.8-kb CYP3A27 
hybridizable mRNA in 2-year rainbow trout tissues 
Net densitometer readings in pixels 
(Background subtracted a and normalized to 18S 
rRNA
b
) 
Tissues  4-kb band  2.8-kb band 
Male  Female  Male  Female 
Brain  165  92  102  13 
Liver  527  76  644  575 
Muscle  OC  OC  OC  OC 
Head kidney  102  OC  68  OC 
Trunk kidney 
Upper small intestine 
64 
OC 
46 
191 
137 
9 
70 
1405 
Stomach top section  6  30  20  97 
Stomach middle section  50  26  151  300 
Stomach bottom  27  28  75  293 
Heart  90  39  61  19 
Testis/ovary  92  51  104  1218 
a The male samples were corrected for background by automatic local average from 
densitometer readings and the female  samples were corrected for  background by 
manually correcting each individual band. Average background reading was 595 ± 
25 pixels. b Average net pixel reading for 18S bands was 965 ± 311 including males 
and females for these Northern blots (Fig. 2.  3A and 3B).  C No visible bands were 
seen for those samples under the experiment conditions. 65 
interest to investigate tissue-specific gene control for CYP3A27 and other P450s in 
rainbow trout. 
Intestine as the major extrahepatic expression site for CYP3A27 
In this  investigation the  major extrahepatic expression  site  for  CYP3A27 
mRNA was in the female upper small intestine (Fig. 2.  3B, lanes 4 and 7 and Table 
2.  3).  A comparable result was  obtained with the  Western blot  result  for  LMC5 
protein (Cok et ai.,  1998). The small intestine is an  important extrahepatic organ, 
which provides a major source of enzymes for the first-pass metabolism of dietary 
xenobiotics and drugs.  In the current study, female  rainbow trout intestine sample 
showed  significantly  more  expression  of CYP3A27  than  did  male  trout.  Many 
factors  could  contribute  to  this  difference  in  addition  to  the  natural  biological 
variations (e.g., sampling time in relation to food intake, the actual section that was 
sampled, water temperature, diet, individual hormone status, etc.).  A CYP3A-like 
P450, P450b, from the small intestine of Atlantic cod has been reported (Husoy et 
ai., 1994). 
Multiplicity of CYP3A27 in rainbow trout 
Southern blot analysis was carried out on rainbow trout genomic DNA  to 
elucidate the complexity of  CYP3A27 gene family. Results (Fig. 2. 5B) suggest that 
multiple  CYP3A27-related  genes  exist  in  the  rainbow  trout  genome,  which 
correlate to our Northern blot data (Fig. 2.  3 and Fig. 2. 4). Northern blot analysis 
of  total RNA showed two major groups of mRNA at 2.8 kb, and 4 kb, and a minor 
group  at  l.9 kb  which  were  hybridizable  to  CYP3A27  probe,  for  most  tissues 
examined.  In addition, there  was  a faint  band at  6 kb  in  the  liver and the  small 
intestine samples (Fig. 3B, lanes 2, 4 and 7). Multiple CYP forms such as CYP2AI, 66 
Fig.  2.  5.  Southern  blot  analysis  of rainbow  trout  genomic  DNA.  A.  Probe 
preparation:  PCR  reaction  was  described  in  the  Methods  and  the  product  was 
separated  on  1%  agarose  gel.  Arrow  points  to  the  expected  637  bp  product, 
3A27PCR637 (reference to  Fig.  2.  2)  which was  subsequently used as a probe in 
the  Southern  blot.  B.  Southern  blot:  Rainbow  trout  genomic  DNA  (3  Jlg)  was 
digested  with,  EcoR  I  (E),  Hind  III  (H),  Kpn  I  (K),  Xba  I  (X)  and  various 
combinations as indicated. The membrane was probed with e
2p]-3A27PCR637. E  E  X  X 
A  B  +  +  +  + 
E  H  K  X  K  H  E  H 
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CYP2B1, CYP2C8-10, CYP2D6, CYP3A and CYP4B forms have been identified 
in human and rodent small intestine and colon (Kaminsky and Fasco, 1991; Kolars 
et  aI.,  1994;  Mckinnon  et  aI.,  1993;  Kolars  et  aI.,  1992).  Further  studies  on 
CYP3A27, and rainbow trout cytochrome P450s in general, are needed in order to 
fully understand the significance of  the multiple mRNA forms, their distribution in 
relation to developmental stages and tissue, the physiological function of each P450 
isozymes (presumably much more in numbers than what is known to date), and the 
tissue-specific  gene  control  (regulation)  of their  expression.  That  information 
should be useful in establishing patterns in the evolution of  these gene families and 
to compare with P450s found in other aquatic vertebrates, mammals and especially 
human.  Such findings  also  could  be  helpful  in  understanding  the  influences  of 
environmental factors on the CYP systems. 69 
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Abstract 
In mammals  the  cytochrome  P450  3A (CYP3A)  subfamily isoforms  are 
primarily  expressed  in  liver  and  intestines  with  lesser  amounts  found  in  other 
tissues.  The  aim  of this  study was  to  examine the cellular localization and the 
expression  pattern  of CYP3A27  in  the  gastrointestinal  tract  (GI-tract)  of a 
freshwater teleost species, the rainbow trout (Oncorhynchus mykiss), a fish model 
used  extensively  for  toxicological and  carcinogenesis research.  Using an  avidin 
biotinylated enzyme complex and 3,3'-diaminobenzidine staining,  strong positive 
immunohistochemical  (IH)  staining  was  observed  for  CYP3A27  protein  in  the 
liver,  and  the  enterocytes  of the  intestinal  ceca  and  the  proximal  descending 
intestine when probed with a polyclonal antibody raised against rainbow trout P450 
LMC5, a CYP3A protein.  The staining intensity decreased distally along the GI­
tract with light staining observed in the area near the vent.  Western blot analysis 
was  supportive  of this  finding.  Northern  blot  analysis  also  demonstrated  that 
CYP3A27  mRNA  was  expressed  along  the  entire  GI-tract.  The major area of 
transcriptional  expression  was  in  the  intestinal  ceca  followed  by  the  proximal 
descending intestine at levels that were about 3-5  fold  and 2-4 fold,  respectively 
greater than that seen in the liver of  the fish studied.  These results suggest that the 
intestine  of  rainbow  trout  may  possesses  substantial  capacity  for  first-pass 
metabolism of xenobiotics by CYP3A27  which makes  it an  excellent model in 
which to study the consequence of  such metabolism. 72 
Introduction 
Rainbow  trout  (Oncorhynchus  mykiss)  have  been  extensively  used  as  a 
sensitive  experimental  model  for  environmental  toxicology  research  in  aquatic 
systems  and  as  an  alternative  vertebrate  species  for  comparative  studies  on  the 
metabolism  of toxic  substances  and  in  chemical  carcinogenesis  studies  with 
chemicals such as  aflatoxin B 1 (AFB 1)  (Bailey et aI.,  1996).  In  trout and other 
teleosts, as in mammals, the cytochrome P450 (CYP) system plays important roles 
not only in the metabolism and excretion of  endogenous and xenobiotic compounds 
but  also  in  the  biotransformation  of certain  xenobiotics  to  reactive  metabolites 
(Buhler and Williams,  1988; GOkS0yr and Forlin, 1992; Buhler and Wang-Buhler, 
1998). 
The small intestine serves as  the major route for the absorption of orally 
ingested chemicals and provides the first site for their oxidative metabolism. CYP 
mediated biotransformation of  such chemicals can occur in intestinal epithelial cells 
(enterocytes),  reducing  the  amount  of parent  drug  or  chemical  available  for 
absorption and thus limiting their beneficial or toxicological effects (Kaminsky and 
Fasco,  1992; Paine et aI.,  1997;  Hall et  aI.,  1999; Zhang et aI.,  1999).  Intestinal 
metabolism results in the formation of  metabolites that in turn can be absorbed and 
transported to  the  liver and other tissues  where they can produce physiological, 
pharmacological or toxicological effects or undergo conjugation prior to excretion. 
Intestinal biotransformation reactions also can convert some chemicals to reactive 
metabolites, leading to a greater toxicity than the parent chemical.  In some cases 
the reactive metabolites, such as those formed from AFB 1 by intestinal CYP3A4, 
covalently  bind  to  enterocyte  macromolecules  (Kolars  et  aI.,  1994).  Since  the 
enterocytes  normally  slough  off of the  villus  tips  after  a  few  days,  the  AFB1 
adducts  then  can  be  harmlessly  excreted,  reducing  the  toxicity  of the  parent 
chemical. 73 
In  humans,  the  CYP3A  subfamily  is  the  most  abundant  CYP  form, 
accounting for 30% of the total CYP content of liver and 70% of the CYPs in the 
small  intestine  (Guengerich,  1990;  Shimada  et  aI.,  1994;  Kolars  et  aI.,  1994; 
Thummel  and  Wilkinson,  1998).  The  major  human  CYP3A  form,  CYP3A4, 
catalyzes the  6~-hydroxylation of steroids (Li et aI.,  1995) and is  involved in the 
metabolism of many clinically important drugs (Guengerich, 1991,  1994; Li et aI., 
1995) and in the bioactivation of  several precarcinogens, including AFB 1 (Aoyama 
et  aI.,  1990;  Smith  et  aI.,  1998).  Its  expression  in  enterocytes  accounts  for  a 
significant  "first  pass  metabolism"  of a  number  of orally  administered  drugs 
(Kolars et aI.,  1994). In previous research (Miranda et aI.,  1989) we have purified 
five hepatic CYPs from rainbow trout liver.  One of these CYPs, designated P450 
LMC5, was shown to be a CYP3A isoform (Miranda et aI., 1989; 1991). 
Since rainbow trout has been used as an experimental model  for studying 
carcinogenesis  and  chemoprevention  (Bailey  et  aI.,  1996),  it  is  important  to 
understand as much as possible about its CYP systems which may play significant 
roles in carcinogen metabolism.  With that goal in mind, CYP3A27 was isolated by 
cloning (Lee et aI.,  1998) from a rainbow trout hepatic cDNA library and detected 
with  polyclonal  antibodies  raised  against  the  previously  purified  rainbow  trout 
LMC5  (Miranda  et  aI.,  1989).  CYP3A27  was  structurally  similar  to  human 
CYP3A4 on the basis of  a comparison of deduced positional amino acid alignment 
(Lee et aI.,  1998).  In addition, purified trout LMC5 P450 was functionally similar 
to human CYP3A4, based on their generally comparable substrate specificities and 
the use of CYP3A inhibitors (Miranda et aI.,  1991).  From Northern and Southern 
blot analysis, however, it appeared that more than one CYP3A isoform was present 
in rainbow trout (Lee et aI., 1998). 
There  is  no  information  available on the  cellular localization of CYP3A 
forms  in  the  GI-tract  of rainbow  trout  and  other  teleosts  despite  the  increased 
attention to  environmental pollution and knowledge of the distribution of CYP3A 74 
isofonns in the GI-tract of humans (peters and Kremers,  1989; Paine et aI.,  1997; 
Zhang  et  aI.,  1999)  and  other  animals  (Rosenberg  and  Kappas,  1989; 
Prueksaritanont et aI.,  1996). Using immunodetection with antibodies raised against 
purified LMC5 P450, Cok et aI.  (1998) found that rainbow trout intestine was the 
major extrahepatic site for CYP3A protein expression. In other fish species, Husey 
et.  al.  (1994) noted that an Atlantic cod CYP, P450b (a putative CYP3A fonn), was 
concentrated in the intestinal mucosa ofthat species. 
The  extrapolation  of animal  data  to  humans  and  the  application  of the 
experimental results to environmental toxicology require basic infonnation on the 
cellular localization and the expression level of  corresponding enzymes in different 
animal species. Moreover, the presence of  similar enzymes in corresponding organs 
from  different animal species may provide an unique opportunity for undertaking 
comparative studies as well as for assessing individual toxicant sensitivities. In the 
present  study,  therefore,  we  have  detennined  the  morphologic  localization  of 
CYP3A27  protein  in  the  rainbow  trout  GI-tract  by  immunohistochemical  (IH) 
staining  techniques.  We also  have  carried  out  semiquantification of the relative 
expression of CYP3A27 mRNA and protein in tissues adjacent to those taken for 
IH studies by Western and Northern blotting, respectively. 75 
Materials and Methods 
Chemicals 
The  Vectastain  Avidin  Biotinylated  Enzyme  Complex  (Universal  Elite 
ABC) kit was  purchased from  Vector Laboratories  (Burlingame,  CA),  and  3,3'­
diaminobenzidine  (DAB)  tetrahydrochloride  was  purchased  from  Polysciences 
(Warrington, PA). Protein A ([125I]-labeled, 30 /lCi/mg) was purchased from  ICN 
(Costa  Mesa,  CA)  and  TRI  Reagent  was  purchased  from  Molecular  Research 
Centers,  Inc.  (Cincinnati,  OH).  MS222  (tricaine methanesulfonate)  was  obtained 
from  Argent Chemicals (Redmond, W  A).  All  other reagents were obtained from 
the same source as previously described (Yang et aI.,  1998; Lee et aI.,  1998) or as 
stated in the text. 
Experimental animals, tissue sampling, and RNA/protein extraction 
Two-year old, 250-350 g, sexually immature rainbow trout (Oncorhynchus 
mykiss)  of  the  Mt.  Shasta  strain  were  supplied  by  the  Marine/Freshwater 
Biomedical Sciences Center aquatic facility of Oregon State University, Corvallis, 
Oregon. Fish were housed in  12.5EC circular water tanks, allowed free  access to 
the semisynthetic Oregon Test Diet (OTD) (Lee et aI.,  1991) and exposed to  a  12 
hrll2 hr light/dark cycle. Trout were anesthetized with about 100 ppm MS 222 and 
were killed by a blow to the head. 
The nomenclature of  the sampling sites used along the GI-tract is shown in 
Fig.  3.  1.  These sites were chosen by  structural differences or diversities in cell 
types between the different regions of the  GI-tract.  We  have modified somewhat 
the terminology used previously by Yasutake and Wales (1983) and by Takashima 
and  Hibiya  (1995)  for  the  anatomical  regions  of the  rainbow  trout  GI-tract, 
substituting,  for  example,  the  term  "intestinal  ceca"  for  the  "pyloric  ceca"  and 76 
Figure  3.  1.  Sampling  sites  along  the  OI-tract  of rainbow  trout.  Two  tissue 
samples from each site were taken, one was used for IH staining and the other was 
used for extracting RNA and protein. Cardiac Stomach 
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adding  "proximal  ascending",  "proximal  descending"  and  "distal"  to  identify 
. different  regions  of the  intestine.  Other  researchers  have  also  used  the  term 
"intestinal ceca" to designate that region of  the teleost gastrointestinal tract (Zilberg 
et  aI.,  2000).  The  esophagus,  stomach,  intestinal  ceca  and  proximal  and  distal 
intestine  were  removed  intact  and  stretched  out.  At  measured  intervals,  5-mm 
sections of  the intestinal tract were removed for IH staining and immediately fixed 
in  10  %  neutral  buffered  formalin.  Liver  samples  were  collected  to  serve  as  a 
positive  control  whereas  the  muscle  sample  was  used  as  a  negative  control. 
Adjacent 5-mm sections of intestine and pieces of muscle and liver were taken for 
tissue RNA and protein analysis. Tissue total RNA and protein were extracted with 
TRI reagent as described earlier (Wang-Buhler et aI.,  1997). The TRI reagent is a 
one-step method for  simultaneous isolation of RNA,  DNA and  protein  from  the 
same tissue sample using a phenol and guanidine hydrochloride containing reagent 
(Chomczynski, 1993). RNA and protein samples were stored at  -80°C until used. 
In addition, liver was taken from post-spawning, sexually mature (3-year old) male 
trout for total RNA isolation. The RNA concentrations (ng / JlI) were determined by 
OD26o  using  a  SpectraMax  250  (Molecular  Devices,  Sunnyvale,  CA)  and  an 
empirical conversion factor of  62.4 for 200 JlI samples in a 96-well UV plate. 
Immunoprobe used for detecting CYP3A27 translational expression 
Polyclonal antibodies (Pab) raised in rabbits against purified rainbow trout 
P450  designated  LMC5  (Miranda et  aI.,  1989)  was  used  as  an  immunoprobe  in 
immunohistochemical  staining  and  Western  blotting  in  this  study  because 
CYP3A27 was cloned from an antibody screening of a rainbow trout liver cDNA 
library (Lee et aI.,  1998) using the same polyclonal antibodies. In previous research 
(Miranda et aI.,  1990), it was demonstrated that the polyclonal antibodies raised 
against purified LMC5 did not cross-react with any ofthe CYPs purified previously 
from rainbow trout liver (Miranda et al., 1989). 79 
Immunohistochemical staining 
Formalin fixed tissues were  embedded in paraffin and the paraffin blocks 
were  stored at  4°C  until  processing by  routine  standard  histological  procedures. 
Tissues were sectioned (5 !lm), mounted on glass slides and the hydrated histologic 
sections  incubated  in  0.3%  H20 2  in  methanol  for  30  min  to  block  endogenous 
peroxidase activity. Normal goat serum was used to block nonspecific biotinylated 
secondary  antibody  staining.  The  tissue  histologic  sections  were  washed  with 
Automation  buffer  (Biomeda  Corp.)  and  then  incubated  with  the  LMC5 
immunoprobe as  the  primary antibody,  0.2  !lg IgG/ml  TBS/T [Tris:HCI,  pH  7.4 
including 0.9% NaCI containing 2% bovine serum albumin (BSA) and 0.05% v/v 
Tween 20]  for  60  min  followed  by  biotinylated  secondary  antibody  and  then  a 
preformed avidin and biotinylated horseradish peroxidase macromolecule complex 
C  in  the  ABC  kit.  Subsequently,  the  chromogen  DAB  was  used  to  localize 
peroxidase in tissue. The DAB  procedure gave a reddish brown precipitate in the 
sections yielding a positive immunoreaction. The slides were counterstained with 
Mayer's hematoxylin. All the samples collected were examined. 
Western blotting 
Western blotting was  performed as  described  previously (Miranda et  aI., 
1989; Cok et aI., 1998) with slight modification. The TRI reagent extracted proteins 
(40 !lg protein per lane) were separated electrically on 7.5% polyacrylamide gels 
(15  em x 20  cm) containing sodium dodecyl sulfate (SDS-PAGE). The separated 
proteins were electro-transferred to  a nitrocellulose membranes and  blocked with 
2% BSA in 10 mM TBS.  Anti-LMC5 IgG was employed as the primary antibody 
(0.2 !lg IgG/ ml  TBS/T) and  [125  I]-labeled protein A ( 20 !lCi in  100 ml  TBS/T) 
served as a secondary antibody. Protein bands containing e
25I]  were visualized by 
autoradiography on Kodak X-OMAT AR (XAR 5) film. The densities of the bands 80 
were quantified by densitometry (PDSI-PC, Molecular Dynamics, Sunnyvale) and 
the amounts of expressed CYP3A protein presented as  fmoll/lg total protein were 
estimated  from  an  equation  generated  by  the  protein  standard  curve  using 
PowerPoint software under the  scattered graph type  and  adding a trend  line  not 
forced through zero (Cok et ai., 1998). 
Northern blotting 
Northern blotting was carried out as described previously (Lee et aI.,  1998). 
Briefly, RNA samples were treated with glyoxylatelDMSO and 6 /lg of total RNA 
in each lane were separated electrically on 0.8% agarose gel in circulating 10 mM 
sodium phosphate buffer, pH 7.0. After separation, RNA was capillary transferred 
to  charged  nylon  membranes  (Hybond-N+,  Amersham),  the  RNA-containing 
membranes  were  stained with methylene  blue  (Molecular Research Center,  Inc., 
Cincinnati,  OH)  to  verify the  integrity  of the  RNA  (Yang et ai.,  1998)  and  the 
membranes then prehybridized with Quickhyb hybridization solution (Stratagene, 
La Jolla, CA).  Hybridization was carried out for 2 hr at 68°C with a 32P-Iabeled 
CYP3A27 cDNA probe. This probe was labeled with [a)2P]-dCTP using the full­
length CYP3A27 cDNA as a template and following the Stratagene's Prime-it II 
random prime kit instructions. After hybridization, membranes were washed twice 
with 2X SSC/O.l% SDS (IX SSC solution contains 150 mM sodium chloride and 
15  mM sodium citrate) at room temperature for  15  min, washed twice with O.IX 
SSC / 0.1% SDS at 50°C for 15 min.  The washed membrane was exposed to X-ray 
film  (XAR  5,  Kodak).  The  band  intensities  were  quantified  by  use  of a 
densitometer and the intensities recorded as pixels and reported by comparison with 
the CYP3A27 RNA standard band intensity as pg//lg total RNA.  The quantitative 
values  of the  detected  mRNAs  were  normalized  with  a  18S  ribosomal  RNA 81 
internal  standard  which  was  detected  by  a  [y}2P]-labeled  universal  IS-mer 
oligonucleotide (Buhler et aI.,  1994). 
Preparation of CYP3A27 RNA standard 
The  CYP3A27  RNA  standard  was  prepared  in  vitro.  Briefly,  CYP3A27 
cDNA  was  cloned  into  the  pSPORTl  vector  (OIBCO  BRL,  Orand  Island,  NY) 
where the N-terminal region of CYP3A27 cDNA was placed in the down stream of 
T7  promoter  sequence.  To  linearize  the  template,  recombinant  pSPORTl 
containing CYP3A27 cDNA (1802 bp) was cut withXbaI restriction endonuclease 
whose recognition site resides on the 40 bp after the end of CYP3A27 cDNA. T7 
RNA  polymerase  (Invitrogen)  was  used  to  transcribe  CYP3A27  cDNA.  The 
template was removed by digestion with DNase (RNase free) after the transcription 
reaction. DNase treated reaction was ethanol-precipitated to remove unincorporated 
nucleotides  (left  in  solution)  and  to  concentrate  the  transcribed  RNA.  The 
transcribed RNA was further selected by using a Chroma Spin column (Clontech 
Lab.,  Inc.,  Palo  Alto,  CA)  to  eliminate  shortly  extended  products  and  digested 
DNA  fragments.  This  in  vitro  transcribed  CYP3A27  RNA  was  used  as  a  RNA 
standard to  estimate the levels of transcriptional  expression of CYP3A27  in the 
trout OI-tract in the Northern blots. 82 
Results 
Immunohistochemical staining of CYP3A27 protein in trout GI-tract and liver 
Tissue  samples  from  3  male  and  3  female  trout  were  examined  by  IH 
staining with similar findings and representative photomicrographs are presented in 
Fig.  3.  2.  In the GI-tract, no  IH  staining was observed in the  esophagus but light 
immunostaining  was  detected  in  the  mucosal  epithelial  cells  of the  cardiac  and 
pyloric  stomach.  There  was  little  or  no  staining  of the  epithelial  surface  of the 
proximal  ascending  intestine  (Fig.  3.  2A)  but  the  enterocytes  lining  the  entire 
length of villi of the  intestinal ceca which  is  attached to  the  proximal ascending 
intestine  showed  intensive  staining  (Fig.  3.  2B).  Adipose  tissue  and  pancreatic 
acinar  tissue,  which  surrounded  the  intestinal  ceca,  did  not  stain.  There  was  a 
differential expression of CYP3A27 protein in the  proximal descending intestine 
with  developing  crypt  cells  exhibiting  a  low  level  of staining  and  the  well­
differentiated  villous  tip  enterocytes  showing  high  intensity  immunoreactivity. 
Mucous  cells  (goblet  cells)  of the  proximal  descending  intestine  contained 
numerous  unstained mucus  droplets  (Fig.  3.  2C).  Weak  staining occurred  in the 
enterocytes of  the distal intestine near the vent (Fig. 3. 2D). The liver which served 
as  a positive control was  intensely stained (Fig.  3.  2E).  Strong positive staining 
occurred  mainly  in  hepatocytes  (Fig.  3.  2E)  but  endothelial  cells  of hepatic 
arterioles, portal veins and sinusoids and biliary epithelial cells did not stain.  There 
were two negative controls employed. The first was  the muscle tissue, which was 
not  expected  to  have  any  CYP3A  isoforms,  and  the  second  was  the  reagent 
negative control with omission of primary antibody.  Staining was not observed in 
either ofthe negative controls. 83 
Figure  3.  2.  Immunohistochemical  localization  of CYP3A27  protein  along 
rainbow trout GI-tract.  A.  Proximal ascending intestine.  B.  Intestinal  ceca.  C. 
Proximal descending intestine.  D.  Distal intestine.  E.  Liver as a positive control. 
There was no staining of  biliary epithelium (arrows). (lOOX) 84 
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Western blot analysis of CYP3A27 protein expression in trout GI-tract 
All  of the  IH  staining  results  were  similar  in  all  the  6  fish  examined, 
therefore, we performed Western blot analysis from one male and one female  fish. 
Results indicated that the  CYP3A27 (LMC5-like) protein expression was  equally 
high in the liver, the  intestinal ceca and the proximal  descending intestine  in  the 
male and female trout examined (Fig.3. 3; Table 3.1). No visible band was seen for 
muscle nor for esophagus and cardiac stomach under the experimental conditions 
used.  Using the purified LMC5  protein standards and an assumed MW of 59,000 
Da,  the  relative translational  expression of CYP3A27  and related  proteins  were 
estimated as  4.5,  3.9,  3.8  and  1.1  fmol/~g total  protein  for  male  liver,  intestinal 
ceca, proximal descending intestine and intestine near the vent, respectively (Table 
3.  1) while for female the corresponding values were estimated at 3.3, 4.3, 4.2 and 
1.6 fmol/~g total protein (Table 3.  1). 
Northern blot analysis of CYP3A27 mRNA expression in trout GI-tract 
Northern blot analysis of CYP3A27 mRNA was performed with the same 
tissues  used  for  the  Western  blot.  Results  showed  that  liver,  intestinal  ceca, 
proximal descending intestine, and intestine near the vent expressed an  estimated 
21, 76, 42, and 42 pgl~g  total RNA, respectively, for the male trout examined while 
the corresponding expression in the female trout was estimated as 10, 50, 42 and 20 
pgl~g total  RNA,  respectively,  in  comparison  to  the  in  vitro  transcribed  RNA 
standard (Table 3.  1).  One total RNA sample from  the  liver of a 3-year male was 
included  in  the  Northern  blot  (Fig.3.  4,  lane  15)  and  the  band  intensity 
corresponded to about 6 pg CYP3A27 mRNA per ~g total RNA in comparison to 
RNA standard. 89 
Figure 3.3.  Immunodetection of CYP3A27 protein expressed along the rainbow 
trout GI-tract.  Western blot analysis of 40  Ilg of total  protein for  each tissue was 
carried  out  as  described  in  the  methods  for  the  translational  expression  of 
CYP3A27 along the GI-tract of rainbow trout using anti-LMC5 IgG as probe. The 
semi-quantification results are presented in Table 3.  1. 90 
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Table  3.  1.  Relative  tissue  expression  of CYP3A27  mRNA  and  protein  in  the 
gastrointestinal  track  of one  male  and  one  female  rainbow  trout  (Oncorhynchus 
mykiss). 
LMCS-like proteins
Q  CYP3A27 mRNA
b 
Tissues  (CYP3A27, etc)  (pg/Jlg total RNA) 
(fmol/Jlg total protein) 
Male (%t  Female (%t  Male (%t  Female (%)C 
Muscle (negative control) 
Liver (positive control) 
Esophagus 
Cardiac Stomach 
Intestinal Ceca 
Proximal Descending 
Intestine 
Intestine Near Vent 
4.S (100)C  3.3 (lOOt  21 (loot  10 (lOOt 
3.9 (8St  4.3 (130t  76 (362t  so (SOO)C 
3.8 (8S)C  4.2 (130t  42 (206)C  42 (420)C 
1.1 (24t  1.6 (SO)C  42 (200t  20 (200t 
Q,  h Translational and transcriptional expressions were  examined by  Western blot 
(Fig.  3.  3) and Northern blot (Fig.  3. 4), respectively as described in the Methods. 
cPercentages were calculated in relation to the liver expression levels in each sex. 
~o  visible bands were  se~n for those samples or the densitometer intensities were 
too close to background under the experimental conditions. 92 
Figure  3.  4.  Demonstration  of relative  expression  of CYP3A27  mRNA  along 
rainbow trout GI-tract. Northern blot analysis was carried out as  described in the 
methods.  Each lane was loaded 6 Ilg of total RNA and the sample identifications 
are  marked.  Liver sample was  used as  a positive control and the muscle sample 
was  used  as  a negative control.  The  semi-quantification of relative expression of 
CYP3A27  mRNA  in  comparison  to  a  synthetic  CYP3A27  RNA  standard  are 
presented in Table 3.  1. 93 
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Discussion 
The  results  of our IH  study  showed  that the  major  site  for  translational 
expression of CYP3A27 protein in the  GI-tract was  in  enterocytes that lined the 
villi  of the  intestinal  ceca  and  proximal  descending  intestine.  The  gradient  in 
CYP3A27 protein immunoreactivity observed in the present study in the proximal 
descending intestine and  intestinal ceca,  ranging from  faint  staining of the  crypt 
cells to intense staining of  the villus epithelial cells, was similar to that observed for 
mammalian P450s (Traber et aI.,  1992).  This  suggested that the  trout CYP3A27 
protein was differentially expressed as a function of  cellular maturation and that the 
more mature villus tip cells preferentially expressed the CYP3A27 isoform (Fig. 3. 
2B and 3.  2C). Western and Northern blots confirmed that the intestinal ceca and 
proximal  descending  intestine  contained  considerably  higher  concentrations  of 
CYP3A27 protein and CYP3A27 mRNA than did the distal intestine near the vent 
(Figs.  3.  3 and  3.  4).  While  levels  of CYP3A27  protein were  generally similar 
between liver, intestinal ceca and proximal descending intestine, expression of the 
CYP3A27 mRNA was about 3-5  times higher on a pg/Jlg total RNA  basis in the 
intestinal ceca than in the liver for both male and female fish examined (Table 3. 
1).  The  reasons  for  these  differences  between  transcriptional  and  translational 
results for  CYP3A27 was likely due to  the probes used.  The probe employed for 
detection of CYP3A27 mRNA in the Northern blotting was highly specific while 
the  polyc1onal  antibody  raised  against the  purified  LMC5  may  recognize  other 
CYP3A isoforms present in the trout intestine. 
Our findings in rainbow trout show that tissue localizations of CYP3A27 
protein and mRNA were quite similar (Figs.  3.  2-4) to  the results obtained with 
CYP3A4 in humans. It has been reported that the highest CYP3A4 content of the 
human GI-tract  was  in the  duodenum, jejunum,  ileum,  and  colon  in  decreasing 
concentration order,  i.e.  the  greatest in  intestinal  segments near the  pylorus and 95 
decreasing distally (de Waziers et aI.,  1990; Kolars et ai., 1994; Paine et aI.,  1997; 
Zhang et ai., 1999). 
At  the  present  time,  there  are  three  structurally  related  CYP3  proteins 
reported in humans:  CYP3A4, the major form  in liver and intestine; CYP3A5, a 
major form  found in the  stomach (Kolars et al.,  1994); and CYP3A7,  the  major 
fetal liver CYP (Komori et aI., 1990). All three enzymes oxidize a variety of drugs 
and other chemicals but there is no  unique specific substrate for the three CYP3A 
forms.  The human CYP3A4 isoform also has been reported to  have an important 
role in the metabolic activation of  AFB 1 (Shimada and Guengerich, 1989; Aoyama 
et aI.,  1990) but CYP3A5 failed to form reactive AFB 1 metabolites (Aoyama et aI., 
1990). Similarly, rainbow trout P450 LMC5 (CYP3A27) also showed little activity 
towards AFB 1 (Miranda et aI.,  1989). If more than one CYP3A enzyme is present 
in trout as suggested by the previous Southern blotting (Lee et aI.,  1998) and our 
current  Western  blot  results  in  comparison  to  our  Northern  blot  results,  it  is, 
therefore, possible that another trout CYP3A isozyme may be present in liver and 
in intestinal ceca capable of bioactivating AFBI. Two CYP3A gene have recently 
been found (Kullman et aI., 2000) in the fresh water fish, medaka (Oryzias latipes). 
In addition to CYP3A4, a number of different CYP enzymes were found to 
be expressed in human small intestine at the translational level including CYPIAl, 
IB1,  2C,  2D6,  2E1  and  3A5  (Zhang  et aI.,  1999)  and  CYP2B6  (Gervot et ai., 
1999). These findings imply that the teleost intestine also could be a preferred site 
for  mUltiple  CYP expression.  Previous immunoblotting results demonstrated the 
presence  of  CYPs  in  the  rainbow  trout  small  intestines  (upper  intestine 
corresponding to the  proximal descending  intestine in  this  report)  was observed 
with trout CYP3A27 (LMC5) and to  a lesser extent for CYP2Kl  (LMC2) while 
CYP2M1  (LMCl) and  LMC3  and  LMC4  (two  as  yet unidentified trout  CYPs) 
were not detected (Cok et aI.,  1998). Recently, CYPIAI and CYPIA3 (Cao et aI., 
2000)  and  CYP2Nl  (Oleksiak  et  aI.,  2000)  were  shown  to  be  translationally 
expressed  in  the  intestine  of the  rainbow  trout  and  killifish,  respectively.  The 96 
present investigation demonstrated a significant concentration of CYP3A27 mRNA 
in the rainbow trout intestinal ceca, but it is not yet known whether or not the other 
CYP forms reported to occur in the intestine of rainbow trout and other fish species 
(Hus0y et.  aI.,  1994; Cok et aI.,  1998; Cao et aI.,  2000; Oleksiak et aI.,  2000) are 
also preferentially localized in the intestine. 
The function of the intestinal ceca in trout is analogous to that of the small 
intestine of humans and  rodents  in so  far  as  being  the  major absorption site  of 
peptides, amino acids and carbohydrates (Buddington and Diamond,  1986). Many 
digestive enzymes also are localized in the teleost intestinal ceca (Berglund et aI., 
1998). Since eukaryotic cells are highly compartmentalized, a protein's localization 
is closely associated with its function (Simpson et aI.,  2000). Based on the results 
of the present investigation on the intestinal distribution of CYP3A27 and possibly 
other CYP3A forms, the trout ceca is also likely a major site for the metabolism of 
dietary  constituents.  The  high  expression  of CYP3A  proteins  in  the  mucosal 
enterocytes  of the  small  intestine  of humans  and  rodents  is  associated  with 
significant  biotransformation  of xenobiotics  by  first-pass  metabolism  in  those 
tissues (Kaminsky and Fasco,  1992;  McKinnon et aI.,  1995).  The localization of 
high concentrations of CYP3A27 in the GI-tract of the rainbow trout suggests that 
first-pass metabolism of  certain xenobiotics also could occur in this species as well 
and thus could contribute to the disposition and biological or toxicological effects 
of  ingested chemicals and drugs. 
It is clear from the present investigation and previous research (Cok et aI., 
1998) that the small intestine is a major site for the expression of CYP3A27 in the 
rainbow trout. The relative expression levels of other CYPs in the trout GI-tract has 
not been established, but the consequences of high CYP3A27 expression in the GI­
tract  of rainbow  trout  may  reflect  a  substantial  capacity  for  the  intestinal 
metabolism of orally  ingested  chemicals  and  drugs  in this  teleost  species.  High 
intestinal first-pass metabolism by the CYP3A isoform could drastically limit the 
concentrations of certain xenobiotics or other chemicals available  for  absorption 97 
and  resulting  metabolites  could  be  rapidly  excreted  or,  in  the  case  of reactive 
metabolite  formation,  covalently  bind  to  enterocyte  macromolecules.  Further 
studies  need  to  be  conducted to  identify  other  CYP3A  isoforms,  establish  their 
tissue  localization  and  determine  the  resulting  metabolic  and  pharmacokinetic 
consequences of  their expression in the rainbow trout small intestine. 98 
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Abstract 
Cytochrome  P450  3A27  (CYP3A27)  is  highly  expressed  in  liver  and 
intestine  of rainbow trout  (Oncorhynchus  mykiss).  In  many  animal  species,  the 
intestine and liver are responsible for the first-pass metabolism of a wide range of 
xenobiotics. In order to  help elucidate its physiological role in the  rainbow trout, 
the catalytic capabilities of  this expressed protein were examined. An open reading 
frame of CYP3A27 in pFastBac donor plasmid was transferred to the baculovirus 
genome  (bacmid  DNA)  through  Tn7  site-specific  transposition  in  DHIOBac 
competent cells.  The  CYP3A27  cDNA  was  positioned  under the  control  of the 
polyhedrin  promoter  of the  Autographa  californica  nuclear  polyhedrosis  virus 
(AcNPV). The recombinant baculovirus containing a full-length CYP3A27 cDNA 
(Bv-3A27) was then transfected into 8podoptera Jrugiperda (8f9) insect cells for 
overexpression  of CYP3A27  protein.  The  expressed  CYP3A27  protein  (714 
pmol/mg total protein) exhibited a maximum CO-reduced spectrum at 448 nm at 72 
hr post-infection following addition of 1 Jlglml exogenous hemin.  The expressed 
CYP3A27 protein comigrated with the purified LMC5 P450 and was recognized by 
anti-P450 LMC5  IgG on Western blot analysis.  The expressed CYP3A27 protein 
was  reconstituted  with  human  NADPH-cytochrome  P450  reductase  and 
cytochrome b5  Supersomes. The reconstitution system showed catalytic activities 
for the  6~-hydroxylation of progesterone, the dehydrogenation of nifedipine,  16~­
hydroxylation oftestosterone, and the 6~-hydroxylation of  testosterone of 700, 330, 
71,  and  52  pmol/minlnmol P450,  respectively.  The present results  demonstrated 
that  the  baculovirus  system  is  useful  for  the  production  of functional  aquatic 
CYP3A forms and that rainbow trout CYP3A27, thus expressed, has the capability 
of  metabolizing steroid hormones as reported for mammalian CYP3A forms. 101 
Introduction 
The cytochrome P450s are a heme-containing superfamily of  enzymes which 
plays  important roles  in  the  phase  I metabolism of foreign  compounds,  such as 
toxic  pollutants  and  drugs.  Cytochrome  P450s  also  catalyze  the  oxidation  of 
endogenous substrates including steroid hormones, fatty acids, prostaglandins, etc. 
(Porter  and  Coon,  1991;  Guengerich,  1991;  Waxman,  1999).  In  mammals,  the 
cytochrome P450 3A (CYP3A) family is involved in a broad range of metabolism 
of  structurally  diverse  foreign  compounds  and  steroid  hormones  and  other 
endogenous chemicals (Guengerich,  1999).  This family  is  distinguished from  the 
other families because: (1) it is the most abundantly expressed P450 form in liver 
and intestine (Kolars, et ai.,  1994; Kaminsky and Fasco,  1992), (2)  it produces a 
characteristic  6~-hydroxylation of steroids (Waxman et al.,  1985;  1988), and (3) it 
is  the  major  family  involved  in  xenobiotic  metabolism,  including  drugs 
(Guengerich, 1999). 
It is reported that there are at least 17 families of P450 in mammals, which 
may  contain 50-60 different P450  genes  in a given species (Nelson et ai.,  1996; 
Nelson,  1999).  Cloning  of CYP3As  has  resulted  in  4  forms  from  humans 
(CYP3A4,  CYP3A5,  CYP3A7,  and  CYP3A43),  5  forms  from  rats  (CYP3Al, 
CYP3A2, CYP3A9, CYP3AI8, and CYP3A23), and 4 forms from mice (Cyp3all, 
Cyp3a13,  Cyp3al6,  and  Cyp3a25)  (Nelson  et  ai.,  1996;  Nelson,  1999).  The 
prediction of the precise function of a single P450 isoform through its purification 
and  metabolite  assay  has  been  a  complex  problem  due  to  the  difficulties  of 
purification  from  the  lipophilic  character  of the  membrane  bound  form,  the 
expressions of structually similar isoforms in the same tissue, and the overlapping 
substrate  specificities  between  different  P450s.  With  the  accumulation  of P450 
numbers with  close similarity, the  possibility may  not be  ruled  out that a single 
band on SDS-P AGE may contain more than one form, reflecting the complexity of 102 
P450  isolation.  Because  there  are  no  clear  protocols  available  to  separate  one 
specific  isoform  from  closely  related  CYP3As,  cDNA-directed  heterologous 
expression systems have  been applied to  obtain a large amount of pure  enzyme 
source for the study of catalytic properties (Gonzalez and Korzekwa,  1995; Buters 
et aI., 1994; Lee et aI., 1995). 
Rainbow trout has been an extremely useful model for the toxicology and 
cancer study because of its sensitivity (Buhler and  Wang-Buhler,  1998;  Bailey et 
al.,  1996).  Seven different cytochrome  P450  families  with  11  cDNAs have  been 
reported from the rainbow trout (Buhler and Wang-Buhler,  1998).  CYP3A27 was 
obtained  by  cDNA  library  screening  using  the  antibodies  generated  against  the 
purified  cytochrome  P450  LMC5  which  displayed  the  significant  activity  for 
steroids and reacted with the antibodies of human CYP3A4 (Miranda et aI.,  1989; 
1991). In mammals members of  the CYP3A family are involved in the metabolism 
of steroid  hormones  and  their  expressions  are  affected  by  endocrine  disrupting 
chemicals  (Kliewer  et  aI.,  1998;  Masuyama  et  aI.,  2000).  In  fish,  Buhler  et  al 
(2000) reported that 17p-estradiol treatment in rainbow trout caused a decreased 
expression level of CYP3A27 mRNA. Although there have been growing issues in 
the aquatic contaminations with the rapid industrial developments and the increased 
use of agricultural chemicals, currently there is no information available about the 
function of fish CYP3A form.  The aim of this study is to determine the catalytic 
activity  of one  fish  CYP3A  form,  a  rainbow  trout  CYP3A27  protein,  through 
eDNA-directed expression in baculovirus expression system. This is the first report 
of the  heterologous  expression of a functional  fish  CYP3A form  in  Spodop/era 
Jrugiperda (s£9)  cells. The enzyme activity of CYP3A27 would provide a useful 
basis for the comparative study as well as environmental toxicology. 103 
Materials and Methods 
Materials 
[14C]-Testosterone  and  [14C]-progesterone  were  purchased  from  New 
England Nuclear Corp (Boston,  MA).  6~-, 7a-,  and  16~-hydroxytestosterone and 
6~-hydroxyprogesterone were  from  Steraloids  (Wilton,  NH).  X-gal  (5-bromo-4­
chloro-3-indolyl-~-D-galactopyranoside), DH5a E.  coli competent cells, DHIOBac 
competent cells,  Sf-90011  SFM,  pSPORTI  vector,  pFastBac vector,  gentamycin, 
ampicillin, kanamycin,  restriction endonucleases, and all Bac-to-Bac Baculovirus 
Expression  System  were  from  Life  Technologies  (Grand  Island,  NY).  L-a­
phosphatidylcholine  (dioleoyl),  Lubrol  PX,  nifedipine,  hemin  chloride,  and 
NADPH  were  purchased  from  Sigma Chemical  Co.  (St.  Louis,  MO).  The  Sf9 
insect cell line was a gift from Dr. George F. Rohrmann (Oregon State University). 
The  baculovirus-expressed  human  P450  oxidoreductase  and  cytochrome  b5 
Supersomes were purchased from GENTEST Co. (Woburn, Mass).  [125I]-protein A 
was obtained from ICN Radiochemicals (Irvine, CA). Immobilon-P membrane was 
from  Millipore Co  (Bedford,  MA)  and reagents used in sodium dodecyl sulfate­
polyacrylamide gel electrophoresis (SDS-PAGE) were from Bio-Rad (Piscataway, 
NJ). All other chemicals and organic solvents for HPLC were of  the highest grade 
from commercial sources. 
Constructions of  expression vector and recombinant baculovirus 
The  pSPORT  1  vector  containing  a  CYP3A27  cDNA  insert  and  the 
pFastBac  expression  vector  were  digested  with  EcoRI  and  Not  I.  The  digested 
DNA fragments containing the CYP3A27 open reading frame  and the linearized 
pFastBac vectors were isolated after agarose gel electrophoresis and ligated into the 
pFastBac  vectors through EcoR  I  and Not  I sites.  The  recircularized  pFast  Bac 104 
plasmid  was  used  to  transform  DR5a  E.coli  competent  cells  and  colonies 
containing  the  recombinant  construct  (pFastBAc-3A27)  were  identified  with 
restriction analysis. The recombinant donor pFastBac containing CYP3A27 cDNA 
placed under the polyhedrin promoter was transformed into DR10Bac competent 
cells  that  contain the  bacmid  DNA  and  the  helper  plasmid.  The  Bacmid  DNA 
contains a mini-F replicon, a kanamycin resistance marker, and  a segment DNA 
encoding the lacZa peptide from a pUC-based cloning vector. Since the insertion of 
a short segment containing the attachment site for the bacterial transposition Tn7 in 
the N  -terminus of the lacZa gene in the bacmid does not disrupt the reading frame 
of the lacZa peptide, the propagation of recombinant bacmid in  E.  coli DR10Bac 
was identified by color selection in the presence of a chromogenic substrate (Blu­
gal)  with the  inducer IPTG.  The  site  specific  transposition of a pFastBac-3A27 
fragment  into  the  bacmid  DNA,  a  baculovirus  shuttle  vector,  was  obtained  by 
transposing a mini-Tn7 element from  pFastBac-3A27 donor plasmid to the mini­
attTn7 attachment site on the  bacmid when the Tn7  transposition functions  were 
provided  by  helper  plasmid.  Colonies  containing  the  recombinant  bacmid  (Bv­
3A27)  were  identified  by  disruption  of the  lacZa  gene.  Before  isolating  the 
recombinant bacmid DNA, the candidate colonies were streaked in the presence of 
X-gal to  ensure they were truly white. The isolated Bv-3A27 was  confirmed with 
PCR by using CYP3A27 specific primers (forward primer: 5' TCT TCT ACC CTG 
CTG AGC 3' and reverse primer: 5' GAA ACT CTG GAG GAT CTC 3' for 945 bp 
PCR product)  and  M13/pUC  forward  and  reverse  primers  which  exist near the 
insertion sites on bacmid DNA (forward primer:  5'  TGT AAA  ACG ACG  GCC 
AGT 3' and reverse primer: 5' CAG GAA ACA GCT ATG ACC 3' for 4.1kb PCR 
product). 105 
Transfection and amplification of recombinant baculovirus 
Sf9 cells were maintained in Sf-900n serum free medium (SFM) containing 
50  J..1g1ml  ampicillin  in  sterile  disposable  plastic  flasks  at  27°C.  Sf9  cells 
(1 x 1  06cells/ml ) in 2ml of Sf-900n SFM containing penicillin/streptomycin at 0.5X 
final concentration (50 units/ml penicillin, 50 l!glml streptomycin) were seeded into 
the flat bottomed cell wells (well diameter 22  mm) and placed in the incubator at 
27°C for 2 hr to allow cells to  attach. Cells were washed twice with Sf-900 SFM 
and  attached Sf9 cells were transfected with 3 l!g  of Bv-3A27 via Cell  FECTIN 
Reagent in 0.8  ml of Sf-900n SFM without antibiotic. After 5 hr of infection, the 
transfection mixture was removed and Sf-900 SFM containing 50 l!glml ampicillin 
(total volume 1.5 ml) was added for 72 hrs. The supernatant solution was collected 
at 72 hr post-transfection and applied in the prepared Sf9 cells at 2 x106cells /ml (in 
final 30 ml) for 5 days. After 5 days for the Bv-3A27 amplification, the supernatant 
was  removed and 5 ml of the  supernatant was  used to  infect 45  ml  of Sf9  cells 
seeded at a density of 2 x 106 cells/ml for  5 days.  The Bv-3A27 supernatant was 
harvested and used for CYP3A27 protein expression analysis. 
Expression of CYP3A27 protein in Sf9 cells 
-, 
( Sf9  i~~~l  _cellS; were  maintained  in  Sf-900II  SFM  containing  50  J..1g1ml 
~,- ',,,.,, '",  •  ."  - '-'- ""--'>  ,------- '''' 
6 _~picii"lin to a  d~nsi~y of 2x10 cells/ml. The  amp1ifi4:_~~1  at a multiplicity 
o.!.~t.l!ection (m.oj) of  about 1 plaque-forming units per cell (1  ml Bv-3A27 to 9 ml 
cells (v/v) ratio) was used to infect cell cultures.  After 24 hr infection, 0-3  J..1g1ml 
hemin chloride (2  mg in 50/50  (v/v)  0.1  M NaOHl100% ethanol)  was  added to 
compensate for  low endogenous  levels  of heme  in  insect cells  (Gonzalez et  aI., 
1991). The infected cells were allowed to grow for 24 to 96 hr post  -infection. Cells 
then were harvested, washed twice with cold phosphate-buffered saline (PBS), and 
.----­106 
lysed  with  15-20  strokes  in  a  tightly  fitting  glass  Dounce  homogenizer  in 
homogenization buffer (0.1  M potassium phosphate buffer, pH 7.4, 1 mM EDTA, 1 
mM  DTT,  0.1  mM  PMSF, 20  % glycerol») The  cell  lysates  were  centrifuged at 
100,000g  for  60  min to  separate  membrane  fractions  from  the  soluble  fraction 
(Patten and Koch,  1995).  The  membrane  fraction  was  resuspended  in  the  P450 
buffer (0.1  M potassium phosphate buffer, pH  7.4,  1 mM EDTA, 20  % glycerol) 
and  stored  at  -70°C until  use.  CYP3A27  protein  expression  was  verified  with 
Western blotting. Total P450 content was measured by CO difference spectrometry 
at time differently collected samples (Omura and Sato, 1964). 
Western blot analysis of expressed CYP3A27 protein 
Proteins  (10  Ilg  per  lane)  were  separated  on  7.5%  acrylamide  gels 
containing sodium dodecyl sulfate (SDS). The proteins were electro-transferred to 
Immobilon-P membranes and  the membranes were  blocked with 2%  BSA  in  10 
mM  Tris:HCI,  pH  7.4  including  0.9%  NaCI  (TBS).  Rabbit  anti-rainbow  trout 
LMC5  IgG (Miranda et aI.,  1989) was used as  a primary antibody (20  Ilg  IgG  in 
100  ml  TBS  containing  2%  BSA  and  0.05%  Tween  20).  The  purified  LMC5 
protein was used as a positive control. 
[125  I]-labeled  protein  A  (20  j.l.Ci  in  100  ml  TBS-T)  was  used  as  a  secondary 
antibody.  The  protein  bands  were  visualized  by  autoradiography  on  Kodak  X­
OMAT film. The bands on X-ray film were scanned by using a ScanJet 4C scanner 
(Hewlett-Packard) and presented with Power Point software (Microsoft). 
Reconstitution and enzyme activity assays 
Cytochrome  P450  content  was  measured  spectrally  (Omura  and  Sato, 
1964).  All  enzyme  activity  was  reconstituted  with  incubation  mixtures  which 107 
include 100 pmol CYP3A27 prepared from Bv-3A27 infected Sf9 cells and human 
NADPH- cytochrome P450  oxidoreductase (19.5  U/reaction) and  cytochrome b5 
(105 pmol / reaction) Supersomes. One unit of reductase activity is  defined as the 
amount of enzyme  which can  reduce  1 nmol  of cytochrome  c per minute.  The 
mixture  was  incubated  for  15  min  at  room  temperature  and  then  substrate  and 
MgS04  (30 mM in final) were added. Reactions were preincubated for 5 min at 30 
°c in a shaking water bath, the reactions were initiated with NADPH (125 mM in 
final). All assays were performed at 30°C for 1 hr. 
Testosterone (250  JlM  in  final)  metabolism was  assayed  in  total  reaction 
volume 0.25  ml  in 0.1  M potassium phosphate buffer (PH  7.4).  Reactions  were 
stopped  with  the  addition  of the  half the  total  reaction  volume  (125  Jll)  of 
acetonitrile and vigorously vortexed for 2 min. After the mixtures were centrifuged 
at 10,000 g for 30 min, the supernatant was analyzed by HPLC. Metabolites were 
measured by HPLC using a C18 Novapak (Waters) reverse phase column of 3.9 x 
1500  mm.  Products  were  eluted  with a  flow  rate  of 2  ml/min  in  a  mixture  of 
CH30H and H20 and detected at 254 nm. 
The metabolism for nifedipine was determined by the method described in 
Shimada  and  Guengerich  (Shimada  and  Guengerich,  1989)  with  slight 
modification. The reactions contained 200 uM of  nifedipine in a final in 0.25 ml of 
0.1  M potassium phosphate buffer (PH 7.85). The reactions were initiated with the 
addition ofNADPH and stopped by the addition of 125  JlI of acetonitrile after 1 hr 
incubation at 30°C. HPLC sample preparations were the same as above. Detection 
was at 254 nm and solvent flow was 0.8 mllmin of  64% CH30H and 36% H20. 
Progesterone  reaction  includes  the  same  amounts  as  described  m 
testosterone metabolism but total  reaction  volume  was  0.5  ml  and  reaction  was 
stopped with the addition of 3 ml  of methylene chloride (Miranda et aI.,  1989). 
After vigorous vortex, reaction mixture was centrifuged at 10,000g for 30 min and 
the organic phase was transferred to a new tube for evaporation under nitrogen gas. 108 
The dried residue was dissolved in  150  f.ll  of 100% methanol for HPLC analysis. 
The  metabolites  were  detected  by  absorbance  at  254  nm  as  described  in  the 
testosterone. 109 
Results 
Construction of Bv-3A27 
Four different candidate colonies were  selected with white  color, verified 
with PCR product size (945  bp from gene specific primers and 4.1  kb  from  M13 
forward  and reverse primers), and transfected into the  SF9 cells to  determine the 
best expressing Bv-3A27. The expression of CYP3A27 protein from four different 
candidates  was  screened by  Western  blotting  with  LMC5  polyclonal  antibodies 
after  72  hr  post-infection.  The  selected  virus  (Bv-3A27)  was  optimized  with 
different  heme  concentrations  and  different  infection  times.  Maximal  spectrally 
active protein was obtained with 1 Ilg hemin Iml addition at 72 hr post-infection. 
Expression of CYP3A 27 protein 
The optimum expression of spectrally active form was determined at 72 hr 
post-infection (Fig.4.  1).  The addition of hemin did not cause cell toxicity, but it 
was  essential  for  the  production  of spectrally  active  form.  The  CO  difference 
spectrum was  used to  quantify the  amount  of active  CYP3A27  protein and  the 
spectrum showed a peak maximum at 448 nm without a peak at 420 nm (Fig.4. 2). 
Cells were routinely monitored during infection (0 hr - 96 hr). The infected 
cells produce occlusion negative (occ-) forms,  much larger nuclei and larger cells 
(1.5x than uninfected cells) with much slower doubling times (Webb and Summers, 
1990). With the increased infection time, cell staining with trypan blue dye (0.4% 
in PBS) was increased from about 2-5% staining at 24hr post-infection to over 90% 
at 96 hr post infection. The spectrally active CYP3A27 was obtained with 30-50% 
staining at 72 hr post-infection. The level of spectrally active CYP3A27 expression 
was 714 pmollmg total protein and the portion ofCYP3A27 expression represented 110 
Fig. 4. 1. Optimum condition for CYP3A27 expression in SF9 insect cells 
Cells at 2 x  10  6 Iml were  infected with the  recombinant baculovirus containing 
CYP3A27 eDNA with the  indicated  amount  as  described  in  Methods.  Different 
amount of  hemin chloride was added to compensate for low level of heme in insect 
cells. Cells in aliquots of 20ml culture were harvested at the indicated time points. 
The  total  membrane  fraction  was  obtained  as  Methods.  P450  content  in  the 
membrane  fraction  was  analyzed  by  CO  difference  spectra  in  O.IM  potassium 
phosphate buffer, pH 7.4, 1 mM EDTA, and 20% glycerol. -  -
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Fig. 4. 2. CO difference spectrum of  membrane fraction obtained from 
Bv-CYP3A27  infected  insect  cells.  The  membrane  fraction  was  isolated  from 
hemin chloride (l Jlglml) fortified SF9 cells either uninfected or infected with the 
baculovirus  containing  trout  CYP3A27  eDNA.  The  isolated  membrane  fraction 
was  resuspended  in  0.1  M  potassium phosphate  buffer,  pH7.4,  containing  20% 
glycerol  and  1 mM  EDT  A  in  final  concentration.  The  difference  spectrum  was 
recorded between 400 and 500 nm. M  ......  ...... 
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around 2.3 % of  total cellular protein. 
The expression of CYP3A27 protein was  increased with infection time as 
analyzed in Western blot results (Fig.4. 3). The expressed CYP3A27 protein from 
baculovirus system had the same mobility as the LMC5  P450 form  purified from 
trout  liver microsome.  The  large  portion  of expressed  CYP3A27  was  found  in 
membrane pellet analyzed by Western blotting. The enzyme activity was obtained 
from the membrane fraction. 
Enzyme Activities 
The  optimum catalytic  activity  was  determined  under various  conditions 
using testosterone as  a model  substrate with  100  pmol of spectrally  determined 
CYP3A27  enzyme.  The  reconstituted  CYP3A27  system  was  catalytically active 
with  human  NADPH-cytochrome  P450  oxidoreductase  (19.5  U/reaction)  and 
cytochrome b5  (105 pmol per reaction) Supersome, MgCb (30 mMireaction), and 
NADPH (125 mM Ireaction). The activity of baculovirus expressed CYP3A27 was 
similar to those of mammalian CYP3A forms based on 6~-hydroxylase activity of 
testosterone  and  progesterone  and  nefedipine  dehydrogenation.  The  catalytic 
activities  were  obtained  as  the  6~-hydroxylation  of  progesterone,  the 
dehydrogenation  of nifedipine,  16~-hydroxylation of testosterone,  and  the  6~­
hydroxylation  of testosterone  of 700,  330,  71,  and  52  pmollminlnmol  P450, 
respectively (Table 4.  1).  The fraction isolated from  uninfected sf9 cells with the 
same reconstitution components did not produce any metabolites (data not shown). 
There were no catalytic activities when the spectrally active Bv-CYP3A27 protein 
was incubated in the absence ofNADPH (data not shown). 115 
Fig.  4.  3.  Immunoblot  analysis  of the  expressed  CYP3A27  and  LMC5  P450 
proteins.  Protein  from  insect  cell  total  membrane  (1 0  ~g  per  lane)  was 
electrophoresed  on  7.5%  SDS-polyacrylamide  gels.  Separated  proteins  were 
electrotransferred to Immobilon-P membrane. Rabbit anti-LMC5  IgG was used as 
primary  antibody.  Lane  1,  molecular  marker;  lane  2,  membrane  fraction  from 
uninfected cells; lane 3, purified LMC5 P450 (100 fmol); lane 4, blank; lane 5 - 8, 
infected cells with baculovirus containingCYP3A27 cDNA for 24, 48, 72, and 96 
hrs. 116 
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Table 4. 1.  Catalytic properties ofbaculovirus expressed CYP3A27 with different 
substrates. 
Specific activity 
(pmol/minlnmol CYP3A27) 
Substrate  Metabolite 
LMC5P450
a  Bv-CYP3A27
C 
Testosterone  6~-hydroxytestosterone  210  52 
Testosterone  16~-hydroxytestosterone  110  71 
Progesterone  6~-hydroxyprogesterone  270  700 
Nifedipine  Dehydronifedipine  330 
a Data for LMC5 P450 is from Miranda et al. (1989). LMC5 P450 is a purified 
protein from the liver microsomes of  male rainbow trout. b Not determined. 
c Bv-CYP3A27 is the protein obtained from CYP3A27 cDNA-directed expression 
in insect cells. All assays were performed in duplicate at 30°C for 1 hr as described 
under Materials and Methods. 118 
Discussion 
CYP3A forms have been extensively investigated in mammals due to their 
important  roles  in  the  xenobiotic  and  steroid  metabolism  (Guengerich,  1999; 
Gonzalez and  Korzekwa,  1995).  The  study  of trout  CYP3A forms  was  initiated 
following the purification of LMC5 P450, a P450 which showed catalytic activity 
against testosterone and progesterone (Miranda et aI.,  1989) and cross-reacted with 
human CYP3A4 antibodies (Miranda et aI.,  1991). Subsequent research suggested 
that there was more than one CYP3A form in trout (Lee et aI.,  1998). Therefore, the 
purification of LMC5  P450  from the trout liver may  not separate completely the 
other CYP3A forms.  CYP3A27 protein was  expressed in COS-7 cells in our lab, 
but the level of expression was too low to  determine CO difference spectrum and 
metabolism.  However,  Western  blot  analysis  showed  the  same  recognition  by 
LMC5  antibodies with P450  LMC5  protein and the  same  migration with  LMC5 
P450 on the SDS-PAGE (data not shown). 
The  baculovirus  system  has  provided  abundant  amounts  of functional 
cytochrome  P450s  (Buters  et  aI.,  1994;  Lee  et  al.,  1995;  Asseffa  et  aI.,  1989; 
Barnes et aI.,  1994).  Variable specific contents of cytochrome P450 protein were 
obtained  from  baculovirus  expression  system,  showing  50-200  pmol  of 
CYP2D6/mg cell protein (pane et aI.,  1996),  1.5 nmol of CYP2ElImg cell protein 
(Patten and Koch, 1995), 107 pmol of  CYP3A4/mg microsomal protein (Lee, et aI., 
1995),  and  460  pmol  of CYP3A4  Img cell  protein  (Buters  et  aI.,  1994).  In  the 
present  study,  expressed  trout  CYP3A27  exhibited  714  pmol/mg  total  cellular 
protein determined from a maximum CO-reduced spectrum at 448 nm after 72  hr 
post-infection  following  addition of 1 llg/ml exogenous  hemin.  SF9  insect  cells 
express almost zero background of cytochrome P450s, therefore catalytic activity 
study  may  not require  the  complete purification of expressed cytochrome  P450. 
CYP3A  forms  obtained  from  the  heterologous  expression  system  have  been 119 
purified by column procedures, however the catalytic activities have been strongly 
affected by several reconstitution factors.  Therefore we used a membrane fraction 
obtained  from  the  recombinant  baculovirus  infected  SF9  cells  to  determine 
CYP3A27 enzyme activity without purification. 
The  CYP3A  form  has  been  a  problem  with  very  low  activity  in 
reconstitution (Guengerich et aI.,  1986), although other P450s are highly active in 
the similar reconstitution system (Distlerath et aI.,  1985; Knodell et aI.,  1987). The 
optimum  condition  for  the  activity  in  reconstitution  system  has  been  confused 
because of different reconstitutions in each laboratory, such as different amount of 
NADPH-cytochrome P450 reductase, cytochrome b5, lipid compositions, divalent 
cations, and other unknown factors (Buters et al.,  1994; Lee et aI.,  1995; Brian et 
aI.,  1990;  Yamazaki  et  aI.,  1995;  Ingelman-Sundberg  et  al.,  1996).  Various 
mixtures  containing  different  type  of  lipids  for  acidic  phospholipid  system 
(Eberhart  and  Parkinson,  1991),  GSH  (Gillam  et  aI.,  1993),  and  detergents, 
cytochrome b5, and divalent cations (Imaoka et aI.,  1992) have been successfully 
used to  increase the activity of expressed CYP3A forms.  It was reported that the 
divalent  cations  may  be  involved  in  the  stimulation  of electron  transfer  from 
cytochrome b5 to P450 and the rate of P450 or cytochrome b5 reduction (Yamazaki 
et aI., 1995;Tamura et al., 1990). 
The  optimal  spectrally  active  form  of CYP3A27  was  determined  by 
different  amount  of hemin  addition  (1- 4  ~g/ml) combined  with  different  cell 
harvest time. The expression level was increased with the increased infection time, 
however spectrally active forms of CYP3A27 was sharply decreased after 72  hr 
post-infection. The staining of trypan blue dye provided a good indication together 
with infection time, resulting in 30-50% cell staining for the spectrally active form 
in any different m.o.i and time applications. The higher amount of hemin addition 
in media slightly decreased expression level and produced strong absorption at 420 
nm  instead of 450 nm.  The overexpression of CYP3A27  may  cause unbalanced 120 
environment in cells, affecting normal folding and targeting process to membrane. 
The abundant amount of hemin addition may affect the other proteins that require 
endogenous hemin for  their functions.  Therefore,  the  optimum condition for  the 
functional  expression in  SF9  cells was  determined at 72  hr post-infection and  1 
J.lglml ofhemin addition at 24 hr post-infection. 
The microsomal enzyme activities from fish liver microsomes are generally 
lower than in mammals (Buhler and Ramusson,  1968;  Miranda et aI.,  1989).  The 
catalytic activity of Bv-3A27 expressed trout CYP3A27 was not improved with the 
additions  of  different  amount  of  L-a-phosphatidylcholine  (dioleoyl),  sodium 
cholate,  GSH,  and  Lubrol  PX.  These  components  are  typically  used  in  the 
reconstitution system in other mammalian CYP3A enzyme studies (Buters et aI., 
1994;  Lee et ai.,  1995;  Guengerich,  1999).  However the  activity of testosterone 
metabolism was  affected  slightly  by the  addition of different amount of human 
NADPH-cytochrome  P450  reductase  and  cytochrome  b5  Supersome  and  MgCb 
concentration.  The  reconstitution  of purified  fish  cytochrome  P450s  with  rat 
NADPH-cytochrome P450 reductase were successfully applied (Klotz et ai.,  1983; 
Goksoyr, 1985) and even replacing scup NADPH-cytochrome P450 reductase with 
the  rat  NADPH-cytochrome  P450  reductase  stimulated  the  catalytic  activity  of 
cytochrome P450A (Klotz et ai.,  1986), suggesting that replacement of NADPH­
cytochrome P450 reductase and cytochrome b5  can affect catalytic activity. In this 
study, human P450 reductase  and cytochrome b5  expressed  in  insect cells  were 
successfully applied in the reconstitution system. 
The  6~-hydroxylation of testosterone,  progesterone, and cortisol represent 
the  major  metabolites  formed  by  CYP3A  forms  in  mammalian  systems 
(Guengerich,  1999;  Waxman  et  al.,  1985;  Waxman  et  ai.,  1988).  The  6~­
hydroxylation of progesterone and testosterone obtained from the purified LMC5 
P450 were 270 and 210 pmol/mininmol P450, respectively (Miranda et al.,  1989). 
However,  the  activity  obtained  from  baculovirus  expressed  CYP3A27  against 121 
progesterone  and  testosterone  showed  700  and  52  pmol/min/nmol  P450, 
respectively.  Compared to  LMC5  P450, baculovirus expressed CYP3A27 showed 
more  6~-hydroxylation  of  progesterone  than  testosterone.  In  testosterone 
metabolism, the baculovirus-expressed trout CYP3A27 revealed major metabolite 
of 16~-hydroxylation of testosterone rather than  6~-hydroxytestosterone. Although 
both  purified  LMC5  and  cDNA  expressed  CYP3A27  systems  are  involved  in 
steroid metabolisms, these results are  not identical to  each other. It is  difficult to 
determine  if LMC5  P450  corresponds  to  CYP3A27  gene  product  or  not.  For 
example, a bovine CYP3A form expressed in Chinese hamster V79 cells showed 
6~-hydroxytestosterone as  a major metabolite,  but  when the  same  CYP3A form 
was expressed in bovine cells, the  6~-hydroxytestosterone was not found as a major 
metabolite,  (Natsuhori  et  aI.,  1997),  indicating  that  CYP3A  enzyme  specificity 
could be affected by different cell environments. 
The comparison of amino acid sequence of CYP3A27 with other CYP3A 
forms  (Lee  et aI.,  1998)  showed the  highest  alignment with  dog  CYP3AI2, an 
isozyme  which produced more  6~-hydroxylation of progesterone  rather than  6~­
hydroxylation of testosterone (Fraser et aI.,  1997). Our data also showed more  6~­
hydroxyprogesterone  metabolism,  suggesting  that  there  may  be  structure  and 
function relationship in catalytic activity. 
Miranda  et  al  (1989)  reported  that  6~-hydroxylation of progesterone  by 
trout liver micro  somes was catalyzed mainly by LMC5. It was also postulated that 
variations of 6~-hydroxylation of progesterone by  LMC5  may  play an important 
factor in the trout sex determination, since there was a marked sex difference in the 
metabolism  of progesterone  by  kidney  and  liver  microsomes  in  mature  trout 
(Williams  et  ai.,  1986).  CYP3A  genes  are  induced  by  steroids,  antibiotics,  and 
environmental  chemicals,  which  may  result  in  the  different  modulation  of the 
endogenous hormone and the dietary xenobiotic levels. The author speculates that 
the  growing  xenoextrogen  issue  in  aquatic  species  could  involve  in  the  altered 122 
levels of  CYP3A forms, because increased or decreased CYP3A levels may change 
normal steroid metabolisms. 
Baculovirus  expressed  trout  CYP3A27  protein  successfully  oxidized 
nifedipine.  Amino  acid  comparisons  and  immunological  studies  with  trout 
CYP3A27  and human CYP3A4 were  reported (Lee et aI.,  1998;  Miranda et aI., 
1991).  The  present  nifedipine  result  also  supports  a  similar  structure-function 
relationship between human CYP3A4 and trout CYP3A27. 
CYP3A27 is the first designated CYP3A form in aquatic species (Lee et aI., 
1998) and the precise functional  study requires cDNA directed expression of this 
gene to  remove other background P450s.  In  this  study,  we  report the  functional 
expression  of CYP3A27  gene  in  the  insect  cell  system  by  using  recombinant 
baculovirus.  The  catalytic  activities  obtained  would  be  considered  to  reflect the 
normal function of  native rainbow trout microsomal CYP3A27. 123 
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Abstract 
In trout and mammals, the major extra hepatic expression site for  CYP3A 
forms is in the intestine. A cDNA encoding a new CYP3A subfamily member was 
isolated from rainbow trout intestinal ceca by RT-PCR, followed by RACE-PCR. 
In  a set of two primers  for  PCR,  a consensus  sequence in  the  highly  conserved 
regions of 17 CYP3A sequences were determined and used for one primer, and the 
second primer was designed based on adapter sequence ligated on the 5'- and 3'­
cDNA ends. The 3'and 5'end nucleotide sequences of RACE-PCR products were 
used for the priming sites for the full length cDNA and then RT-PCR was applied 
to verify the sequence of the cloned cDNA by using a set of gene specific primers. 
The  resulting  2615-bp  cDNA  contained an  open  reading  frame  of the  1554-bp 
encoding a 518 amino acid residue protein (Mr=59057.13, PI= 6.15) with 26 amino 
acid  differences  when  compared  with  the  previously  cloned  rainbow  trout 
CYP3A27.  The  cDNA  was  highly  homologous  to  those  of CYP3A  forms  and 
assigned as CYP3A45 by the P450 Nomenclature Committee. The deduced amino 
acid sequence of rainbow trout CYP3A45 was 88% identical with trout CYP3A27, 
68%  with  killifish  CYP3A30,  55%  with  chicken  CYP3A37,  53%  with  dog 
CYP3A12,  and  52% with human CYP3A4 in positional alignment comparisons. 
Northern  blotting  by  a  CYP3A45  specific  nucleotide  probe  showed  that  major 
expression site was the intestinal ceca rather than liver in  both male and  female 
trout.  Recombinant  baculovirus  containing  a  CYP3A45  cDNA  (Bv-3A45)  was 
constructed  under  polyhedrin  promoter  of the  Autographa  cali/ornica  nuclear 
polyhedrosis virus (AcNPV) and used to express CYP3A45 protein in Spodoptera 
Jrugiperda  (Sf9)  cells.  The  Western  blot  result  showed  that  the  expressed 
CYP3A45  protein comigrated with purified LMC5  P450  and was  recognized by 
anti-LMC5 polyclonal antibodies.  Expressed CYP3A45 protein showed a peak at 
450nm in CO difference spectrum analysis. 126 
Introduction 
Cytochrome  P450  enzymes  are  a  superfamily  of  heme  containing 
monooxygenases  that  are  involved  in  oxidative  metabolism  of many  drugs, 
environmental chemicals, and endogenous compounds (Guengerich,  1991; Nebert 
and  Gonzalez,  1987).  The  P450  superfamily  is  divided  into  families  and 
subfamilies on the basis of  amino acid sequence similarities (Nelson et aI., 993). In 
certain cases cytochromes P450 catalyze the production of toxic or carcinogenic 
metabolites (Smith et aI.,  1994). However, in most cases cytochrome P450s protect 
animals and humans from harmful foreign chemicals by facilitating the elimination 
of potentially  toxic  compounds  (Kaminsky  and  Fasco,  1991;  Hall  et  aI.,  1999; 
Ingelman-Sundberg et aI.,  1999). 
The human CYP3A  subfamily is  the  most abundant P450  form  found  in 
liver and small intestine (Wrighton et aI., Shimada et aI.,  1994; Kolars et aI.,  1994; 
Guengerich,  1990).  CYP3A4  plays  a  significant  role  in  the  metabolism  of 
approximately  half  the  drugs  in  use  today  (Bertz  and  Granneman,  1997; 
Guengerich,  1999).  CYP3A4  is  expressed  in  several  tissues,  but liver and  small 
intestine are the sites of major interest regarding first pass metabolism of orally 
administered  drugs  and  xenobiotic  chemicals  (Kolars  et  al.,  1994;  Guengerich, 
1991, 1994). 
The rainbow trout has been useful  as  a model  species for  carcinogenesis, 
aquatic  toxicology,  and  comparative  metabolism  investigations  (Bailey  et  aI., 
1996). These studies include the induction of liver cancer by aflatoxin B 1 (AFB 1) 
(Bailey  et  aI.,  1996),  induced  CYP1A1  levels  as  an  indicator of contamination 
caused by P  AHs or dioxin related compounds  (Stegeman  and  Lech,  1991),  and 
increased  vitellogenin  levels  in  trout  hepatocytes  as  an  indication of estrogenic 
pollution (White et aI., 1994). 
In  mammals,  in  addition  to  the  liver,  cytochrome  P450-mediated 
biotransformations  also  occur  in  the  intestinal  mucosa  where  they  provide  an 127 
important first  line of defense  against  ingested toxins  or carcinogens  (Hietanen, 
1980; Kolars et aI., 1994). To extrapolate experimental animal data to humans, it is 
important  to  know  the  levels  of all  the  enzymes  involved  and  their  catalytic 
activities. For example, in the case of  CYP3A forms, their levels are extremely low 
in the liver of adult female rats compared to their male counterparts determined by 
nifedipine oxidation, but there has been no  sex  or age  dependence of nifedipine 
metabolism described in humans (Guengerich et aI.,  1986). 
The P450 system in rainbow trout is diverse as in mammals. Little is known 
about the distribution of  specific isoforms of  cytochrome P450 in the intestinal tract 
in rainbow trout.  In  the  previous study,  we  showed  high  expression of rainbow 
trout CYP3A27 in liver and intestinal ceca (Lee et aI.,  2001), suggesting that this 
species  support the  first  pass  metabolism  in  intestine  and  liver as  in mammals. 
Furthermore,  multiple  forms  of CYP3A27-related  genes  were  evidenced  by 
Southern and Northern blot analysis, especially strong expression of  multiple forms 
in intestinal ceca in a Northern blot study (Lee et aI.,  1998).  The cDNA-directed 
expression of  trout CYP3A27 protein showed catalytic activity against testosterone, 
progesterone, and nifedipine as seen in the mammalian CYP3A forms (Lee et aI., 
200la). The relationship between the  DNA sequence and the catalytic specificity 
has been an important issue, because substrate specificities of P450s are sometime 
overlapped  within  the  same  subfamily,  for  example  CYP3A4  and  CYP3A5  in 
humans.  However,  the  specificities  of some  P450s  can  be  quite  different,  even 
though they  are  within the  same subfamily.  For  example,  CYP2C9  metabolizes 
only tolbutamide, however CYP2C 19 cannot metabolize tolbutamide but oxidizes 
only mephenytoin (Wrighton et aI., 1993). 
High nucleotide sequence homology in members of the same subfamily of 
P450s  has  hampered  the  isolation  of a  specific  isoform  through  cDNA  library 
screening or PCR due to the cross-reactions. In the present study, a new CYP3A 
form, CYP3A45, was cloned by using high homology region through RACE-PCR. 
We assayed the levels of CYP3A45 mRNA in trout liver and gastrointestinal tract 128 
by  using  a  CYP3A45  specific  probe.  The  cloned  CYP3A45  cDNA  was 
heterologously  expressed in  baculovirus system to  determine  its catalytic role  in 
trout. 129 
Materials and Methods 
Materials 
The [1251]-labeled protein A  (30~Ci/ug), [y}2p]ATP (SA>4000 Ci/mmole), 
and [a}2P]ATP (SA>3000Ci/mmol) were purchased from ICN (Costa Mesa, CA). 
A  TOPO  TA  Cloning  kit  was  purchased  from  Invitrogen  (Carlsbad,  CA). 
Restriction enzymes were from GIBCO BRL (Grand Island, NY) or Stratagene (La 
Jolla, CA). Marathon eDNA Amplification kit was from Clontech (Palo Alto, CA). 
SuperScript One-Step RT-PCR system, ELONGase enzyme Mix, X-gal (5-bromo­
4-chloro-3-indolyl-p-D-galactopyranoside),  DH5a  E.  coli  competent  cells, 
DHlOBac  competent  cells,  Sf-90011  SFM,  pSPORTl  vector,  pFastBac  vector, 
gentamycin,  ampicilline,  kanamycin,  and  all  Bac-to-Bac  Baculovirus Expression 
System  were  from  Life  Technologies  (Grand  Island,  NY).  Hemin  chloride  was 
purchased from Sigma Chemical Co (St. Louis, MO). The Sf9 insect cell line was a 
gift from Dr.  G.  F.  Rohrmann (Oregon State University). Immobilon-P membrane 
was  from  Millipore  Co.  (Bedford,  MA)  and  reagents  used  in  sodium  dodecyl 
sulfate  - polyacrylamide  gel  electrophoresis  (SDS-P  AGE)  were  from  Bio-Rad 
(Piscataway, NJ). All other chemicals and organic solvents for HPLC were of the 
highest grade from commercial sources. 
Experimental animal and tissue sampling 
Total RNA from  various tissues was  obtained by using TRI  Reagent and 
quantitated as described earlier (Lee et aI.,  1998). Tissues used for RNA extraction 
were  livers,  muscle,  cardiac  stomach,  pyloric  stomach,  intestinal  ceca,  proximal 
ascending  intestine,  proximal  descending  intestine  in  two  year  old  immature 
rainbow  trout  of  the  Mt.  Shasta  strain  supplied  by  the  MarinelFreshwater 
Biomedical Sciences Center aquatic facility of  Oregon State University. 130 
Construction of adapter ligated eDNA library 
The selection ofpoly(At RNA from total RNA obtained from the intestinal 
ceca was  perfonned by  using  oligo(  dT)  cellulose  from  MessageMaker  Reagent 
Assembly  system  (GIBCO  BRL,  Grand  Island,  NY).  The  mixture  of  one 
microgram of poly(At RNA  in 4  J..lI  water and  cDNA synthesis primer (52-mer) 
(Fig 5.  IB) (10  J..lM of 5'-TIC TAG AAT TCA GCG GCC GC(T)30 N\N-3'; N\  = 
G,  A,  or C; N =  G,  A,  C,  or T)  was heated at 70°C for 2 min, chilled on ice.  The 
reaction  mixture  contains the  first-strand  buffer (final  reaction  contains  50  mM 
Tris, pH 8.5, 8 mM MgCh, 30 mM KC1,  1 mM dithiothreithol), each dNTP at 2.5 
mM, and 20 units of AMV reverse transcriptase. Reaction was incubated for one hr 
at 42  0c.  The reaction of total  15~1 was  placed on  ice  to  tenninate  first  strand 
synthesis. The first-strand synthesized was used immediately for the second-strand 
synthesis. Ten microliter of first-strand reaction was mixed with the second-strand 
buffer (in final  100 mM KC1,  10 mM ammonium sulfate, 5 mM MgCh, 0.15 mM 
P-NAD, 20  mM Tris, pH  7.5, 0.05  mglml bovine serum albumin), each dNTP at 
4.0  mM,  and a enzyme mixture (Ecoli DNA polymerase,  24  units;  Ecoli DNA 
ligase, 4.8 units; and Ecoli RnaseH, 1 unit) to a final volume of  80  J..ll.  The reaction 
was incubated at 16  °C for  1.5  hr, and then 10 units of T4  DNA polymerase was 
added  to  create  blunt  ends  on  the  double-stranded  cDNAs.  The  reaction  was 
tenninated  and  ethanol  precipitated  after  phenol/chloroformlisoamylalcohol 
extraction.  The  precipitated  cDNA  pellet  was  dissolved  in  water  and  used  for 
adapter ligation. The reaction of  adapter ligation was prepared by adding 20  ~M of 
Marathon cDNA adapter (Fig.  5.  lA), ligation buffer (in final  50  mM  Tris-HCL, 
pH 7.8, 10 mM MgCh, 1 mM DTI, and  ImM ATP), and T4 DNA ligase (in final 
400 units). The reaction was incubated for  16 hr at 16  °C,  heated at 70 °C  for  5 
min,  and  stored at -20 °C  until  ready  for  Rapid  Amplification of cDNA  Ends­
Polymerase Chain Reaction (RACE-PCR). 131 
A. cDNA adapter sequence 
5'-T  AA T ACGACTCACTAT  AGGGCTCGAGCGGCCGCCCGGGCAGGT  - 3' 
-----------.~  3'-H2N-CCCGTCCA-P04-5' 
APt 
AP2 
B. Primers used for the construction of adapter ligated cDNA library 
Adapter primer I (API, 27-mer): 5'- CCATCCTAATACGACTCACTATAGGGC-3' 
Adapter primer 2 (AP2, 23-mer): 5'- ACTCACTATAGGGCTCGAGCGGC-3' 
eDNA synthesis primer (52-mer): 5'-TTCTAGAA  TTCAGCGGCCGC(T)3o N IN-3' 
Fig. 5. 1. The cDNA adapter sequence and primers used for cDNA synthesis and 
RACE-PCR. The API and AP2 primers were used in RACE-PCR combined with 
gene  specific  primers.  The  AP 1  and  AP2  binding  sites  can  be  generated  by 
extension of  the gene specific primers (GSP). The AP2 primer was used for nested 
PCR to  increase  specificity  using  the  first  amplified  RACE-PCR  product  as  a 
template.  The exposed 3'  end of the cDNA  adapter with an amino  group was to 
prevent extension of the  3'end by Taq polymerase,  which would  create an API 
binding site and allow nonspecific amplification. The cDNA synthesis primer was 
used in the first strand cDNA synthesis (N1 = G, A, or C; N = G, A, C, or T). 132 
An assembly of  CYP3A members and the design of RACE-PCR primers 
The assembly of 17 CYP3A amino acid sequences that were retrieved from 
GenBank  indicated  high  sequence  similarity  regions  across  species  and  the 
conserved regions were selected for primer sites (Table 5.  1).  In the table 5.  1, the 
list of 16  CYP3A members  is  described  in  decreasing  order of the  amino  acid 
alignment  with  CYP3A27  in  a  BLAST  search  result.  The  design  of nucleotide 
primers for CYP3A specific regions was based on the formerly cloned CYP3A27 
cDNA and was described in table 5.  1. 
RACE-PCR for the isolation of CYP3A forms 
The adapter ligated cDNAs (in final  10 lll) were diluted 50 times in Tricine­
EDTA  buffer  (10  mM  Tricine-KOH,  pH  8.5,  0.1  mM  EDTA)  and  then  one 
microliter was used for the RACE-PCR template. For 3' RACE-PCR, s954 primer 
('s' indicates sense and 954 means 954th nucleotide on CYP3A27 cDNA) (5' -CGG 
GTG GAT ITC ITA CAG CTG ATG -3') and API primer were applied first, and 
then AP2 primers were used with s954 as a nested PCR. In 5' RACE-PCR, a1433 
primer (5'-GIT CTC CIT ACT GAA CCG CTC TGG-3') ('a' indicates antisense 
and 1433 is from 1433
rd nucleotide of CVP3A27 eDNA), API and AP2 were used 
described as in the 3'RACE-PCR. PCR contains primers at 20 pmol each, a mixture 
of  elongase, and each dNTP at 2.5 mM per reaction. PCR cycle parameters include 
initial  denaturation  (3  min,  94°C,  1  cycle),  40  cycles  of  a 
denaturation/annealing/extension  (94°C,  30sec/ 64°C,  30  secI72°C,  3  min),  and 
final  extension  at  72°C  for  30  min.  PCR  was  performed  on  a  Robocycler 
(Strategene, La Jolla, CA). 133 
Table 5.  1. Design of the RACE PCR primers.  For the PCR amplification of the 
CYP3A  form  in  rainbow trout,  primers were  designed  based on the  amino  acid 
sequence alignments of 17 CYP3A forms that were obtained from GenBank. From 
the consensus amino acid sequence shown by rectangle boxes, nucleotide primers 
were deduced based on trout CYP3A27 cDNA. 
Access 
Gene  (source)  Amino  acid residues in selected area 
number 
For  5'  RACE  For  3'  RACE 
419a------------428a 
CYP3A27  (trout)  U96007  F  K 

CYP3A12  (dog)  X54915  F  K 

CYP3A8  (monkey)  853047  F  L 

CYP3A4  (human)  M18907  F  L 

CYP3A4  (human)  X12387  F  L 

CYP3A9  (rat)  U46118  F  R 

CYP3A24  (sheep)  U59378  F  R 

Cyp3a13  (mouse)  X63023  F  R 

CYP3A6  (rabbit)  J05034  F  R 

CYP3A5  (human)  J04813  F  R 

CYP3A7  (human)  D00418  F  L 

Cyp3a25  (mouse)  Y11995  F  C 

CYP3A6  (rabbit)  M19139  F  R  
CYP3Al  (rat)  Ml0161  F  R 

CYP3A23  (rat)  D13912  F  R 

CYP3All  (mouse)  X60452  F  Q 

YP3A2  (rat)  M13643  F  H  
P  E  R  F  8  KEN 
P  E  R  F  8  K  E  N 
P  E  R  F  8  K  KN 
P  E  R  F  8  K KN 
P  E  R  F  8  K  KN 
P  E  R  F  8  K  KN 
P  E  R  F  8  K  KN 
P  E  R  F  8  K  KN 
P  E  R  F  S  K  KN 
P  E  R  F  S  K  K  K 
P  E  R  F  S  K  KN 
P  E  R  F  S  KEN 
P  E  R  F  S  KKN 
P  E  R  F  S  K  E  N 
P  E  R  F  S  K  E  N 
P  E  R  F  S  K  E  N 
P  E  R  F  S  K  E  N 
Consensus  amino  acid sequence:  R  V  D 
269
a  -----------278
a 
RVDFLQL 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
RMD  F  L  Q  L 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
R  L  D  F  L  Q  L 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
RVD  F  L  Q  L 
F  L  Q  L  M 
I  D 
I  N 
I  D 
I  D 
I  D 
I  N 
I  N 
I  N 
I  N 
I  D 
I  D 
MN 
I  N 
MN 
MN 
MN 
L  N 
3'  RACE  PCR  primer  (s954)b:  5'  -CGG  GTG  GAT  TTC  TTA  CAG  CTG  ATG-3' 
Consensus  amino  acid sequence:  N  E  K  S  F  R  E  P 
5' RACE  PCR  primer  (a1433) c:  5'- GTT  CTC  CTT  ACT  GAA  CCG  CTC  TGG-3' 
a The position of amino acids is from the amino acid sequence of trout CYP3A27 
protein.  b  In  3'  RACE-PCR  primer,  's'  indicates  sense  strand  and  954  is  the 
position of nucleotide in CYP3A27 cDNA.  C In 5' RACE PCR primer, 'a' means 
antisense strand and 1433 is the same as described in 3' RACE-PCR primer. 134 
Cloning and Sequencing of cDNAs 
The amplified DNA fragments were cloned into the T  A Cloning vector and 
sequenced  by  using  automatic  DNA  sequencer  (ABI  PRISM  Model  377)  with 
fluorescence dye-labeled dideoxynucleotides. The identified nucleotide sequences 
were compared with those of the previously cloned CYP3A27. After confirming a 
new CYP3A form, the end information of nucleotide sequence was used as priming 
sites for a full length cDNA by using API  and AP2 (nested PCR) primers. Thus, a 
set of primers contains  3' end specific primer and  AP I  and  AP2.  Since adapter 
ligation reactions could  generate  a chimera form  between cDNA  fragments,  the 
sequenced  full-length  cDNA  was  verified  by  RT-PCR  by  using  a  set  of gene 
specific primers. 
RT-PCR was carried out by using a cDNA pool prepared from intestinal 
ceca without adapter ligation reaction as a PCR template. Gene specific primers 
obtained from RACE-PCR sequences are as follows, where 'a' indicates antisense 
direction and the number are from the position of  CYP3A45 nucleotide sequence: 
a2592, 5'-GTGTGATGATTITA  TTGGTTTGTGATG-3'; a2553, 5'  -CCAAGCAG 
CTCGTGGGATCATCT-3', sl, 5'-GAGCAACGGTCGTIAGTCGAG-3'; 
slO, 5'-CGTIAGTCGAGATCTACCACG-3'. First PCR was done with a pair of 
a2592 and sl and the nested peR was done a set of  sID and a2553 with the same 
thermal cycling parameters ofRACE-PCR except annealing temperature 55°C for 
30 sec. The amplified DNA size and sequence data from RT-PCR verified a new 
CYP3A cDNA from intestinal ceca. 
Northern blot analysis 
Total  RNA  from  tissues  was  extracted  by  usmg  TRI  Reagent  and 
quantitated as described by Cok et ai.,  1998. Northern blotting was carried out as 135 
described previously (Lee et al., 1998). Six  J..lg of total cellular RNA per lane were 
separated on 0.8% agarose gel. After separation, RNA was capillary transferred to a 
charged nylon membrane  (Hybond-N+)  and then membranes  were  prehybridized 
with  Quickhyb  hybridization  solution  (Stratagene,  La  Jolla,  CA).  CYP3A45 
specific  probe  (820  bp)  was  obtained  by  PCR  amplification 
(sI734:5'ACCCTAGAGCACCCCACC-3';  a25535'­
ACCAAGCAGCTCGTGGGATCATCT-3'). Probe labeling was from Stratagene's 
Prim-it II random prime method with [a)2P]dCTP. Hybridization was carried out 
for  2  hr  at  68°C  with  labeled  3 'untranslated  region  of  CYP3A45.  After 
hybridization,  membranes  were  washed twice  with  2X  SSC/O.1 %  SDS  at  room 
temperature for  15  min,  washed twice with O.1X  SSC/0.1% SDS  at 50°C  for  15 
min  (IX SSC  solution  contains  150  mM  sodium  chloride  and  15  mM  sodium 
citrate). The washed membrane was exposed to  X-ray film (XAR 5,  Kodak).  The 
quantitative values of the pixels were normalized with the internal standard.  The 
18S ribosomal RNA was used as an internal standard which was detected by a ['Y-
32P]dATP-Iabeled  universal  15-mer  oligonucleotide  (Buhler  et  al.,  1994). 
Quantitation of Northern blots was  carried out using  a Personal  Densitometer SI 
(PDSI-PC, Molecular Dynamics, Sunnyvale). 
Constructions of  Expression vector and recombinant baculovirus 
CYP3A45 cDNA (1.8 kb) containing an open reading frame  was  isolated 
by EeoR I digestion of  the pCR 2.1-TOPO cloning vector and ligated into e~astBac 
expression vector through EeoR I sites. The recircularized pFast Bac plasmid was 
used  to  transform  DH5a  E.coli~ competent  cells  and  colonies  containing  the 
correctly  oriented  recombinant  construct  (PFastBAc-~A45) were  identified  with 
restriction analysis. The recombinant donor pFastBac  ~ec.tQr containing CYP3A45 
cDNA  placed  under  the  polyhedrin  prorhoteii  was  transformed  into  DBIOBac 
,competent cells that  con~~-~~"'b~~~i~-D;:J~ and  the helper plasmid.- ~~~  ;i~~ 
~"'-""",~~-:l:~:::.":"~,"_"'''''''''_  .<'  - ......- ...-;:--~~---------_.,~= 136 
specific  transposition  of apFastBac-3A15  fragment  into  the  bacmid  DNA,  a 
b.aculovirus...shuttle..lleCtor, was obtained  ~y transposigg  a{Ti~i~i~~~.Jro~ 
pFastBac-3A45  donor plasmid to  the Jnini-attTn7  attaclurie-l)t  site on the  bacmid 
"'"  ',.  '"'~'''  •• "  ~r.~  ~  __  -_  •• :._ 
when the Tn7 transpositi()ll: functions were provided by a helper plasmid. CQlonies 
containing ;~~:c~~bin~t~~,:~,~j"~_~~~;~Wwere identified ~L<!~~~p!i_;E_ ~ii~~ 
lacZa gene. Before isolating the recombinant bacmid DNA, the candidate colonies 
wk'"l::t:- -:~ 
-_·were  streaked  in  the  presence  of X-gal  to  ensure  they  were  truly  white.  The 
orientation of isolated Bv-3A45 was confirmed with the size ofPCR product (2-kb) 
by  using  a  set  of  CYP3A45  specific  primer  (reverse  pnmer:  5' 
CCAGGTCTCAGCGGAGAAGTATGG-3') and  a M13/pUC forward primer (5'­
TGT AAAACGACGGCCAGT-3') which exist near the insertion sites on bacmid 
DNA. A set of CYP3A45 specific primers were also used to verify 700-bp of PCR 
product  (forward:  5'-ACTTCCATCTGAATGGTGAG-3'and  reverse  primer:  5'­
AGTATCTATCTCCTCCTGCA-3 '). 
Expression of CYP3A45 protein in insect cells 
The  expression  of CYP3A45  protein  in  insect  cells  was  carried  out  as 
described previously (Lee et ai., 200la). Briefly, Sf9 cells (lx10
6cells/ml) in 2ml of 
Sf-900  SFM  containing  penicillin/streptomycin  at  0.5X  final  concentration  (50 
units/ml penicillin, 50 Ilglml streptomycin) were seeded into the flat bottomed cell 
wells in the incubator at 27°C for 2 hr to allow cells to attach. Attached Sf9 cells 
were  transfected with the  3  Ilg  of Bv-3A45  via Cell  FECTIN  Reagent  without 
antibiotic. After 5 hr of  infection, the transfection mixture was removed and Sf-900 
SFM containing 50 Ilglml ampicillin (total volume  1.5  ml) was added for 72  hrs. 
The  supernatant  solution  was  collected  at  72  hr  post-transfection  and  the 
recombinant baculovirus was amplified in the prepared Sf9 cells at 2 x10
6cells/ml 
for  5  days  twice  as  described  earlier  (Lee  and  Buhler,  2001a).  The  high 137 
concentrated Bv-3A45 supernatant was harvested and used for CYP3A45 protein 
expression. Sf9 insect cells were maintained in Sf-90011 SFM containing 50 Ilglml 
ampicillin to a density of 2x10
6 cells/ml. The amplified Bv-3A45 at a multiplicity 
of  infection (m.o.i.) of  about 1 plaque-forming units per cell (1  ml Bv-3A45 to 9 ml 
cells (v/v) ratio) was used to  infect cell cultures.  After 24 hr infection,  1  Ilg/ml 
hemin was added to compensate for low endogenous levels of heme in insect cells 
(Gonzalez  et  aI.,  1991).  Infections  were  allowed  for  24  to  96  hr.  Cells  were 
harvested,  washed  twice  with  cold  phosphate-buffered  saline  (PBS),  and 
homogenized with 15-20 strokes in a tightly fitting glass Dounce homogenizer in 
buffer (0.1  M potassium phosphate buffer, pH 7.4,  1 mM EDTA, 1 mM DTT, 0.1 
mM PMSF, 20 % glycerol). The celllysates were centrifugated at 100,000g for 90 
min to separate membrane fractions from soluble fraction. The membrane fraction 
was resuspended in the P450 buffer (0.1  M potassium phosphate buffer, pH 7.4, 20 
%  glycerol) and stored at -80°C until use.  CYP3A45  protein was verified with 
Western blotting. Total P450 content was measured by CO difference spectrometry 
at time differently collected samples (Omura and Sato, 1964). 
Western blot analysis 
Proteins  (20  Ilg  per  lane)  from  cell  lysate  were  separated  on  7.5% 
polyacrylamide gels containing sodium dodecyl sulfate (SDS). The proteins were 
electro-transferred to Immobilon-P membranes and the membranes were blocked 
with 2% BSA in 10 mM Tris:HCI, pH 7.4 including 0.9% NaCI (TBS). Rabbit anti­
rainbow trout LMC5 IgG (Miranda et al., 1989) was used as a primary antibody (20 
~g IgG in 100 ml TBS containing 2% BSA and 0.05% Tween 20) for 1 hr.  [125  1]­
labeled protein A  (20  ~Ci in  100 ml TBS-T) was used as a secondary antibody. 
After washing with TBSrr, the immunoreactive protein bands were visualized by 
autoradiography on Kodak X-OMAT film. The bands on X-ray film were scanned 138 
by using a ScanJet 4C scanner (Hewlett-Packard) and presented with Power Point 
software (Microsoft). 139 
Results 
Construction of RACE - PCR template 
Three  microgram  of mRNA  was  obtained  by  twice  oligo  d(T)  reSIn 
selections from total 495  ~g  RNA isolated from intestinal ceca tissue (592 mg). As 
a control, the same amount of  human placental mRNA provided by a kit (Clontech) 
was  used  as  the  starting  material.  One  microgram  of the  messenger  RNA 
population  was  reverse  transcribed  to  a  cDNA  (-)  strand  primed  by  oligod(T) 
residues.  The  secondary strand was created by  a mixture of Rnase H and  E.  coli 
DNA  polymerase.  The  cDNA  ends  were  filled  with  T4  DNA  polymerase,  and 
ligated with adapter primers (Fig. 5. 2). Before performing the RACE reactions, the 
integrity of adapter ligated cDNA library (template) was tested by  various ways, 
such as asymmetric PCR,  a pair of known gene  specific primers from  CYP3A27 
and  transferin  receptor,  and  different  dilutions  of template.  Since  API  primer 
binding site can only be generated by extension of  the gene-specific primer (GSP), 
there was no amplification in an API PCR (asymmetric PCR). Two sets of  primers 
designed  from  CYP3A27  cDNA  and  transferin  receptor  sequence  resulted  in 
expected bands (data not shown), suggesting that adapter ligated cDNA population 
can proceed for RACE-PCR. 
RACE -PCR and sequence analysis 
The optimal template was detennined to one microliter use out of 10 times 
diluted  template  per  PCR  reaction.  Next,  a  gene-specific  amplification  was 
perfonned in 5' and  3' directions,  depending  on  single  GSP  specificity.  The  5' 
RACE-PCR didn't generate the expected size (more than 1.4 kb) in amplifications, 
suggesting weak specificity  of annealing.  Actually,  it  was  found  after  complete 
sequencing of CYP3A45 that the designed 5'GSP was not specific with CYP3A45 140 
Figure 5. 2. The Scheme of  RACE- PCR for CYP3A45 cDNA cloning 
The  poly(At obtained  from  the  intestinal  ceca  used  for  the  first  strand  cDNA 
synthesis primed with cDNA synthesis primer by AMV reverse transcriptase. The 
first-strand synthesis reaction was used immediately for the second-strand synthesis 
by using  an enzyme mixture of E.coli DNA polymerase, E.coli DNA ligase, and 
E. coli RnaseH. The assembly of 17  CYP3A family  nucleotide sequences showed 
high  sequence  homology regions  across  species  and  those  sharing  regions  were 
selected  for  primer sites  based on formerly  cloned  trout CYP3A27  cDNA.  The 
PCR  amplified  DNA  fragments  were  sequenced  by  using  automatic  DNA 
sequencer (ABI PRISM Model 377). After confirming a new CYP3A form, the end 
information of nucleotide  sequence  was  used  for  priming  sites  for  a  full-length 
cDNA.  The  amplified  full-length  cDNA  was  subcloned,  sequenced,  and  again 
checked by RT-PCR. RT-PCR contains a set of gene specific primers and a cDNA 
pool prepared from intestinal ceca mRNA which has no adaptor ligation. •  • 
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mRNAs from intestinal Ceca 
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RT-PCR by a pair of  gene specific primers • 142 
cDNA. However, 3'RACE-PCR generated multiple bands in expected sizes (over 1 
kb).  All of amplified bands were  cloned,  sequenced,  and compared with fonner 
CYP3A27 cDNA.  One of sequenced fragments (1.7kb) was a new gene fragment 
and provided 3'end sequence infonnation as well as high homology with CYP3A27 
cDNA. The continuous PCR with a new 3'GSP and API as a first round PCR, and 
then nested primers of  a nested 3'GSP and AP 2 resulted in around a 2.5 kb ofPCR 
product.  This  DNA  fragment  was  gel  purified,  subcloned  into  a  TOPO  cloning 
vector,  and  completely  sequenced.  The  scheme  of RACE-PCR  in  cloning  of 
CYP3A45 from trout intestinal ceca was described in Fig. 5. 2. 
Confirmation of cloning by RT-PCR 
During adapter ligations, there may be the possibility of unwanted ligations 
between  cDNA fragments,  resulting  in chimera fonns.  Therefore,  RT-PCR was 
perfonned to avoid this possibility. RT-PCR product was obtained as expected 2.5­
kb size DNA (data not shown) and the nucleotide sequence of PCR product was 
verified by DNA sequencing, showing the  same  nucleotide  sequence of RACE­
PCR product. 
Sequence analysis of CVP3A45 cDNA 
On the  basis  of its  nucleotide  and  amino  acid  sequences,  the  identified 
cDNA  was  assigned  CYP3A45  by  the  P450  Nomenclature  Committee.  The 
obtained 2615-bp cDNA contained an open reading frame of 1554-bp encoding for 
a 518 amino acid protein (Mr=59057.13, PI= 6.15) with 26 amino acid differences 
from  the previously  cloned rainbow trout CYP3A27 (Fig.  5.  3).  The  CYP3A45 
cDNA contained a 3' flanking region of 91O-bp,  a 5' flanking  region of 150-bp, 
and a putative polyadenylation signal, AAT  AAA.  Comparison of the amino acid 143 
Fig. 5. 3. Nucleotide and deduced amino acid sequences ofrainbow trout CYP3A45. 
The initial ATG start codon is single underlined and the stop codon has an asterisk. 
The putative heme binding domain,  residues  439  to  454 amino  acids,  is  double 
underlined. The shaded amino acids indicate different amino acids from CYP3A27 
protein. The polyadenylate signal, AA  T  AAA, is indicated by box. 144 
GAGCAACGGTCGTTAGTCGAGATCTACCACGTCACAGAAGAACCACACTAGAACCGGGCAGACCCAACTCAAAGGAAAG  79 
AACCTGTCAGACCATCGGAGAAGTGAATTCGAACGAGCCTTTGTTTTGAGAAGCAGCAGGGTGCCGAACCGG  151 
ATG  ATG AGT  TTT  CTG  CCA  TAC  TTC  TCC  GCT  GAG  ACC  TGG  ACC  CTC  CTG  GCC  CTC  CTC  ATC  211 
M  M  S  F  L  P  Y  S  F  A  E  T  W  T  L  L  ALL  I  20 
ACC  CTC  ATT  GTA  GTG  TAC  GGG  TAC  TGG  CCC  TAT  GGT  GTA  TTC  ACT  AAG  ATG  GGT  ATC  CCT  271 
T  L  I  V  V  Y  G  Y  W  P  Y  G  V  F  T  K  M  G  I  P  40 
GGT  CCC  AAA  CCC  CTA  CCT  TAC  TTT  GGC  ACA  ATG  TTG  GAG  TAT  AAA  AAG  GGC  ATC  ACT  AAC  331 
G  P  K  P  L  P  Y  F  G  T  M  LEY  K  K  G  I  T  N  60 
TTT  GAC  ACA  GAG  TGC  TTT  CAG  AAG  TAC  GGG  AAA  ATC  TGG  GGG  ATC  TAT  GAT  GGG  AGG  CAG  391 
F  D  T  E  C  F  Q  K  Y  G  I  W  G  I  Y  D  G  R  Q  80 
CCT  GTT  CTG  TGT  ATC  ATG  GAC  AAA  AGC  ATA  ATC  AAG  ACC  GTC  CTG  ATT  AAA  GAG  TGT  TAC  451 
P  V  L  C  I  M  D  K  S  I  I  K  T  V  L  IKE  C  Y  100 
AAC  ATC  TTC  ACC  AAC  CGC  AGG  GAC  TTC  CAT  CTG  AAT  GGT  GAG  ATG  TTT  GAT  GCG  TTG  TCC  511 
N  I  F  T  N  R  R  F  H  LNG  E  B  FDA  L  S  120 
GTT  GTC  GAG  GAC  GAT  GCA  TGG  AGA  CGG  ATC  CGC  AGT  GTC  CTC  TCA  CCT  TCC  TTT  ACC  TCT  571 
V  ;  E  D  D  I  W  R  R  IRS  V  L  S  P  S  F  T  S  140 
GGA  CGA  CTG  AAA  GAG  ATG  TTT  GGT  ATC  ATG  AAG  CAG  CAC  TCT  GCT  AAC  CTG  CTG  AAC  GGA  631 
G  R  L  K  EMF  G  I  M  K  Q  H  S  L  L  B  G  160 
ATG  AAG  AAG  CAG  GCA  GAT  AAA  GAC  CAG  ACC  ATC  GAA  GTG  AAG  GAG  TTC  TTT  GGG  CCC  TAC  691 
M  K  K  Q  A  D  K  D  Q  TIE  V  KEF  F  G  P  Y  180 
AGT  ATG  GAC  GTG  GTC  ACC  AGC  ACA  GCC  TTC  AGT  GTG  GAC  ATT  GAC  TCT  CTG  AAC  AAC  CCT  751 
S  M  D  V  V  T  S  T  A  F  S  V  DID  S  L  N  N  P  200 
TCA  GAC  CCC  TTC  GTC  TCC  AAC  GTC  AAG  AAG  ATG  GTC  AAG  TTT  GAC  CTT  TTA  AAC  CCA  CTG  811 
S  D  P  F  V  S  N  V  K  K  M  K  F  D  L  ~  N  P  L  220 
TTC  CTC  CTA  GTC  GCT  TTG  TTT  CCC  TTC  ACT  GGT  CCT  ATC  TTG  GAG  AAG  ATG  AAG  TTT  TCT  871 
F  L  L  V  A  L  F  P  F  T  G  P  I  L  E  K  M  K  F  S  240 
TTC  TTC  CCG  ACT  GCG  GTG  TTG  GAC  TTC  TTT  TAC  GCC  TCG  CTG  ATT  AAG  ATC  AAA  TCT  GGA  931 
F  F  PTA  V  G  D  F  F  Y  A  S  L  K  I  K  S  G  260 
CGT  GAC  ACT  GGG  AAC  TCA  ACT  AAT  CGG  GTG  GAT  TTC  TTA  CAG  CTG  ATG  ATC  GAC  TCT  CAG  991 
R  D  T  G  N  S  T  N  R  V  D  F  L  Q  L  MID  S  Q  280 
AAA  GGC  AGT  GAC  ACA  AAG  ACA  GGA  GAG  GAA  CAG  ACT  AAA  GGA  CTG  ACT  GAT  CAT  GAG  ATC  1051 
K  G  S  D  T  K  T  GEE  Q  T  K  G  LTD  H  E  I  300 
TTG  TCT  CAG  GCC  ATG  ATC  TTC  ATC  TTC  GCC  GGC  TAC  GAG  ACC  AGC  AGC  AGT  ACT  ATG  AGT  1111 
L  S  Q  A  M  I  F  I  FAG  YET  S  SST  M  S  320 
TTC  CTG  GCC  TAT  AAC  TTG  GCA  ACC  AAC  CAC  CAT  GTC  ATG  ACC  AAA  CTG  CAG  GAG  GAG  ATA  1171 

F  LAY  N  L  A  T  N  H  H  V  M  T  K  L  Q  EEl  340 

GAT  ACT  GTG  TTC  CCC  AAC  AAG  GCT  CCA  ATC  CAG  TAC  GAA  GCT  CTG  ATG  CAG  ATG  GAC  TAT  1231 

D  T  V  F  P  N  K  A  P  I  Q  YEA  L  M  Q  M  D  Y  360 

TTG  GAC  TGT  GTG  TTG  AAC  GGG  TCT  CTG  AGA  CTG  TAC  CCC  GTC  GCC  CCG  CGA  CTG  GAG  AGG  1291 

L  D  C  V  L  N  &  S  L  R  L  Y  PAP  R  L  E  R  380 

GTC  GCC  AAG  AAG  ACG  GTG  GAG  ATC  AAC  GGC  ATC  GTC  ATC  CCC  AAA  GAC  TGC  GTT  GTC  CTG  1351 
V  A  K  K  T  V  E  I  N  G  I  V  I  P  K  D  C  V  L  400 
GTT  CCC  ACG  TGG  GCC  CTC  CAC  CGT  GAC  CCA  GAG  ATC  TGG  TCT  GAC  CCT  GAG  GAG  TTC  AAA  1411 
V  P  T  W  I  L  H  R  D  PEl  W  S  D  PEE  F  K  420 
CCG  GAG  AGG  TTC  AGT  AAG  GAG  AAC  AAG  GAG  CCT  ATT  GAT  CCG  TAC  ACG  TAC  ATG  CCA  TTT  1471 
PER  F  S  KEN  K  E  I  I  D  P  Y  T  Y  M  ~  440 
GGG  GCG  GGG  CCC  AGG  AAC  TGT  ATC  GGG  ATG  CGC  TTC  GCC  ATG  ATA  ATG  ATG  AAA  CTG  GCC  1531 
GAG  P  R  N  C  I  G  M  R  F  A  I  I  M  I  K  L  A  460 
ATG  GTC  GAG  ATC  CTC  CAG  AGT  TTC  ACT  TTC  TCC  GTC  TGC  GAC  GAG  ACC  GAG  ATC  CCT  TTG  1591 
M  V  ElL  Q  S  F  T  F  S  V  C  D  E  TEl  P  L  480 
GAG  ATT  GAC  AAC  CAG  GGT  TTG  CTG  ATG  CCA  AAA  CGA  CCA  ATC  AAA  CTG  AGG  CTG  GAG  CCC  1651 
E  I  D  N  Q  G  L  L  M  P  K  R  P  I  K  L  R  LEI  500 
CGT  AAC  AAC  ACC  CTT  AGC  AAC  ACC  ACC  GCC  ACC  TCT  CTG  AAG  AGT  CCA  ACA  ACG  TGA  1708 
R  I  N  Tis  N  T  TAT  ILK  S  P  T  T  •  518 
CCAAATGCAGGAGCACCCCACCCTACCCTAGAGCACCCCACCCTACCCTAGAGCCCCCCACCCTACCCTACCCTGGAGAACC  1790 
CTACCATATACAGTGGGGCAAAAAAGTATTTAGTCAGCCACCAATTGTGCAAGTTCTCCCAATTAAAAAGACGAGAAGCCTG  187 2 
TAATTTTCATCATAGGTACACTTCAACTATGACAGACAAAATGAGAAAAAAATCCAGAAAATCACATTGTAGGTTTTTTATG  1954 
AATTTATTTGCAAATGGTGGTGGAAAATAAGTATTTGGTCACCTACAAACAAGCAAGATTTCTGGCTCTCACAGACCTGTAA  2036 
CTTCTTCTTTAAGAGGCTCCTCTGTCCTCCACTCGTTACCTGTATTAATGGCACCTGTTTGAACTTGTTATCAGTATAAAAG  2118 
ACAACTGTCCACAACCTCAAACAGTCACACACACAATGAATGTTCAAGTTCAGTCAGTTCAATCAGAAATTACATTTAAAAT  2200 
GGCACATAGCTTACAAAGCGCTGGATTGAATGCTGGTCTCAGTCTCATGCTTGGTTTGAGTAGGACTCAAAAACCCATTTCC  2282 
ACCAGATAAAAGAGAGATAGTAATCCTATAAATGCATTAGAGGACATGTCTTGTTAAAGTTAGACACCAGGGGGTATTAAAT  2364 
CCATGGCATGATGTCATGTCTGGATCCTGCACACTACTGGCTGGGGCTGGAATTCTCCTAGAATGTAGAACTCTAGCTGGTG  2446 
TTCTCTAGAACTGTACTCTCATTCTGTTCCTCTGGGTGTTCTGCTGTCCATTCATTCCAAAATATAATCTTTACTGTCTGTT  2528 
GAGATGATCCCTGCAGCTGCTTGGTTTTAACTTTAATCATCACAAAC~TCATCACACTAATGTAAAAAAAAAAAA 2610 
AAAAA  2615 145 
sequences of the probable heme-binding domain of trout CYP3A27, residues 439 
to  453,  with  CYP3A45  showed  a complete  match,  suggesting highly  conserved 
amino acids with P450 functions. The N-tenninalleucine-rich region was observed 
in  CYP3A45  amino  acid  sequence,  which  has  been proposed to  be  involved  in 
membrane  recognition  and  binding  (Black,  1992).  The  deduced  amino  acid 
sequence of  rainbow trout CYP3A45 was 88% identical with trout CYP3A27, 68% 
with killifish CYP3A30, 55% with chicken CYP3A37,  53% with dog  CYP3AI2, 
and 52% with human CYP3A4 in positional alignment comparisons. 
Transcriptional expression of CYP3A45 
Northern blotting was carried out to investigate the expression of  CYP3A45 
at  the  transcriptional  level  by using  CYP3A45  specific  probe  which  contains  a 
different region from that of CYP3A27 cDNA at the C-tenninal region and the 3' 
untranslated region of CYP3A45 (Fig.  5.  4). There was no cross-reaction between 
in  vitro  prepared CYP3A27 RNA  and the  CYP3A45  probe (Fig.  5.  4A,  lane  1). 
Strong  expressions of around 2.7  kb  bands  were  found  in  entire  gastrointestinal 
tract,  including intestinal  ceca, proximal descending  intestine,  and  intestine  near 
vent.  However very faint bands were  found  in the liver of both male  and female 
fish. Internal standard probed with 1406R (Buhler et aI., 1994) was 18S rRNA (Fig. 
5.  4B).  The  net  sample  readings  were  obtained  after  corrections  with  internal 
standard  values  and  background  subtraction  and  then  presented  in  Fig.  5.4C. 
Whereas the strong expression site for CYP3A27 was in male liver and intestinal 
ceca (Lee et aI.,  1998), the present results suggest that the major expression site for 
CYP3A45 could be in intestinal tissues. 146 
Fig. 5. 4. Northern blot analysis of  liver and gastrointestinal tract CYP3A45 mRNA 
of2-year old rainbow trout. (A) Total RNA 6 Ilg was loaded in each lane. 
Lane  1,  in vitro transcribed CYP3A27 RNA  100  pg;  lane 2 and  8 intestine near 
vent; lane 3 and 9, proximal descending intestine;  lane 4 and 10,  intestinal ceca; 
lane 5 and 11, cardiac stomach; lane 6 and 12, liver; lane 7 and 13, muscle. (8) A 
blot of the  188 rRNA was used as  an internal standard shown at the bottom. (C) 
The densities in pixel reading ofthe samples were corrected for the background and 
average net pixel reading from 188 bands. 147 
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Recombinant baculovirus construction 
The construction of recombinant baculovirus containing CYP3A45  cDNA 
was carried out as described earlier and under material methods (Lee and Buhler, 
2001b). Briefly, The constructed Bv-CYP3A45 colonies were selected with white 
color, verified with PCR. The expected 2 kb size of PCR product was obtained by 
using a set of  CYP3A45 specific primer and a M13/pUC forward (primer sequence 
was described in material and method), suggesting the right insertion of CYP3A45 
cDNA under the polyhedrin promoter (data not shown). A set of  CYP3A45 specific 
primers  aimed  at  a  700  bp  PCR  product  (primer  sequence  were  shown  in  the 
material  and  method)  was  obtained to  double  verify  the  insertion of CYP3A45 
cDNA in the baculovirus genome (data not shown). The constructed Bv-CYP3A45 
was  transfected  into  insect cells  via CELLFECTIN  reagent  as  described  earlier 
(Lee and Buhler, 200Ib). After amplification of Bv-CYP3A45  in insect cells, the 
expression of CYP3A27 protein from  four  different candidates was  screened by 
Western blotting with LMC5 polyclonal antibodies after 72 hr post-infection. 
Western blot analysis and protein expression of CYP3A45 in insect cells 
The protein of membrane fraction obtained from  Bv-3A45  infected insect 
cells  was  analyzed  on  SDS-PAGE.  The  expressed  CYP3A45  protein  from 
baculovirus system had the same mobility as the purified LMC5  P450 form  from 
trout  liver  microsome  (estimated  Mr  =  59000  on  SDS-PAGE)  (Fig.  5.  5), 
suggesting that it is a structurally CYP3A related protein. 
The  selected  virus  (Bv-3A27)  was  scaled  up  to  get  a  large  amount  of 
CYP3A45  protein, and optimized with exogenous  1  ~g hemin Iml addition.  The 
expression of CYP3A45 protein was increased with infection time and cells were 149 
Fig. 5. 5. Immunoblot of  rainbow trout  CYP3A45 protein produced by 
recombinant baculovirus containing CYP3A45 cDNA in SF9 cells at different 
infection times. Twenty  Ilg protein was loaded in each lane. Lane 1, purified 
LMC5 protein 100 fmol; lane 2, SF9 cells without infection~ lane 3, Molecular 
marker; lane 4,96 hr infection; lane 5, 72 hr infection; lane 6, 48 hr infection. o 
l£)  ....... 
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routinely monitored during infection (0  hr-96 hr).  With  increased infection time, 
cell staining with trypan blue dye (0.4% in PBS) was increased to over 90% at 96 
hr post-infection, which was observed in other infections with baculovirus systems 
such  as  trout  CYP3A27  (Lee  and  Buhler,  2{)0Ia)  and  zebrafish  CYP2K6  (in 
preparation). The spectrally active CYP3A45 was obtained with 30-50% staining at 
72  hr  post-infection.  Although  the  strong  CYP3A45  protein  was  detected  by 
Western blot analysis, the level of spectrally active form  at 450 nm was very low 
around 187 pmol/mg total protein, and major peak found was found at 420nm (data 
not shown). 152 
Discussion 
The cDNA cloning of CYP3A45  was perfonned according to  the  strategy 
shown in Fig. 5.2. The successful RACE-PCR was obtained from 3' RACE-PCR 
but not from 5' RACE-PCR. Although there was an identical amino acid sequence 
region in 5'GSP design, the codon usage between CYP3A27 and CYP3A45 in that 
region  was  different  in  the  3'direction of 3'GSP  primer that  may  explain  why 
5'RACE-PCR didn't produce  the  expected  PCR  amplification.  RT-PCR  clearly 
showed  a  single  band  around  2.5  kb  (data  not  shown)  and  the  nucleotide 
sequencing of this  DNA  verified  a new  CYP3A  fonn.  Nucleotide  and  deduced 
amino  acid  sequences  are  shown  in  Fig.  5.  3.  The  BLAST  search  indicated 
homologous  regions  throughout  P450  family  and  more  specifically  in  CYP3A 
subfamily.  This  clone  consisted  of 2615  nt,  including  the  poly(A)  signal,  and 
contained  an  open  reading  frame  encoding  518  amino  acids.  Compared  with 
CYP3A27, deduced CYP3A45 protein sequence showed 26 amino acid differences 
and  88%  amino  acid  sequence homology.  There  was  no  amino  acid  lacking  or 
addition in the translation product between CYP3A27 and CYP3A45, resulting in 
an  identical  518  amino  acid  length.  In  the  comparison  of cDNAs  between 
CYP3A27  and  CYP3A45,  there  were  121  nt differences  in  1802  bp  alignment. 
There was a lot of CT-repeats in the 3' untranslated region of CYP3A27 cDNA 
(Lee et al., 1998) but the CYP3A45 didn't contain the CT repeats in corresponding 
area, providing a CYP3A45 specific nucleotide probe. 
CYP3A4  is  the  most  abundantly  expressed  fonn  in  human  liver  and 
intestine (Guengerich, 1994; Kolars, et aI.,  1994). CYP3A5 is weakly expressed in 
human liver but found in entire gastrointestinal tract and a major fonn in stomach 
(Kolars,  et aI.,  1994).  In rats, CYP3A23  is the major expressed fonn in the liver 
(Komori and Oda, 1994) and CYP3A9-like fonn has been reported to a major fonn 
in the gastrointestinal tract (Gushchin et aI.,  1999). In the previous study, the level 
of CYP3A27 mRNA was highest in intestinal ceca and liver (Lee et al.,  1998) by 153 
using  a  full  length of CYP3A27  cDNA  as  a probe.  The  expression  patterns  of 
CYP3A27  were  decreased  distally  from  strong  expression  of intestinal  ceca  to 
weak expression in the vent region (Lee et aI., 1998; Lee et al., 2001) similar to that 
reported in mammals. The transcriptional level of CYP3A45 mRNA was examined 
by  Northern  blotting  in trout  intestinal  tract  and  liver.  Loading  controls  were 
performed using 18S rRNA to normalize the data (Fig. 5. 4A and B). The strongly 
hybridized  bands  at  around  2.7  kb  were  found  in  intestinal  ceca,  proximal 
descending intestine,  and intestine near vent in both male  and  female.  But,  very 
weak bands were detected in liver, cardiac stomach, and pyloric stomach in both 
male and female examined. No visible bands were detected in muscle in both sexes. 
Former Northern blot data probed with full-length CYP3A27 cDNA indicated that 
intestinal ceca and proximal descending intestine were major expression sites (Lee 
et al.,  2001).  However,  another Northern blot (Lee et aI.,  1998) probed with the 
same  probe showed  strong  expression  in  both intestinal  ceca  and  liver  in  male 
examined. The present Northern data was conducted by the same RNA used in Lee 
et aI.  (2001) to  get  direct comparisons  in  these  fish.  In  the  comparison of data 
between two Northern blots, there was a major different expression between liver 
and  intestinal  tract.  In  the  present  study,  Northern  blot  probed  with  CYP3A45 
specific  nucleotide  showed  strong  expression  in  intestinal  ceca,  proximal 
descending intestine,  and intestine  near vent but  very  faint  bands were  obtained 
from livers in both male and female examined (Fig. 5. 4C). The portion of CYP3A 
mRNAs in total tissue would be high in the intestine tissues because in addition to 
P450  metabolism,  liver has  more  biochemical  metabolism  and  protein synthesis 
than  those  of intestine  tissues  do.  The  collective  comparisons  suggest  that 
CYP3A45 could be an intestinal specific form especially in rainbow trout. 
The catalytic  activity of cytochrome  P450  3A4  is  important in issues  of 
steroid and xenobiotic metabolism induding human drugs. Several issues remain to 
be  solved regarding the functional  expression through heterologous systems,  the 
need  for  cytochrome  b5,  divalent  cations,  and  acidic  phospholipid  systems  for 154 
optimal activity (Guengerich,  1999). In the present study, trout CYP3A45 protein 
was heterologously expressed in insect cells by recombinant baculovirus containing 
CYP3A45  open  reading  frame  as  described  in  Lee  and  Buhler  (2001a).  The 
expressed CYP3A45 protein was analyzed on SDS-PAGE probed by rabbit anti­
LMC5 IgG (Miranda et aI., 1989) (Fig.5. 5). The expressed CYP3A45 protein from 
baculovirus  system showed the same electrophoretic mobility as  purified LMC5 
P450  form  from  trout  liver microsome (estimated Mr  =  59000  on  SDS-PAGE), 
suggesting that it is structurally CYP3A related protein. The membrane fraction of 
insect cells infected with recombinant baculovirus containing CYP3A45 showed a 
peak at 450 nm at CO difference spectra (data not shown). Although the expression 
level was very high in Western blotting analysis, the CYP content measured by CO 
different spectrum was small (187 pmollmg total protein) compared to  CYP3A27 
and  CYP2K6  that  showed  714  pmol  and  around  1.5  nmollmg  total  protein, 
respectively (Lee and Buhler, 2001a; in preparation). 
The  present study  reports  a  new  CYP3A  form,  CYP3A45,  cloned  from 
rainbow trout intestinal ceca. The results established different tissue expression of 
two CYP3A forms,  CYP3A27 and CYP3A45, in transcription levels.  More work 
needs  to  be  carried  out  to  determine  precisely  this  transcriptional  different 
expression in other tissues and the role of  CYP3A45 in cellular metabolism. 155 
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Chapter 6 
Conclusion 
Study in this thesis focuses on the molecular cloning of  rainbow trout 
CYP3A  forms  and  the  characterization  of  their  functional  properties  as  a 
contribution  to  basic  information  on trout  CYP  systems  as  well  as  to  provide 
comparative data that  may  be  useful  for  human  health.  To achieve  these  goals, 
isolation of CYP3A cDNAs, tissue distribution, cellular localization, and catalytic 
properties were investigated. The obtained results were compared with information 
on mammalian CYP3A isoforms. 
Screening of trout  adult and  embryo  liver cDNA  libraries  constructed  in 
Agtll  and  Agt22A,  respectively,  resulted  in  the  cloning  of the  first  CYP3A 
subfamily member from aquatic species. This CYP3A form,  named CYP3A27 by 
the P450 Nomenclature Committee, contains an open reading frame  coding for a 
protein of 518 amino acids and a calculated molecular weight of 59,206 Da (PI = 
6.39). In comparisons between species by positional alignment, the deduced amino 
acid sequence of rainbow trout  CYP3A27  was  54  to  56  % identical  with dog, 
monkey, human, rat, and sheep CYP3A forms. Marked differences in sex, age, and 
tissue expression of CYP3A27 in rainbow trout were observed at the mRNA level 
as shown by Northern blots. The major extrahepatic expression site for CYP3A27 
was intestinal ceca. Southern blot analysis demonstrated that multiple CYP3A27­
related genes exist in rainbow trout. 
In mammals, the cytochrome P450 3A subfamily is primarily expressed in 
liver  and  intestine  with  lesser  amounts  found  in  other  tissues.  To  examine  the 
cellular localization and the expression pattern of CYP3A27 in the rainbow trout 
gastrointestinal tract (GI-tract), an immunohistochemical (IH) study together with 157 
supporting Northern and  Western  blotting  was  carried out.  The  most  intense  IH 
staining for CYP3A27 protein was  in the liver and the intestinal ceca of the  01-
tract.  IH  staining  intensity  was  fairly  high  in  the  enterocytes  of the  proximal 
descending  intestine  but  then  decreased  distally  along  the  OI-tract  with  little 
staining observed in the  vent area.  The  results of CYP3A27 mRNA and protein 
analysis  by Northern and  Western blotting were  in good agreement with the  IH 
observations.  These  data  indicated  that  the  expression  patterns  of CYP3A27  is 
quite similar to that of mammals and confirmed that the rainbow trout possesses the 
potential  capacity  for  intestinal  CYP3A27  catalyzed  first-pass  metabolism  of 
xenobiotics  which  makes  the  trout  an  excellent  system  in  which  to  study  the 
consequence of  such metabolism. 
In many animal species, the intestine and liver are responsible for the first­
pass metabolism of  a wide range of  xenobiotics. In order to learn about the catalytic 
properties of  CYP3A27, a heterologous gene expression system was used as source 
of large scale production of functional protein. The cDNA-directed expression of 
CYP3A27  in  baculovirus  system  in  insect  cells  yielded  a  functional  CYP3A27 
protein (714 pmoVmg total protein) that showed maximum CO-reduced spectrum 
at 448  nm.  In  Western blot analysis the expressed CYP3A27 protein comigrated 
with  the  purified  LMC5  P450  and  was  recognized  by  anti-P450  LMC5  IgO. 
CYP3A27  expressed  in  insect  cells  showed  catalytic  activities  for  the  6(3­
hydroxylation  of progesterone,  the  dehydrogenation  of  nifedipine,  the  16(3­
hydroxylation of testosterone, and the 6f3-hydroxylation of testosterone that are the 
characteristics  of mammalian  CYP3A  forms.  These  results  demonstrated  that 
rainbow trout CYP3A27 has the capacity to metabolize steroid hormones and may 
have  a role  in first-pass  metabolism  of xenobiotics  as  reported  for  mammalian 
CYP3A forms. 
A  cDNA encoding a  new CYP3A  subfamily  member  was  isolated  from 
rainbow trout intestinal ceca by RT-PCR,  followed  by RACE-peR. The isolated 158 
cDNA was assigned CYP3A45 by the P450 Nomenclature Committee. This 2615­
bp cDNA contained an open reading frame  coding for  a 518  amino acid residue 
protein  with  26  amino  acid  differences  when  compared  with  CYP3A27.  The 
deduced amino acid sequence of rainbow trout CYP3A45 was 88% identical with 
trout CYP3A27, 68% with killifish CYP3A30, and 55% to 52% with chicken, dog, 
and human CYP3A forms  in positional alignment comparisons. Northern blotting 
probed by a CYP3A45 specific nucleotide showed that major expression site was in 
the intestinal ceca and the proximal descending intestine rather than liver in both 
male  and  female  trout.  Recombinant baculovirus  containing a CYP3A45  cDNA 
was constructed to express CYP3A45 protein in Spodoptera frugiperda (Sf9) cells. 
The expressed CYP3A45  protein comigrated with purified LMC5  P450 and was 
recognized  by  LMC5  polyclonal  antibodies  in  Western  blot  analysis. 
Heterologously  expressed  CYP3A45  protein  showed  a  peak  at  450nm  in  CO 
difference  spectrum  analysis.  Further  research  needs  to  be  done  to  know  its 
metabolic function. 
In mammals, cDNAs of  CYP3A subfamily have been reported 1 to 5 forms 
per each species.  Together with Southern and  Northern blot analysis, the  author 
suggests that rainbow trout contains more than one CYP3A forms. Two of  CYP3A 
forms  in  rainbow  trout  were  cloned  in  this  study.  The  information  of their 
nucleotide  sequences,  sex  and  age  differential  expression,  and  tissue  specific 
distribution would help to gain a better understanding of  the trout cytochrome P450 
systems. 
Cytochrome  P4503A  enzymes  are  capable  of metabolizing  a  number  of 
diverse chemical substances. However, the broad specificity is accompanied by low 
substrate turnover numbers compared to  other P450s.  Furthermore, in  fish,  there 
are lower P450 catalytic activities compared to  mammals and  less  information is 
available  regarding  CYP3A  forms.  In  this  study,  heterologous  gene  expression 159 
system for the large amount of functional CYP3A forms provides a basis for better 
future understanding ofthe teleost CYP3A system. 
The regulation of CYP3A expression has  been an  important  subject  in 
mammals  and  fish.  It was  reported  that  CYP3A  expressions  are  affected  by 
endocrine disrupting chemicals and steroids. An understanding of the regulation of 
trout CYP3A forms would be helpful in aquatic toxicology and would lead to the 
increased attention to water pollution issues. 160 
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